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CHAPTER 1.  INTRODUCTION 
General Introduction   
Fluorescence spectroscopy has been widely used in the study of the structure and 
dynamics of molecules in complex systems.1-4  Steady-state and time-resolved fluorescence 
methods are commonly used to characterize emissive properties of fluorophores.  Time-
resolved fluorescence measurements are generally more informative about the molecular 
environment of the fluorophore than steady-state fluorescence measurements because the 
competing or perturbing kinetic processes such as collisional quenching, solvent relaxation, 
energy transfer, and rotational reorientation, which affect the fluorescence, occur on the 
timescale of the flurophore’s lifetime (10−9 s).  Thus, time-resolved fluorescence 
spectroscopy can be used to quantify these processes and gain insight into the chemical 
surroundings of the fluorophore.  This thesis discusses a range of complex systems and 
phenomena that may fruitfully be examined by means of fluorescesence spectroscopy, in 
particular: steady-state fluorescence, fluorescence quenching, fluorescence lifetime, time-
resolved fluorescence anisotropy, fluorescence resonance energy transfer (FRET), and 
excited-state solvation dynamics.  
Low Density Lipoprotein 
Lipoproteins are complex aggregates of lipids and proteins that render the lipids 
compatible with the aqueous environment of body fluids and enable their transport 
throughout the body.5  In general lipoprotein is composed of an outer shell of phospholipid, 
which renders the particle soluble in water; a core of fats called lipid, including cholesterol 
and a surface apoprotein molecule that allows cells to recognize and take up the particle.  
Lipoproteins are characterized by their density and classified into five main groups based on 
 2 
different ratio of protein to lipids as chylomicrons (CM), very low density lipoproteins 
(VLDL), intermediate density lipoproteins (IDL), low density lipoproteins (LDL) and high-
density lipoproteins (HDL).5  
Cholesterol is a building block of the outer layer of cells (cell membranes), and is 
transported through the blood as lipoprotein.  LDL is the main carrier of cholesterol in the 
human circulatory system.  It can be viewed as a spherical particle (diameter ~ 22 nm)6 
(Figure 1.1) containing three different regions—the outer surface layer, the core region and 
an interfacial region between these two.6,7  The surface monolayer mainly consists of 
phospholipid molecules and a single molecule of the protein, apoB-100 (one of the largest 
monomeric proteins known) which consists of 4536 amino acid residues.  There are 37 
tryptophans among 4536 residues.6,7  Apo-B100 acts like a belt that surrounds the LDL and 
interacts with both the lipids of the LDL and with the aqueous environment as it is 
amphipathic in nature.  The core of LDL is enriched with triglycerides and cholesteryl esters.  
A large LDL particle carries ~3000 lipid molecules.  The interfacial layer consists of 
interpenetrating core and surface lipids.  
In photodynamic therapy (PDT), a photosensitizing (dye molecule) agent acts against 
malignant tumors under the influence of light.  Lipoproteins and serum albumin are the main 
carriers for the photosensitizers. It has been demonstrated that hydrophobic photosensitizers 
are carried in blood by LDLs and hydrophilic photosensitizers are largely carried by albumin 
and globulin.8  After intravenous injection of a hydrophobic photosentizers, they are carried 
and accumulated to tumor cells because the hyperproliferating cells require an extra supply 
of cholesterol and phospholipids.9  Efficient transport and subsequent specific localization of 
photosensitizer in the body for PDT, requires detail studies on the interaction of LDL and 
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photosensitizer. 
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Figure 1.1.  Schematic diagram of LDL particle.  The surface monolayer mainly consists of 
phospholipids and the protein, apoB-100.  The core of LDL is enriched with triglycerides 
(TGs) and cholesteryl esters (CEs).  The interfacial layer consists of interpenetrating core and 
surface lipids.  The diameter of a LDL particle is ~ 22 nm, including a surface monolayer ~ 2 
nm. 
 
Hypericin 
 
Hypericin (Figure 1.2) is a naturally occurring perylene quinone pigment obtained 
from plants of the genus Hypericum.10  It is particularly the major component of the botanical 
dietary supplement, St. John’s Wort (Hypericum perforatum).  It displays virucidal activity 
against several types of viruses including the human immunodeficiency virus (HlV), as well 
as antiproliferative and cytotoxic effects on tumor cells.11-21  It has been argured that the light 
is not necessary for its antiviral activity, but is enhanced in the presence of light.16,17,22-24  
Excited state properties of hypericin have been extensively studied in order to understand the 
role of light on its biological activities.25-30  Several mechanisms have been proposed for the 
photodynamic action of hypericin including the two most common and well-known 
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mechanisms, type I and type II.  Several reactive species such as superoxide radial anion 
( O2
−), hydroxyl radical ( •OH ), as well as hypercin radicals and radical ions are involved in 
type I mechanism.14,31,32  In type II oxygen-dependent photosensitization mechanism, 
hypericin generates singlet oxygen (1O2) via energy transfer from triplet state of hypercin to 
ground triplet state of oxygen.21,33  Petrich and coworkers34,35 suggest an alternative origin of 
photo-induced virucidal activity that involves light-induced acidification through proton 
transfer in the excited state of hyepricin, which is likely to precede solvent acidification. 
 
Figure 1.2.  Structure of Hypericin.        
Previous work from our group36,37 shows that hypericin strongly interacts and forms 
rigid complex with proteins such as human serum albumin (HSA) and two different isoforms 
of glutathione S-transferase (GST), HA1-1 and HP1-1.  Kascakova et al.38 reports hypericin 
binding to LDL and conclude that multiple hypericins interact with LDL.  Hypericin exists as 
aggregates in aqueous physiological solution.  The photodynamic actions of hypericin are 
greatly diminished when it is aggregated.39  Binding with biological macromolecules helps 
hypericin to solubilize in its monomeric form, which is believed to be important for virucidal 
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action.39-41  This lipophilic molecule interacts mainly with LDL and to a lesser extent with 
HSA upon its incorporation in the blood. Several studies have shown that photosensitizers 
mixed with LDL before administration leads to an increase in photodynamic efficiency in 
comparison with the administration of photosensitizers alone.42-45  It is important to study the 
interaction of hypericin with LDL in physiological condition for efficient use as 
photodynamic drug.  More specifically, how many monomeric hypercins exist in a LDL 
molecule?  Where do they bind (surface or core of LDL)?  And how strong the binding is?  
Previous binding study of hypercin with LDL by steady-state fluorescence 
spectroscopy showed quenching of tryptophan fluorescence emission from Apo B-100 in 
LDL with increase in hypericin concentration.38  This observation prompted the authors to 
conclude that the hypericin molecules reside somewhere near the apoB-100 part of the LDL, 
and based on these observations, they proposed that hypericin accumulates at the interfacial 
region of the LDL molecule—i.e. between the surface and the core regions.  In chapter 3 we 
continue the investigation of the location of hypericin in LDL by exploiting steady-state 
fluorescence quenching, fluorescence resonance energy transfer (FRET) and time-resolved 
fluorescence anisotropy measurements.  These techniques are discussed in chapter 2.  Our 
results indicate that multiple hypericins can penetrate considerably deeply into the LDL 
molecule and up to ~20 nonaggregated hypericin molecules can exist in LDL.  The 
accommodation of multiple hypericins in LDL should not be surprising considering the 
diameter of LDL (~220 Å).  The very inefficient quenching and single exponential rotational 
correlation time (~ 10.3 ns) of hypericin in 1:1 LDL:Hyp complex suggest that a single 
hypericin is rigidly held, and thus probably resides fairly deeply in LDL.  Energy transfer 
from the tryptophans to hypericin is efficient, suggesting that hypericin can be moderately 
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close to the surface, where apoB-100 is located.  All results collectively indicate that 
hypericin lies in an intermediate location between surface and core—i.e. the interfacial 
region.  
Micelles  
Surfactants belong to a class of molecules with surface-active properties.  The 
surfactant molecule consists of two parts, namely, a polar head group (water-liking or 
hydrophilic) and a non-polar hydrophobic tail (water-hating or hydrophobic).46  The 
surfactant may be anionic, cationic, zwitterionic or non-ionic depending on the charge 
characteristics of the head group.47  When surfactants are dissolved in water at low 
concentration, they accumulate at the surface and orient themselves in such a way so that the 
polar head groups interact with the water and the hydrophobic regions are removed from the 
aqueous environment.  In this arrangement at the surface, the surfactants disrupt the cohesive 
forces of water molecules at the surface and thus lower the surface tension.  At the Critical 
Micelle Concentration (CMC), the surface becomes completely loaded with surfactant and 
any further additions of surfactants form aggregates in which the hydrophobic portions are 
oriented within the cluster and the hydrophilic portions are exposed to the water.  Such 
aggregates are called micelles.48-50  The fundamental reason for micelle formation is the 
attainment of a minimum free energy state.  The enthalpy change (∆H) of micelles formation 
is very small.  The primary driving force is the increase of entropy (∆S) that occurs when the 
hydrophobic regions of the surfactant are removed from water and the ordered structure of 
the water molecules around this region of the molecule is lost.51  The average form of a 
micelle is often spherical because a spherical shape produces the minimum surface area-to-
volume ratio.  However, other geometries such as ellipsoids extended tubes are also possible.      
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The structure of a micelle formed by ionic surfactants (Figure 1.3a) is generally 
described by three regions: the core, the Stern layer, and the Gouy-Chapman double layer.52  
The core is composed of the hydrocarbon chains of the surfactant molecule.  The core is 
surrounded by a concentric shell consisting hydrophilic head groups together with (1−α)N 
counterions (α is the degree of ionization and N is the aggregation number) and considerable 
number of water molecules, known as Stern layer.  The rest of the counterions (αN) require 
to neutralize the charge on the kinetic micelle are bound to the micelles surrounding the Stern 
layer as diffuse Gouy–Chapman double layer.  For most ionic micelles the degree of 
ionization α is between 0.2 and 0.3; that is, 70–80% of the couterions are considered to be in 
the Gouy-Chapman double layer.51  However micelles formed by non-ionic surfactants 
consist of a hydrophobic core formed from the hydrocarbon chains of the surfactant 
molecules surrounded by a shell, known as palisade layer.  The palisade layer is composed of 
the oxyethylene chains of the surfactant, which is heavily hydrated.  Triton X-100 (TX-100), 
cetyl trimethyl ammonium bromide (CTAB) and sodium dodecyl sulfate (SDS) are 
commonly used non-ionic, cationic and anionic surfactant, respectively.  These surfactants 
form nearly spherical micelle in water above CMC.  The CMC values for TX-100, CTAB 
and SDS are 0.23 mM, 0.9 mM and 8 mM, respectively.  Each micelle contains 100-150 
surfactant molecules with a radius of ~50 Å for TX and CTAB and 30 Å for SDS.53  Studies 
show that the palisade layer is ~ 25 Å thick while the Stern layers of CTAB and SDS are 
quite thins ~ 6–9 Å.53-56  The palisade layer is mainly composed of the oxyethylene units 
containing a large number of water molecules around these groups and the water molecules 
are hydrogen bonded, either among themselves or with the head groups of the surfactant 
molecules. 
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Figure 1.3.  Diagrammatic representation of cross section of an anionic (a) normal micelle 
and (b) a reverse micelle, showing charged layers.  The core of the normal micelle consists of 
the hydrocarbon tails of the surfactant molecules.  The Stern layer consists of the head 
groups, bound counterions and significant amount of water.  The Gouy-Chapman region is a 
diffuse double layer containing unbound counterions.  The core of reverse micelle is 
composed of the hydrophilic groups around the nanometer-sized water droplet surrounded by 
a shell of the hydrocarbon chains. 
 
 Reverse micelles (Figure 1.3b) are formed when an amount of water and surfactants 
are dissolved in non-polar organic solvent.57  It has a core composed of the hydrophilic 
 9 
groups around the nanometer-sized water droplet surrounded by a shell of the hydrocarbon 
chains.  The tiny water droplets trapped at the core of reverse micelle is known as water pool.  
One typical value used to characterize the reverse micelle is the ratio of water to surfactant, 
often described by w0=[H2O]/[Surfactant].  If the reverse micelle is spherical, the radius of 
the water pool is directly proportional to w0.58  Thus w0 controls the size of the droplets and 
can be tuned from few nanometers to several tens of nanometers (nm).  Surfactants able to 
form reverse micelles can also be anionic, cationic, zwitterionic and nonionic.  The most 
widely used reverse micelle is that formed by water, an alkane, and the anionic surfactant 
dioctyl sodium sulphosuccinate, better known as AOT (Aerosol-OT).59  The water inside the 
reverse micelle is different from bulk water, such as a structural change in the hydrogen-
bonded network occurs and the scenario changes when w0 is varied.60   
PRODAN   
 
6-Propionyl-2-(N,N-dimethylamino)naphthalene (PRODAN) (Figure 1.4) is a highly 
fluorescent, hydrophobic molecule, first synthesized and characterized by Weber and Farris 
in 1979.61    PRODAN is a push-pull, charge-transfer chromophore that produces a 
substantial change in its excited-state dipole moment upon photoexcitation owing to the 
presence of an electron-donating dimethylamino group and electron-withdrawing propionyl 
group connected to the aromatic spacer by a single bond.  Its absorption and emission spectra 
are strongly dependent upon the polarity of its environment.61  PRODAN has a single broad 
emission spectrum with a dramatic solvatochromatic shift (~130 nm) of its maximum, 
ranging from 401 nm in cyclohexane to 531 nm in water.61  The excited-state kinetics of 
PRODAN are complex, and the origins of its solvatochromatic nature have been debated.62-68  
Theoretical calculations suggest a planar structure in the ground state.  But the geometry of 
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its charge-transferred emissive state (twisted intramolecular charge transfer or planar 
intramolecular charge transfer) has not yet been confirmed.62,65-77 It is generally agreed that, 
PRODAN undergoes excited-state intramolecular charge-transfer following excitation from 
the ground state.  The charge-trasferred state, CT, is formed from an initially excited state 
referred to as the locally-excited state (LE).78  In nonpolar environments, emission is from 
the LE state, while in polar environments the emission is from the CT state.78   
It has been used as an optical probe of the function and dynamics of proteins and 
membranes.79-86  It has also been employed to study solvation dynamics in polar liquids, 
ionic liquids, and supercritical fluids.87-91 Fluorescent probes based upon the PRODAN 
chromophore, namely, DANCA 92 and Aladan 93 are also used to solvation dynamics of 
protein.  There are significant differences in the study of solvation dynamics of the same 
protein based on the nature of the fluorescent probes employed.  More specifically DANCA 
92, aniline-2-aminonaphthalene-6-dimethylsulfonamide (ANSDMA) 94, and coumarin 153 95 
were used to study the solvation response of myoglobin replacing the heme.  DANCA 
yielded a complicated solvation response with significant contributions into the nanosecond 
regime.  ANSDMA provided a single-exponential response of ~ 9 ns (although rapid 
components might have been neglected because of the time resolution of the experiment).  
Using coumarin 153 Petrich and coworkers95 showed that almost 60 %  of the solvation is 
complete within the time resolution of the experiment (300 fs) and that this initial response is 
followed by a slower one.  Most importantly, there was excellent agreement between the 
solvation correlation function, C(t) , from fluorescence upconversion experiments and those 
obtained from molecular dynamics simulations.    It is important to note that DANCA and 
ANSDMA are both capable of charge transfer in the excited state and can emit from dual 
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excited states.  However, coumarin 153 is exquisitely inert, which is one of the reasons it has 
been so extensively employed as a probe of solvation.95-107   
 
Figure 1.4.  Chemical structure of PRODAN.   
 
Recently Boxer and coworkers 108 have incorporated Aladan at different buried and 
exposed sites of the immunoglobin binding domain, B1, of protein G (GB1) and measured 
the time-dependent Stokes shift.   All the sites showed a bimodal relaxation with an inertial 
ultrafast response of ~80-140 fs followed by a much slower relaxation on the timescale of 
several picoseconds to several nanoseconds, depending upon the location of the probe.  They 
also found an interesting observation.  The time-resolved emission spectra of Aladan at fully 
and partially exposed sites of the protein showed a blue shift at long times (> 1 ns).  The 
authors suggested that this blue shift could be attributed either to different chromophore 
populations having different lifetimes and solvation dynamics or to aggregation effects.  
Aladan is a PRODAN based probe, it can emit from both LE and CT states depending upon 
the polarity of the environment.  The coexistence of different excited states with different 
properties of the same chromophores could have significant consequences for the accurate 
characterization of solvation dynamics in a heterogeneous environment, such as a protein.  If 
there is a ground-state conformational change or aggregation of the protein that can perturbs 
the environment of the chromophore in such a manner that both the excited state can exist 
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which can also lead to a blue shift in time-resolved emission spectra.  Novaira et al. 109,110 
have already reported dual fluorescence from both LE and CT of PRODAN in reverse 
micelles.  In order to resolved this discrepancy, in chapter 4 we study the contributions of LE 
and CT states of PRODAN to its solvation dynamics, in particular, in reverse micelles 
formed by sodium 1,4-bis-(2-ethylhexyl) sulfosuccinate (AOT)/n-heptane/water.  We have 
found that the LE and CT states of PRODAN solvate on different time scales and conclude 
that PRODAN’s use as a probe of heterogeneous environments must be used with caution.    
Excited-State Intramolecular Proton/Hydrogen Atom Transfer 
 Intramoleculer proton (H+) or hydrogen atom (H) transfer occurs most commonly 
within molecules containing an intramolecular hydrogen bond between the hydrogen-atom 
donor and acceptor group in the electronic ground state.111  Absorption of photon in these 
kind of molecules cause the intramolecular redistribution of electronic charge that induces 
fast reorganization of the molecular structure that involves motion of H or H+ is generally 
referred as excited-state intramolecular hydrogen atom (ESIHT) or proton transfer 
(ESIPT).112  It can be named “hydrogen atom” or “proton” transfer depending upon the 
degree of charge transfer.113  Since this process involves the transfer of a hydrogen atom over 
a small distance, it is ultrafast and occurs in the subpicosecond time scale.112,114-123  Proton or 
hydrogen atom transfer reactions are one of the simplest chemical transformations.  Despite 
the chemical simplicity, subtleties in the shapes of the relevant potential energy surfaces, 
quantum mechanical tunneling, and extremely high reaction rates have made these reactions 
difficult to understand.113,117  
 Excited-state proton transfer (ESPT) has been attracting considerable attention 
because it plays a crucial role in photochemistry and photobiology.124-130  H/D isotope effect 
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on the proton (or H-atom) transfer reaction is usually used as a probe for the existence or 
non-existence of a barrier on the potential energy surface.112  Herek et al.114 studied the 
dynamics of H-atom (and D-atom) motion in methyl salicylate (MS), and reported that both 
the process takes place within 60 fs with no isotope effect, unlike the structurally related 1-
hydroxy-2-acetonapthone (HAN), which exhibit a prominent isotope effect.  The absence of 
isotope effect in MS was attributed to a barrierless reaction.  The ESIPT reaction in 2-(2′-
hydroxyphenyl)-5-phenyloxazole (HPPO) occurs in the femtosecond time scale with a time 
constant of ~220 fs.115  Deuteration of HPPO (OH/OD) leads to a decrease in ESIPT rate by a 
factor of 4 to 6.  The isotope effect was attributed to proton tunneling.  Elsaesser and 
coworkers116 studied intramolecular proton  and deuterium transfer in the excited state of 2-
(2′-hydroxyphenyl)benzothiazole (HBT).  In nonpolar solvent, proton and deuterium transfer 
time of 160 fs and 150 fs were found, respectively.  They suggested a barrierless potential 
energy surface of the excited-state reaction with a rate determined by the period of low-
frequency vibrations of large amplitude because the measured time constants correspond to 
the period of molecular vibrations of low frequency.  Schwartz et al.117 reported a proton 
transfer time of 240 fs for 3-hydroxyflavone in methycyclohexane.  No significant changes in 
the fast ESPT dynamics upon deuteration were found.  Petrich and coworkers15,118-123 
reported ESIHT in hypericin and hyprocrellin A.  A ~ 10ps for hypercin and 10-250 ps for 
hyprocrellin A were assigned as the ESIHT time.  The 10 ps component neither in hypericin 
nor hypocrellin A exhibited a deuterium isotope effect.  Interestingly, the long-lived 
component (50-250 ps) of hypocrellin A showed an isotope effect of 1.4.  The absence of 
isotope effect in hypericin was explained in term of adiabatic limit of proton transfer where 
the vibrational energy levels of the proton stretch mode lie well above a small barrier.  The 
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similar adiabatic limit of proton transfer model was applied for hypocrellin, which leads to an 
isotope effect due to tunneling or activated crossing of the barrier when deuteration lowers 
the ground vibrational energy below the top of the barrier.123            
Curcumin 
Curcumin (Figure 1.5), 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-
dione, is a naturally occurring yellow-orange pigment derived from the rhizomes of Curcuma 
longa (turmeric).  Turmeric has been traditionally used as a spice and food coloring in Indian 
cooking and medicine.131  Its yellow color is primarily caused by a group of structurally 
related polyphenols collectively known as curcuminoids, which are composed of curcumin 
(77%), as the major bioactive component, and two of its derivatives, demethoxycurcumin 
(17%) and bismethoxycurcumun (3%).  Currently, curcumin is the subject of a large number 
of investigations in the fields of biology, medicine, and pharmacology owing to its profound 
effects on human health.  It exhibits a variety of biological and photochemical properties, 
including antioxidant, anti-inflammatory, and anticancer activity.132-136  Recently, it is also 
established that curcumin has the ability to prevent protein aggregation in debilitating 
diseases such as Alzheimer’s and Parkinson’s.137,138 
 
Figure 1.5.  Chemical structure of curcumin.  
Curcumin has great potential to be an effective photodynamic agent.139-146  In 
particular, studies have demonstrated the use of curcumin to treat melanoma.147-153  It has 
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been shown that the photodynamic action is greatly enhanced in the presence of light for 
destruction of tumor cells.144-146  Photolytically produced active oxygen species such as 
singlet oxygen, hydroxyl radical, superoxide or hydrogen peroxide are mainly suggested for 
its activity.139,140,154-158  In addition, Slobodan et al. demonstrated that H-atom transfer is a 
preferred antioxidant mechanism of curcumin by laser flash photolysis and pulse 
radiolysis.159  Currently, there is much interest in developing a detailed level of 
understanding in the photophysics and photochemistry of curcumin in order to further exploit 
its medicinal effects.  It has been proposed that the presence of a labile hydrogen as a result 
of ESIHT plays a role in the medicinal effects of other naturally occurring pigments such as 
hypericin and hypocrellin.119-121,123,160  Curcumin has two tautomeric forms, namely the β-
diketone and keto-enol.  It has been shown that curcumin exists predominantly as a keto-enol 
tautomer in a number of solvents with various polarities.161  It follows that strong 
intramolecular hydrogen bonding is present in the keto-enol tautomer of curcumin, which 
provides a favorable interaction for stabilization of this tautomeric form.  Thus, there is a 
high probability that curcumin may undergo excited state intramolecular hydrogen atom 
transfer (ESIHT) that results in partial deprotonation, which induces fragmentation to yield 
the medicinal degradation products mentioned earlier.   
In chapter 5 the excited state photophysics of curcumin is studied by means of 
ultrafast fluorescence upconversion spectroscopy.  The results show two decay components 
in the excited-state kinetics with time scales of 12-20 ps and ~100 ps in methanol and 
ethylene glycol.  The resulting prominent isotope effect in the long component upon 
deuteration indicates that curcumin undergoes ESIHT in these solvents.  The short 
component (12-20 ps) is insensitive to deuteration, and study of solvation dynamics of 
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curcumin in these solvents show that this decay component is due to solvation of excited-
state curcumin. 
Two major challenges in the application of curcumin as an effective treatment agent 
are lack of bioavailability and severely limited stability in aqueous environments.  Because of 
the low aqueous solubility, curcumin tends to aggregate and precipitate in water, limiting its 
bioavailability.162-165  In addition, curcumin undergoes rapid degradation in water and buffer 
solutions, with a reaction half-life of 9.5 minutes at pH 7.2.166  It has been demonstrated that 
the degradation is mostly due to deprotonation of curcumin, producing the degradation 
products: vanilin, ferulic acid, and feruroyl methane.166,167  It is interesting that most of these 
products have medicinal properties as well.  Previous studies have shown that encapsulation 
of curcumin in surfactant micelles and binding to proteins resolve these two major issues.162-
164  Micellar systems may potentially play an important role in leading to improved clinical 
use of curcumin.  It is established that micelle-captured curcumin is well dispersed in 
aqueous solutions, thereby increasing the bioavailability significantly.162,163,165  Moreover, 
curcumin is trapped in the regions of the micelle where the presence of free water molecules 
is relatively limited, preventing alkaline hydrolysis, which is the major mechanism for 
degradation.166,167  It is therefore plausible that association to micelles plays a considerable 
role in enabling curcumin to exhibit its medicinal characteristics.  Apart from preventing 
degradation, micelles also serve as well defined model systems for biomembranes.  It has 
been shown that a large portion of curcumin is membrane bound in a biological 
environment.168  Investigations on the behavior of curcumin in micelles may provide 
valuable insight into the properties of curcumin in biomembranes.  
It is known that intra- and intermolecular proton transfer processes are affected in 
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confined environment due to the structure, various interfaces and dynamics of the 
environment.169-172  Fleming and coworkers found nearly two to three fold increase in the rate 
of ESPT of protonated 1-aminopyrene in β-cyclodextrin as compared to bulk water.169  A 
higher basicity of water molecules in the immediate vicinity of cyclodextrin has been 
suggested.  Zewail and coworkers have also reported appreciable reduction in the ESIPT rate 
of 2-(2′-hydroxyphenyl)-4-methyloxazole from 300 fs in bulk aprotic solvents to pico and 
nanosecond timescales when encapsulated in β-cyclodextrin.170  Macanita and coworkers 
have observed two orders decrease in rate constant for deprotonation of the 4-methyl-7-
hydroxyflavylium cation (HMF) upon going from water (10-6 s range) to anionic sodium 
dodecyl sulfate (SDS) micelles (10-4 s range).171  The decrease in the rate constant was 
attributed to the preferential stabilization of the flavylium cation by the anionic micelle 
relative to the neutral anhydrobase form.  Analogous effects of SDS micelles on 
deprotonation rate constants have also been observed for the naturally occurring anthocyanin 
oenin.172 
In chapter 6 we have investigated the ESIHT of curcumin in sodium dodecyl sulfate 
(SDS), dodecyl trimethyl ammonium bromide (DTAB) and triton X-100 (TX-100), which 
are anionic, cationic and nonionic in nature, respectively.  By comparing the excited-state 
decay kinetics obtained by fluorescence upconversion spectroscopy, we show that the time 
constant of ESIHT of curcumin in these micelles ranges from 50 – 80 ps.  This slow 
component exhibits a pronounced isotope effect, producing a decay time constant of 80 – 130 
ps in the micelles, which is assigned to ESIHT.  In addition to ESIHT, a fast component of 3 
– 8 ps is also observed.  Results from the study of solvation dynamics of curcumin in the 
micellar media confirm that the faster component is due to solvation dynamics.  The ESIHT 
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rate of curcumin in the TX-100 micelle is lower than those in the other two micellar system.  
The intermolecular hydrogen bonding between curcumin and the TX-100 surfactant may 
contribute to this effect.  
Transmissible Spongiform Encephalopathy (TSE)  
Transmissible spongiform encephalopathies (TSEs) are slowly progressive, 
insidiously degenerative diseases that affect the central nervous system (CNS) of both 
humans and animals.173-176  TSEs are transmissible because they are capable of being 
transferred from one animal to another, spongiform because they create sponge-like texture 
in the brain of the affected animal and encephalopathies because they are neurodegerative 
diseases of the brain.177  TSEs are believed to be transmitted by abnormally shaped protein 
lacking nucleic acid, which are resistant to enzymatic degradation, called prion 
(proteinacious infectious particle).178  This prion protein (PrP) exists in two forms, normal 
(PrPc) and its pathological isoform (PrPres).177,178  PrPres is resistant to protease digestion. The 
PrPc becomes PrPres when the tertiary structure of PrPc changes from a normal α-helix to a 
misfolded β-pleated sheet, resulting in altered function.177,178  PrPc is expressed most 
abundantly in the CNS tissue of mammals.  Researchers believe that TSE disease is initiated 
when PrPres interact with PrPc and precipitate a shape change in the protein itself.177  The 
structural malformation of this protein alters its function and ultimately results in cell 
damage. 
Bovine spongiform encephalopathy (BSE) of cattle (“mad-cow disease”) is a fatal, 
neurodegerative transmissible spongiform encephalopathy (TSE).  In human, the new variant 
Creutzfeldt-Jakob disease (vCJD) is believed to be transmitted BSE from cattle through 
human food chain.179  BSE is infectious but not contagious because it is not excreted, thereby 
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preventing transmission from cow to cow. It can be transmitted orally, for example, spread 
through BSE contaminated food.  Clinical tests shows that prion protein, the causative agent 
of BSE, accumulates in the brain, spinal cord, eyes, tonsils, trigeminal ganglia, dorsal root 
ganglion, distal ileum of the small intestine and 3rd eyelid of the BSE affected cows.  It has 
been also shown that ruminant brain and spinal cord contain highest infectivity of prion 
protein.180,181  As the oral route of infection is most probable way of transmission of BSE to 
human, it is important to prohibit the use of BSE risk material (e.g, brain and spinal cord) of 
cattle in human food chain.182,183 
Among other animals, scrapie is the most widespread TSE affecting sheep and goats 
worldwide.  It is characterized by a gradual onset; and advanced cases show typical disease 
characteristics including unthriftiness, compulsive itching, balance and ambulatory 
abnormalities, convulsions, and eventual death.  The disease has been observed for centuries.  
Scrapie is contagious and thought to be easily spread via contact with placenta and placental 
fluids or environmental contamination.177  At present, it is incurable and the most common 
form of control is quarantine, euthanasia, and proper disposal of the carcass.  Scrapie is not 
considered to be infectious to humans.  However, there is evidence that scrapie was 
transmitted to cattle and thereby initiated the Europian “mad-cow” disease. 
Lipofuscin 
Lipofuscin is a yellow-brown, granular, heterogeneous, high-molecular weight 
intracellular complex aggregate of material that undergoes age-related progressive 
accumulation mainly in postmiotic cells, such as neurons, cardiac muscle and retinal 
epithelium.184-190  Although extensive studies have been carried out for more than a century, 
the biochemistry, formation mechanisms, fluorescence emission and composition of 
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lipofuscin are still a matter of debate and controversy.185  Even though lipofuscin can be 
produced from different types of biological materials due to different side reactions of 
essential biology, the cross linking of carbonyl-amino compound is recognized as a common 
process during their formation.185  One of the most pronounced characteristics of lipofuscin is 
its yellowish-orange autofluorescence when excited with UV or blue light.   
It is known that the amount of fluorescent lipofuscin in CNS tissue increases as a 
result of spontaneous and experimentally induced Creutzfeldt-Jakob’s disease (CJD).  
Boellaard et al. have demonstrated a relationship between lipofuscin production, a decline in 
autophagocytosis activity, and the experimental induction of CJD in mice.191  Furthermore, 
there is substantial documentation linking neurological disease produced by TSEs to eye 
damage and the accumulation of lipofuscin.191-199  
 Since lipofuscin has been characterized as highly fluorescent pigment of cell, 
fluorescence spectroscopy can be used to characterize and differentiate the autofluorescence 
from different type of tissues.  The introduction of specified risk materials (SRM), such as 
central nervous system (CNS) tissues, during the processing of foods destined for human 
consumption has become a concern because of bovine spongiform encephalopathy (BSE).  
There are no sufficiently rapid methods for detecting CNS tissue.  In chapter 7 we have 
investigated the applicability of fluorescence spectra and signal intensities from CNS (brain 
and spinal cord) and non-CNS tissues of cattle for real-time detection of SRM, brain and 
spinal cord in human food chain.  We have shown that fluorescence intensity from brain and 
spinal cord is higher than that of non-CNS tissues and small quantities of bovine spinal cord 
can be reliably detected in the presence of raw bovine skeletal muscle, fat, and vertebrae.  
There are no current methods which can detect TSE disease in live animals. Only post-
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mortem examinations and laboratory tests can confirm if the animal has been suffering from 
TSE disease.  Any technique which is capable of testing a live animal for TSE disease is of 
great interest.  CNS tissues are mostly affected by TSE disease and eye is the direct entry 
point to reach CNS tissues.  In chapter 8, we investigate the use of fluorescence signatures of 
sheep eye to identify scrapie, which we use as a model for TSEs.  Our data indicate that the 
fluorescence spectra from scrapie-positive retinas are more structured and intense compared 
to the scrapie-negative retinas.  We suggest that the eye, in particular the retina, is a useful 
tissue for noninvasive examination of some neurological pathologies such as scrapie.  
Thesis Organization 
General introductions on essential topic are discussed briefly in chapter 1.  The rest 
of this thesis is organized into the following chapters  
Chapter 2 provides basic principles and outlines of steady-state and time-resolved 
fluorescence techniques that are used throughout this thesis along with analysis of 
experimental data. 
Chapter 3 describes interaction of hypericin with biologically important macromolecule, 
low-density lipoprotein (LDL). 
Chapter 4 discusses the contributions of the locally excited (LE) and charge-transferred 
(CT) states of the fluorescent probe molecule PRODAN to its solvation dynamics in the 
heterogeneous environment. 
Chapter 5 establishes excited-state intramolecular hydrogen atom transfer (ESIHT) of the 
medicinal pigment curcumin in bulk solvent. 
Chapter 6 presents excited-state intramolecular hydrogen atom transfer (ESIHT) of the 
medicinal pigment curcumin in cationic, anionic and neutral micellar environments.  
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Chapter 7 demonstrates real-time detection of central nervous system tissues on bovine 
carcasses exploiting fluorescence signatures of the tissues. 
Chapter 8 provides the feasibility for diagnosis of transmissible spongiform 
encephalopathies (TSEs) exploiting retinal fluorescence spectra. 
Chapter 9 summarizes this thesis and discusses future work.   
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CHAPTER 2.  EXPERIMENTAL TECHNIQUES AND DATA ANALYSIS 
Overview 
Spectroscopy has made an outstanding contribution to the present state of atomic and 
molecular physics and lasers have always played an important role in this area.  Fluorescence 
spectroscopy has been widely applied for probing structure and properties molecules or 
environments in chemical and biological systems.1-3  The information on molecular structure 
and on the interaction of molecules with their surroundings may be derived in various ways 
from the absorption and fluorescence spectra generated when electromagnetic radiation 
interacts with matter.  Although steady-state techniques have always played important roles 
in fluorescence spectroscopy, a thorough knowledge of dynamical processes is of 
fundamental importance for many branches of physics, chemistry, or biology.  The 
investigation of ultrafast processes, such as electron transfer, proton transfer, energy transfer, 
rotational motion and isomerization of excited molecules of an optically pumped system 
opens the way to study in detail the dynamic properties of excited molecules.  In order to 
study these processes experimentally, one needs a high-time resolution of the instrument so 
that the resolvable minimum time interval is shorter than the time scale of the process under 
investigation.  Recent development of ultrashort mode-locked lasers that deliver intense short 
light pulses with width down to femtosecond range and of new detection techniques allow a 
very high time resolution, which has made impressive progress in the study of fast processes.  
This chapter focuses on steady-state and time-resolved florescence techniques used in the 
research described in this thesis, as well as some fundamental concepts associated with the 
physical processes being studied and the data analysis involved.      
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Fluorescence Spectrophotometer 
 A diagram of a typical fluorimeter is shown in Figure 2.1.4  It consists of a 150 W 
continuous ozone-free xenon lamp generating a continuum of visible and ultra-violet light, a 
monochromator to select the required wavelength for excitation, a sample compartment, and 
a second monochromator coupled with a photomultiplier tube (PMT) to analyze the 
fluorescence signal.  The grating in the excitation and emission monochromator can disperse 
light from 200 to 900 nm.  The entrance and exit slits of each monochromator control the 
intensity and wavelength spread (bandpass) of the light.  Illumination from the Xe-lamp is 
collected by an elliptical mirror and directed toward the entrance slit of the excitation 
monochromator.  The excitation monochromator selectively delivers a narrow band of 
wavelengths of excitation light that strikes the sample.  A portion of the incident light is 
absorbed by the sample, and some of the molecules in the sample fluoresce.  The emitted 
light enters the emission monochromator, which is positioned at 90o angle (right angle 
geometry) with respect to excitation light path in order to minimize the risk of transmitted or 
reflected incident light reaching the detector.  No monchromator is perfect and it will 
transmit some stray light, that is, light with other wavelength than targeted.  The emitted light 
is transmitted in a narrow range of centered about the specified emission wavelength and 
exits through the adjustable slits, and finally striking the detector.  The signal is amplified 
and generates a voltage that is proportional to the measured emitted intensity.  The right 
angle geometry is used when the sample is transparent.  There is geometry for collecting 
fluorescence, known as front faced geometry.  In this geometry the fluorescence is collected 
from the sample from the same surface at which the sample is illuminated by excitation light.  
The front face geometry is used primarily when the sample is opaque or solid. 
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 A fluorescence spectrum of a sample is recorded by scanning the emission 
monochromator for a constant wavelength of the excitation light (λex).  Similarly, an 
excitation spectrum is acquired by scanning the excitation monochromator at a fixed 
emission wavelength (λem).  The source light has different intensities at all wavelengths, and 
it may vary over time during each experiment or between each experiment.  This can distort 
the spectrum and corrections are necessary to get a instrument-independent spectrum.  In 
order to correct this, fluorimeter is equipped with an additional reference photodiode (PD) 
which measures a fraction of source light (~8%) separated using a beam splitter (BS) after 
the exit slit of excitation monochrommator before it enters the sample compartment.  By 
rationing the fluorescence signal to the reference signal, correction is made for variation in 
excitation light intensity as a function of wavelength.  Additionally, the transmission 
efficiency of the grating, and detection efficiency of PMT varies with wavelength.  A 
correction factor file is supplied from the company; automatically correct the response 
characteristics of grating and PMT-tube.  The correction factor γ (λ) is a number by which 
the experimental intensity (Iexp) be multiplied to get corrected intensity (Icorr).5 
)()()( exp λλγλ II corr =     (2.1)  
It is important to check if the excitation and emission monochromator are properly calibrated 
before acquiring any spectra from sample.  For this purpose, Xe-lamp and water Raman 
spectra are obtained everyday after turning on the system.  A maximum at 467.125 nm in Xe-
lamp spectrum and a maximum at 467±0.5 nm in water Raman (λex= 350 nm) confirm the 
calibration of the excitation and emission monochromator, respectively.         
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Figure 2.1.  Schematic representation of fluorescence spectrophotometer.  Xe - Xe-lamp, M - 
mirror, G - grating, BS - beam splitter, PD - photodiode and PMT - photomultiplier tube. 
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Ti:Sapphire Crystal  
The titanium sapphire, Ti:Al2O3, is the most widely used tunable solid-state laser.  
The sapphire crystal has a hexagonal structure with aluminum at the center and oxygen atoms 
at the vertices.6,7  Ti:Al2O3 crystal is grown by doping 0.1-0.5% (by weight) of Ti2O3 with 
Al2O3, where some of the Al+3 ions are replaced by Ti+3 ions. Ti+3 ion possesses only one 
electron in the 3d shell.  Crystalline field perturbs the electronic energy level of Ti+3 ion 
producing a triply degenerate 2T2 ground state and a doubly degenerate 2E excited state.  A 
schematic energy level diagram of Ti:Al2O3 is shown in Figure 2.2a.  There are no d-state 
energy level above the upper 2E level due to simplest electronic configuration (3d1) of Ti+3 
ion, eliminating the possibility of excited state absorption of the laser radiation, that is 
important for the efficiency and tunability of the laser. Ti:Al2O3 is a four level laser medium.  
At room temperature only the lowest vibrational level of 2T2 is populated as spacing between 
two vibrational energy levels is larger than kT.  Optical pumping excites the electron of Ti+3 
to (2E, νn), then relaxes quickly to the bottom of the vibronic band due collision before 
making the laser action.  Laser action happens during the transition from (2E, ν0) to (2T2, νm).  
The cycle is close by fast vibration relaxation to the (2T2, ν0).  The fluorescence lifetime is 
3.2 µs.  Strong interaction of the 3d electron with the crystal field results in the large 
equilibrium Ti-O distance for upper state compared to lower level.  This causes a wide 
separation between emission and absorption band with large width.  The absorption band 
centered at 490 nm makes it suitable for pumping with a number of sources such as argon 
laser, frequency-doubled Nd:YAG, Nd:YLF lasers.  We use frequency-doubled diode-
pumped Nd:YAG laser from Spectra Physics.  This laser provides high power (up to 10 W) 
stable pumping radiation at 532 nm in TEM00 spatial mode.  The fluorescence peaks at 780 
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nm with a 180 nm band width (FWHM).  Therefore Ti:sapphire laser output is tunable from 
675 nm to 1110 nm.  Absorption and emission spectra of Ti:sappire crystal is shown in 
Figure 2.2b.  In order to prevent accumulation of heat in the crystal, the supporting mount is 
cooled by running continuous flow water.          
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Figure 2.2.  Schematic energy level diagram of Ti:Sapphire (a).  Absorption and emission 
spectra of Ti:Sapphire crystal (b).6 
 
Optical Oscillator  
A laser consists of at least three components: a gain medium, a pump source and two 
mirrors that form an optical cavity.6,8  The pump source creates a population inversion in the 
gain medium; the gain medium amplifies light by stimulated emission and the optical cavity 
traps the light and makes them oscillate back and forth between the two mirrors.  The mirror 
R1, is fully reflective with reflectivity ~ 100% for the radiation inside the cavity, called high 
reflector.  The mirror R2 has some transmission to allow a fraction of light trapped in the 
cavity, known as output coupler.  The entire system consisting of mirrors and the gain 
medium is called optical resonator or laser oscillator (Figure 2.3).  The intensity of stimulated 
emission increases when it propagates along the cavity axis and passes through the pumped 
laser medium and reflected back through it, stimulating further emission in the same 
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direction.  This means that laser photons undergo multiple reflections within the cavity, being 
amplified at each pass through the laser medium.  If the amplification is large enough to 
overcome various losses (such as diffraction losses from the edges of the mirrors, absorption 
and scattering by the mirrors and in the laser medium etc.), a single photon can be amplified 
by several orders of magnitude to produce a huge number of coherently generated photons 
trapped inside the resonator.  
R1 R2
Pump beam
Gain medium
Output beam
 
Figure 2.3.  Schematic arrangement of a resonator.  R1 is the total reflector and R2 is the 
partial reflector (output coupler).9  
 
Let us assume that the stimulated light intensity increases from I0 to Il after traveling 
from one end mirror to the other with a cavity length of L.  Incase of no loss and a gain 
coefficient of k, Il can be expressed as10 
kL
l eII 0=       (2.2) 
If we define a single loss coefficient by γ for all the losses, then the Il can be written as  
Lk
l eII
)(
0
γ−=       (2.3) 
The final intensity after a round trip including the reflectance of two mirrors, r1 and r2, is 
given by  
Lk
l eIrrI
)(2
021
γ−=      (2.4) 
The round trip gain, G, is defined as the ratio of the intensity Il and the initial intensity I0 is 
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written as 
Lkl err
I
I
G )(221
0
γ−==      (2.5) 
If the gain in the resonant cavity is <1, the cavity will cause cessation of the oscillation.  It is 
important that the gain, G, must be ≥1 to initiate and sustain of oscillation.  The threshold 
gain coefficient kth while 1)(221 =
− Lkerr γ  is obtained from eq 2.5, and expressed as 
21
1
ln
2
1
rrL
k th += γ      (2.6) 
Laser Modes  
Lasers oscillate in both longitudinal and transverse modes.  One can observe an 
intensity distribution not only along the laser resonator axis, but also in the plane 
perpendicular to the direction of the laser beam propagation.  The origin of these modes can 
be understood when the boundary condition of the laser cavity is considered.  One boundary 
condition is that the electromagnetic field must be able to self-replicate in phase after one 
round trip of the laser cavity.  This gives rise to the longitudinal mode structure of the laser.  
For a two-mirror linear cavity of length L, the operating wavelength, λ, must satisfy  
Ln =)
2
(
λ
     (2.7) 
where the n is an positive integer, known as the mode order.  Using λν /c= , eq 2.7 yields  
L
nc
2
=ν      (2.8) 
The frequency separation ν∆ between adjacent modes ( 1=∆n ) is  
L
c
nn 21
=−=∆ + ννν      (2.9) 
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This indicates that total number of longitudinal modes depend on the spontaneous emission 
band width.  If we assume, 0λ as peak and λ∆ as half width at half height of the spontaneous 
emission band (Figure 2.4), then we can write11 
Ln o 2)(max =∆− λλ      (2.10) 
Ln o 2)(min =∆+ λλ      (2.11) 
The total numbers of modes (N) is given by 
2
0
0022
0
minmax
4
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2
λ
λ
λλλλ
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∆
≅∆−−∆+
∆−
=−=
LL
nnN    (2.12) 
where 220 λλ ∆>> .  If the stimulated emission from Ti:Sapphire laser has a band width of 
~300 nm, then a cavity of 30 cm may potentially support ~250,000 modes. 
 The second boundary condition explains the transverse nature of the laser beam.12  In 
free space, electromagnetic field falls to zero away from resonator axis.  This condition 
predicts the transverse mode structure and the observed intensity profiles of the laser output.  
The cross section the laser beam exhibits the nature of the transverse electromagnetic mode, 
TEMnm, where m and n are integers representing the number of nodes in the direction 
orthogonal to the direction of propagation beam.  If the light is propagates in the z direction, 
the x, y dependence of the beam is given by6,11,13 
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where Hm and Hn are the Hermite polynomials.  The H0 = 1 at zero order.  This leads to 
TEM00, known as the fundamental mode, which has Gaussian spatial distribution.  This is the 
most common mode in almost all the laser, and is expressed as 
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 The intensity distribution in the Gaussian beam can be written as 
2
22
0)( w
r
eIrI
−
=       (2.15) 
where r is the radius of the beam, I0 is the intensity of the beam at r = 0, and w is the radius 
of the beam at 20
−= eII . 
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Figure 2.4.  Schematic demonstration of the number of longitudinal modes.11 
Mode-Locking 
 In a free-running laser, both longitudinal and transverse mode oscillate 
simultaneously without any fixed mode-to-mode phase and amplitude relationship.6,11  We 
will assume that the laser oscillates in fundamental transverse, TEM00.  In a Ti:Sapphire laser 
cavity, there is over 100,000 longitudinal modes exist within the frequency region as long as 
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the gain remains greater that the cavity losses.  When laser operates in multi-mode regime, 
there is generally a strong competition among the modes to be amplified by the stimulated 
emission of the same atoms, molecules or ions in the gain medium.  This competition causes 
big fluctuations in the relative phases and amplitudes of the modes, resulting big fluctuation 
of the instantaneous intensity.  The purpose of mode-locking is to organize the competition 
between modes in such a way that the relative phases stay constant.  Mode-locking is a laser 
operation in which many longitudinal modes of the cavity are simultaneously forced to 
oscillate with a precise phase relation.  If the phases of multi-longitudinal modes are locked, 
then the modes constructively interfere at some point in the cavity and destructively interfere 
elsewhere, resulting in a single circulating pulse.  Each time this pulse reaches the output 
coupler, part of it escapes the laser cavity and the output thus consist of a train of pulses 
separated by the circulating time of the cavity (Figure 2.5).14 
 In order to get very short pulse, it is better to get as many longitudinal modes 
oscillating as possible with all their phases locked together in the mode-locked operation.  
The minimum pulse duration, ∆τp, is limited by the Fourier transform of the spectrum.  From 
the uncertainty principle, we get 
π
ντ
2
1
≥∆∆ p       (2.16) 
This principle indicates that to obtain very short pulses we need a wide gain bandwidth.  For 
example, the gain bandwidth of Ti:Sapphire is ~1014 Hz, and pulses as short as 10 fs can be 
produced from this laser.  This corresponds to the oscillation of millions of longitudinal 
modes oscillating.15  
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Longitudinal modes
Sum of longitudinal modes Output pulse
Total reflector Output coupler
2L 2L
L  
Figure 2.5.  In a mode-locked laser, the longitudinal cavity modes interfere constructively 
with each other at one point in the cavity because of their slightly different wavelengths, 
producing a short pulse of light, which travels around the cavity.14   
 
Let us consider that a laser is oscillating with N = 2m+1 longitudinal modes.  The 
modes can be assumed as plane wave, tieEtE ω0)( = .  The mode at the center of the gain 
bandwidth has angular frequency ω0. Above and below of this frequency, there are ± m 
additional modes with an angular frequency separation of ∆ω.  The total electric field 
resulting from N = 2m+1 modes is represented as11 
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m
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where ∆φ is the phase difference between the neighboring modes.  The summation for a 
finite series is expressed as 
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The total intensity is written as 
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If ∆φn changes with time in a random way, the resultant intensity, I(t), also changes randomly 
with time as shown in Figure 2.6a.  When ∆φn between modes is constant, the oscillator is 
mode-locked and very short pulse is obtained as a result of the interference of N 
synchronized longitudinal modes.  This situation is shown in Figure 2.6b.  
It is clear from eq 2.19, that the first maximum of the pulse at time t1, when 
01 =∆+∆ nt φω      (2.20) 
The next maximum occur at time t2 when 
πφω 22 =∆+∆ nt      (2.21) 
Subtraction of eq 2.20 from eq 2.21 yields 
πω 2)( 12 =−∆ tt      (2.22) 
The separation between two pulses, TR = t2-t1, is given by 
c
L
TR
212
=
∆
=
∆
=
νω
π
     (2.23) 
Mode-Locking Methods 
 The methods of mode-locking can be divided into two categories: active and passive 
mode-locking.  We will restrict our discussions on the passive mode-locking methods that are 
our interest.  There are two types of passive mode-locking techniques: staurable absorber 
mode-locking and Kerr-lens mode-locking.   
Saturable Absorption Mode-Locking.  Saturable absorber mode-locking is 
achieved by placing a saturable absorber (such as a dye solution or semiconductor saturable 
absorber mirror) with saturation at low light intensity and relaxation time of the upper state 
population shorter than the duration of the mode-locked pulse close to one of the end 
mirror.16-18  This method is based on intensity dependent transmission property of the 
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saturable absorber.  It allows transmission of high intensity light and absorbs low intensity 
light.  In an unlocked laser, there is random sequence of light burst as shown in Figure 2.6a.  
The most intense fluctuation preferentially suffers the lowest absorption losses and thus 
experiences the largest net gain.  It therefore grows faster than other large number of small 
intensity fluctuations which encounter larger absorption in the saturable absorber and are 
effectively suppressed.  After a few resonator round trips, the higher intense peak becomes so 
powerful that it depletes the inverted population of the active laser medium almost 
completely.  This means all the energy of the cavity is concentrated in one single pulse.  This 
is the mode-locked situation because selecting a single intensity maximum in the time 
domain is equivalent to establishing a phase relation among the longitudinal modes in 
frequency domain.    
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Figure 2.6.  Example of time behavior of the total intensity, I(t) for many longitudinal 
oscillating cavity modes in (a) free-running regime, corresponding to random phases ∆φn and 
(b) mode-locking regime, corresponding to constant ∆φn.17    
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Kerr-Lens Mode-Locking.  The field of ultrafast pulse generation has been 
revolutionized by the development of the Kerr-lens mode-locking technique.  In saturable 
absorber mode-locking method, the duration of the mode-locked pulse is limited by the 
recovery time of the saturable absorber, usually ~ 1 ps.  Pulses of much shorter duration (~ 6 
fs) can be produced using Kerr-lens mode-locking because it is based on the nonlinear 
refractive index at high intensity that arises from distortions of the atom’s electron cloud 
whose response being on the femtosecond timescale.  The optical Kerr effect is a third order, 
non-linear phenomenon that is based on the intensity-dependent refractive index change of a 
material at high-intensity electric fields.  The behavior of the refractive index under the Kerr 
effect can be described as6,11,17-19 
n(r,t) = n0 + n2I(r,t)     (2.24) 
where n0 is the linear refractive index, n2 is the nonlinear refractive index coefficient, and I is 
the instantaneous beam intensity.  A laser operate in TEM00 mode has a Gaussian intensity 
distribution, eq 2.15, is more intense in center than edges.  This means that the strong 
intensity maxima at the center of the beam will be much more strongly focused than edges, 
as velocity of light (v) through the matter is speed of light (c) divided by the refractive index 
(n) of the medium (Figure 2.7a).  If an aperture is placed at a suitable distance from the Kerr 
medium in a laser cavity so that a higher fraction of focused beam is transmitted and low 
intense (CW) part of the beam is blocked, then the Kerr medium with an aperture acts like an 
effective fast saturable absorber, which introduces low losses when instantaneous pulse 
intensity is increased and leads to mode-locking condition of the laser (Figure 2.7b).  The 
Kerr-lens mode-locking can also be achieved by making a narrower pump beam exciting the 
gain medium so that there is better overlap between the pump beam and the mode-locked 
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beam, than that of CW beam (Figure 2.7c).8  This is because pump beam exciting gain 
medium always forms an intrinsic aperture, known as soft aperture, and cavity modes that 
have the largest overlap with the excited gain medium experience the largest gain. 
Narrow
Pump
Pump
CW
Pulsed
Aperture
Mirror
Mirror
z
r
w
(a)
(b)
(c)
Crystal Low intensity
High intensity
 
Figure 2.7.  Schematic representation of (a) Kerr-lens or self-focusing, (b) hard-aperture 
mode-locking and (c) soft-aperture mode-locking.8 
 
The Kerr nonlinearity is usually not strong enough to self-start the mode-locking 
when the laser runs freely.  In order to initiate Kerr-lens mode-locking, a strong intensity 
fluctuation must be induced by perturbing the cavity.  The simplest method in our laboratory 
setup is to slightly tap one of the resonator mirrors.  Perturbation of a cavity mirrors allows 
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sweeping the frequencies of competing longitudinal modes, and produce a strong amplitude 
modulation due to mode beating.  The most intense mode-beating pulse will be strong 
enough to initiate mode-locking.  It is also noticed that our Ti:Sapphire laser runs in pulse 
regime from continuous wave output when the laser table (where the laser is mounted) is 
banged on.  The output is then comprised of very short pulses and maintains itself once it has 
been initiated.  
Group Velocity Dispersion  
We have discussed in the previous section that any pulse of light can be viewed as a 
superimposition of many waves having different frequencies.  Generally, duration of pulse is 
inversely proportional to the range of frequencies of waves that are superposed to form the 
pulse.  Electromagnetic waves of different frequencies travel with different velocities through 
a medium.  This is known as dispersion.20,21  Dispersion plays a critical role broadening an 
optical pulse while propagating through a medium as its spectral components travel with 
different velocities.  In order to understand the effect of dispersion on pulse broadening, let 
us consider a monochromatic plane optical wave is propagating in the x direction. The 
electric field can be written as 
E = E0e
i(kx−ωt )     (2.25) 
Here λπ /2=k  is known as the propagation constant.  If a pulse is composed of a number of 
this kind of waves with different ω, then the superimposed envelope or the pulse propagates 
with group velocity (vg).  The group velocity is defined as 
dk
d
vg
ω
= , whereas the carrier 
waves propagate with v p =
ω
k
, known as phase velocity.  If the refractive index of the 
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medium, n, depends on ω, then k is expressed as 
k(ω) =
ωn(ω)
c
     (2.26) 
When an optical pulse propagates through a medium with refractive index n(ω), its time 
profile will change because the group velocity with which pulse moves, shows dispersion 
dvg
dω
=
dvg
dk
dω
dk
=
1
vg
d2ω
dk 2
    (2.27) 
If 
d2ω
dk 2
≠ 0, different frequency components of the pulse face different velocities, and change 
the shape of the pulse during traveling through the medium.  The quantity, 
d 2k
dω 2
, is a 
measure of variation of the group velocity with frequency and, is defined as group velocity 
dispersion (GVD), β.  It is expressed in term of ω and λ as22 
β =
d2k
dω 2
=
1
c
2
dn
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+ ω
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dω 2
 
 
 
 
 
 =
λ3
2πc 2
d2n
dλ2
   (2.28) 
where ω = 2πc/λ.  In order to analyze the effect of dispersion, let us consider the phase (φ) 
shift with frequency.  When a pulse passes through a medium of length L, the time delay 
produced by the medium is 
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The phase of a wave passing through a material of length L is characterized by the refractive 
index of the medium, and is given by 
φ(ω) =
ωn(ω)
c
L = k(ω)L     (2.30) 
The phase, φ(ω) can be expanded in a Taylor series6,11 around the center frequency ω0 of the 
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pulse spectrum assuming the phase varies slowly with frequency as 
φ(ω) = φ(ω0) + ′ φ (ω −ω0) +
1
2
′ ′ φ (ω −ω0)
2 + ...  (2.31) 
where ′ φ =
∂φ
∂ω
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is the group delay dispersion 
(GDD).  A Gaussian pulse with center frequency ω0 and width (FWHM) τ0 is represented 
by13,23 
E in (t) = E0e
−
2 ln 2t 2
τ 0
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    (2.32) 
This pulse after passing through a material of length L and adding the phase delay on its 
components according to eq 2.31 is represented by 
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By comparing eqs 2.32 and 2.33, it can be shown that the pulse width broaden as13,23,24 
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Prism Pair 
 In a Ti:Sapphire oscillator a pulse travels back and forth through the Ti:Sapphire 
crystal and receives slight chirp for each round-trip due to GVD.  The pulse broadening by 
the Ti:Sapphire crystal is caused by the positive GVD (β >0),  which means longer 
wavelengths travel faster than shorter ones.  In order to obtain the shortest possible pulses 
from the laser cavity, the overall GVD has to be minimized by using optical components that 
intentionally produce negative GVD (β <0).  In our Ti:Sapphire oscillator, we use the prism 
pair to minimize GVD.  The glass material in prism itself produces positive dispersion but 
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the arrangement of the two prisms (P1 and P2) is such that it creates a longer path through the 
prism material for red wavelengths compared to blue, and introduces a negative GVD (Figure 
2.8).22,25  The chirped pulse enters the P1 and spatially dispersed.  The blue wavelengths bend 
more than red after P1 because the red components of the pulse travel faster through the 
prism material than blue component and therefore experience less refraction.  The red 
components are delayed with respect to blue components by having traversed more glass of 
P2.  A high reflecting mirror is placed after P2 in order to double pass through the prism pairs.  
The degree of negative GDV can be tuned by changing the distance between the two prisms, 
L, or the distance d, as it change the optical path difference between red and blue 
components. 
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Figure 2.8.  A prism pair arrangement for group velocity dispersion (GVD) compensation.22 
 
Ti:Sapphire Oscillator 
 Ti:Sapphire oscillator is a Kerr-lens mode-locked laser that produces femtosecond 
pulses.  The design of our oscillator is shown in Figure 2.9, and is based on the design by 
Murnane and coworkers.26  The cavity consists of two curve mirrors (M1, M2), three flat 
 56 
mirrors (M3, M4 and OC), a Ti:sapphire rod, and a pair of intracavity prisms (P1 and P2).  
Ti:Sapphire crystal is the lasing medium, which is cut at the Brewster angle to minimize the 
losses.  The oscillator is pumped with 5 W power at 532 nm of a diode-pumped frequency-
doubled Nd:YAG CW laser from Spectra Physics, Millennia. A lens (L) is used to focus the 
pump beam inside the crystal collinearly with the laser axis.  Two curve mirrors are placed in 
such a way so that it can form a telescope with the crystal in the focal plane in order to 
achieve the Kerr-lens effect.  The prisms used in this laser are made of fused silica and cut to 
an apex angle (69°) such that the angle of incidence corresponds to the Brewster angle at 
minimum deviation.  The prism pair is used to compensate for the dispersion introduced in 
the crystal.  The spectrum is dispersed by the first prism (P1), collimated by the second prism 
(P2) and redirected by high reflector (M4) back into the resonator.  The Ti:Sapphire emits in 
the range from 675 to 1110 nm but the laser operates most effectively at ~ 800 nm.  Tuning 
in this laser is accomplished by placing an adjustable slit in front of the high reflector where 
the beam is spectrally and spatially dispersed.  The slit is oriented vertically, and translated 
horizontally to adjust the wavelength.  The cavity is asymmetric, i.e., the side with the 
dispersion-compensating prisms is longer than the other arm of the laser.  The asymmetric 
cavity arrangement is critical for operating the laser in high-power TEM00 mode-locked 
mode.  Total length of this cavity is 170 cm, corresponding to a pulse repetition rate of 88 
MHz.  The output from the oscillator is obtained from the end mirror with transmission of 
10% at ~ 790 nm, known as output coupler (OC), situated opposite to the dispersion-
compensating prisms side.  The average output power is ~500 mW depending upon the 
alignment.  In order to initiate mode-locking, we first align the laser for maximum power in a 
continuous mode of operation.  Then a slight tap on one of the curved mirrors initiates the 
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mode-locking, with a TEM00 pulsed mode.  
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Figure 2.9.  Schematic diagram of Ti:Sapphire oscillator.  M – mirror, L – lens, C – crystal, 
P – prism, OC – output coupler.  
 
Second Harmonic Generation and Sum Frequency Mixing 
 Nonlinear optical phenomena arise owing to the inability of the induced dipoles in the 
medium to respond in a linear fashion to the alternating electric field E associated with a light 
beam.21  When light wave propagates through a medium, the alternating electric field E 
produces a change in the spatial and temporal electric charge distribution mainly to outer 
electron cloud of atom’s in the material, resulting an induced dipole whose macroscopic 
manifestation is known as induced polarization.  The oscillation of the induced dipoles in 
response to weak electric field is small, and the polarization is proportional to the electric 
field E.  However, as the strength of the electric field increases, the proportionality begins to 
fail, resulting a nonlinear response of the material in the presence of strong electric field.    
The magnitude of induced polarization per unit volume P of a material is dependent 
on the magnitude of the applied electric field E.21,27  In the presence of weak electric field, 
the linear polarization P1, is represented by P1 = ε0χ
(1)E , where ε0 is the permittivity of free 
space and χ(1) is the linear susceptibility representing linear response of the material.  But 
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when the electric field is very strong, P is no longer linear and can be expanded as a power 
series of E  
P = P1
+
+ P2 + P3 + ... = ε0χ
(1)E + ε0χ
(2)E 2 + ε0χ
(3)E 3 + ...  (2.35) 
Let us assume that two oscillating electric fields of frequencies ω1 and ω2 incident upon a 
material.  The total field can be written as8 
E(t) = E1e
−iω1t + E1
*e iω1t( )+ E2e− iω2t + E2*e iω2t( )  (2.36) 
The second order nonlinear polarization ( 2)2(02 EP χε= ) can be expressed as
8  
P2 = ε0χ
(2)[E1
2e− i(2ω1 )t + (E1
*)2e− i(2ω1 )t + E2
2e− i(2ω2 )t + (E1
*)2e−i(2ω2 )t + 2E1E1
* + 2E2E2
*
+2E1E2e
−i(ω1 +ω2 )t + 2E1
*E2
*e− i(ω1 +ω2 )t + 2E1E2e
−i(ω1 −ω2 )t + 2E1
*E2
*e− i(ω1 −ω2 )t ]
 (2.37) 
The results include frequencies that are exactly twice the frequency of the fundamental 
waves, 2ω1 and 2ω2.  It is obvious that if the two waves have the same frequency of ω, then 
an output at 2ω can be obtained, is referred as second harmonic generation (SHG).  The other 
new terms (from eq 2.37) involving ω1+ω2 and ω1-ω2 lead to sum and difference frequency 
generation, respectively.  This qualitatively indicates that coupling of two light waves is 
possible in a material if the intensity of the light is high enough.  One wave changes the 
properties of the medium in such a way that the other wave is affected by the changed 
properties of the medium.27  Pulsed lasers generating short pulses can achieve laser beam 
intensity greater than 1012 W/cm, and nonlinear effects become easily feasible with pulse 
laser.  
Second-order nonlinear polarization is responsible for the second harmonic, sum and 
difference frequency generation.  A crystal having a center of symmetry makes no 
contribution to second-order polarization, P2.  In this crystal, reversing the applied electric 
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field does not change its polarization, as the new lattice encountered by the reverse electric 
field is physically the same.21,27  More specifically, upon inversion, E→ −E. Since the E-field 
is squared in P2 = ε0χ
(2)E 2,  P2 = −P2  is true if P2 = 0 for crystal with center symmetry.  For 
P2 to be nonzero, the crystal must lack of symmetry.    
Phase Matching  
The velocity of any plane wave with frequency ω through a medium is determined by 
phase velocity v p = ω /k = c /n(ω), and is characterized by the refractive index n(ω).  Since 
the interacting waves in a nonlinear process have different frequencies, i.e., different phase 
velocities in the nonlinear material, it is important to maintain a proper phase velocity 
relation among them to maximize the efficiency of nonlinear output.  This relation is known 
as phase matching.11,28-30  The phase matching condition can be realized from the energy and 
momentum conservation of photons.  Energy (  hω ) and momentum (  hk ) conservation for 
three-wave mixing in dispersion free media is given by 
ω1 + ω2 = ω3      (2.38) 
k1 + k2 = k3      (2.39) 
From eq 2.26 and 2.39, the phase matching condition for collinear propagation can be 
summarized as 
ω1n(ω1) + ω2n(ω2) = ω3n(ω3)    (2.40) 
This condition (eq 2.40) can not be satisfied for normal dispersive materials because the 
index of refraction increases with frequency, i.e., n(ω3) > n(ω2),n(ω2) .  However, it is 
possible to satisfy the phase matching condition in birefringent medium. 
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Phase Matching Angle  
In a birefringent crystal, the index of refraction of the medium is not constant in all 
propagation directions.31  There are two orthogonally polarized modes of propagation for 
each wave.  One of these waves called ordinary wave which experiences index of refraction, 
no, that does not depend on the direction of propagation, whereas the extraordinary wave 
whose index of refraction, ne, is dependent on its direction of propagation.  The refractive 
indices (no, ne) and their dependence on the propagation direction in a uniaxial birefringent 
crystal can be depicted by the index ellipsoid.  The index ellipsoid is written as28-30   
x 2
nx
2 +
y 2
ny
2 +
z2
nz
2 =1     (2.41) 
For a uniaxial crystal, nx = ny = no and nz = ne.  The eq 2.41 becomes30 
x 2 + y 2
no
2 +
z2
ne
2 =1     (2.42) 
For positive uniaxial crystal no < ne, and for negative ne < no.  For example, β-barium borate 
(BBO), a negative uniaxial birefringence crystal, is used for sum frequency mixing in our 
fluorescence upconversion technique.  In this section, we will limit our discussion to negative 
uniaxial crystal.  An arbitrary point on ellipsoid can be expressed in polar coordinate.  The 
dependence of ne(θ) when extraordinary wave propagates at an angle θ with the optical axis 
can be easily derived if we insert x = ne(θ)sinθ cosφ,  y = ne(θ)sinθ sinφ, and z = ne(θ) cosφ in 
eq 2.42, and is given by6,31-34  
1
ne
2(θ)
=
cos2 θ
no
2 +
sin2 θ
ne
2     (2.43) 
where ne(θ) = no at θ = 0o and ne(θ) = ne at θ = 90o.  There are two types of phase matching, 
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type I and type II, depending upon which of the three waves ω1, ω2, ω3 propagates as an 
ordinary or as an extraordinary wave.  Type I corresponds to o + o → e and type II 
corresponds to e + o →  e for negative uniaxial crystal.  
In collinearly phase-matched SHG, there is only fundamental wave with frequency ω  
i.e., ω1 = ω2 = ω and ω3 = 2ω.  A schematic representation of phase matching condition for 
SHG in a negative uniaxial crytal is shown in Figure 2.10.  For SHG, Type I phase matching 
condition is no
ω = ne
2ω (θpm ), according to eq 2.40.  This leads to a phase matching angle
31 
based on eq 2.43 
sin2 θpm =
(ne
2ω )2
(no
ω )2
(no
2ω )2 − (no
ω )2
no
2ω )2 − (ne
2ω )2
 
 
 
 
 
     (2.44) 
For type II phase matching the polarization of the fundamental wave is not on the plane 
defined by the optical axis and the propagation vector.  Therefore, the fundamental wave 
consists of two components, one in the plane, travels with v p = c /no, and another 
perpendicular to the plane, travels with v p = c /ne.  According to type II phase matching, we 
can write the phase matching condition from eq 2.40 as 
1
2
[ne
ω (θ pm ) + no
ω ] = ne
2ω (θpm )     (2.43) 
The phase matching angle can be derived from eq 2.43, and is expressed as31 
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sin2 θpm
=
1
2
no
ω    (2.44) 
Similarly, condition for sum frequency generation in type I and type II phase matching are 
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given as 
ω1no
ω1 + ω2no
ω2 = ω3ne
ω3 (θpm )  (type I)    (2.45) 
ω1ne
ω1 (θpm ) + ω2no
ω2 = ω3ne
ω3 (θpm )  (type II)   (2.46) 
and the phase matching angles are expressed as31 
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and 
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Figure 2.10.  Schematic representation of (a) index ellipsoid as described by eq 2.41 and (b) 
phase matching condition for SHG in a negative uniaxial crytal.28,29  In figure (a), for a given 
direction, the intersection curve of a plane perpendicular to k and the ellipsoid is an ellipse.  
The lengths of the axes of this ellipse correspond to their respective indices.  For a uniaxial 
crystal, the index ellipsoid is an ellipsoid of revolution about the optical axis.  Figure (b) 
describes phase matching angle for SHG when fundamental light with frequency ω 
propagates as ordinary wave and second harmarmonic (2ω) light propagates as extraordinary 
wave.   
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Tripler  
The output from the Ti:Sapphire oscillator is frequency tripled by a tripler from U-
Oplaz Technologies, Inc. The optical layout of the tripler is shown is Figure 2.11.  The output 
polarization of Ti:Sapphire oscillator is parallel to the laser table.  The input beam (ω) is 
polarized vertically by the first half wave plate (WP1) and focused onto the type I phased 
matched SHG crystal using a lens (L1).  The residual of fundamental (ω) and second 
harmonic (2ω) beam after the SHG crystal are polarized vertically and horizontally, 
respectively.  After SHG, there is a time delay between ω and 2ω pulses due to the GVD by 
the crystal.  This time delay is ~100 fs for 1 mm crystal.  It is very important to compensate 
the time delay for efficient generation of femtosecond (fs) third harmonic pulses.  The time 
delay is compensated using a specially designed birefringent crystal, known as time plate 
(TP).  The no axis of refractive index of the crystal is along z-axis and ne axis in the x-y plane.  
In this configuration, ω and 2ω propagate through the crystal as ordinary and extraordinary 
waves respectively, and the time delay is overcome depending upon the rotation angle, 
thickness, cutting angle and indices of refraction of the crystal because the ordinary and 
extraordinary wave travels with different speed.  The tripler uses a type I BBO crystal to 
generate the third harmonic pulse.  Since type I phase matching demands parallel polarization 
of the two different frequencies light, a half wave plate (WP2) before third harmonic crystal 
is used to make both ω and 2ω polarized horizontally.  The output third harmonic beam is 
vertically polarized.  The output frequencies are separated using high reflecting dichroic 
mirrors (M3, M4, M5 and M6). 
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Figure 2.11.  Schematic diagram of the tripler. WP - wave plate, L - lens, SHG - second 
harmonic generation, M - mirror, TP - time plate, THG - third harmonic generation.  
 
Time-Correlated Single Photon Counting (TCSPC) 
 
Principle   
Let us consider that a dilute solution of fluorescent species is excited with a short 
pulse of light at time, t = 0.  A certain number of molecules get excited to S1 and some of 
them relax back to ground state (S0) from S1.  The rate of relaxation of the population, n, of 
excited molecules is given by first-order differential equation35,36 
dn
dt
= −kn      (2.49) 
Integration of eq 2.49 yields an exponential decay of the excited state population 
nt = n0e
−
t
τ      (2.50) 
where nt and n0 represent excited state population at time t and t = 0, respectively.  The τ is 
the excited state lifetime, which is related to k by 
τ =
1
k
      (2.51) 
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The fluorescence intensity, I, is proportional to the excited state population and also decays 
exponentially  
It = I0e
−
t
τ      (2.52) 
In order to measure the intensity of emitted light at a particular time t, one needs to count the 
number of photons that are being emitted at that time.  One cannot predict when a photon 
will be emitted following an excitation pulse due to random nature of the emission of 
photons.  If we excite a single molecule with a short pulse, the probability (P) of emitting a 
photon after a time delay ∆t with respect to the time of excitation is given by35 
τ
t
etP
∆
−
∆ ~)(      (2.53) 
This indicates that the statistics for the detection of single photon emission time 
following excitation can reproduce excited population decay instead of measuring light 
intensity, which is a cooperating effect of many photons.  Time-correlated single photon 
counting (TCSPC) detects only one photon at a time as it is based on the above hypothesis 
that the probability distribution for the emission of a single photon is equivalent to the actual 
intensity versus time distribution for all photons detected.7,37  A schematic diagram of 
TCSPC is presented in Figure 2.12.  A pulsed light excites the sample at a high repetition 
rate. The sample emits fluorescence photons, which are detected by very sensitive detector, 
usually micro-channel plate (MCP) that is capable of responding to a single photon with a 
defined and measurable electric output pulse.  A reference photodiode (PD) triggered by the 
excitation pulse is usually used to start the time-to-amplitude converter (TAC).  TAC can be 
viewed as very precise stopwatch.  The role of TAC is to measure the delay time between the 
excitation pulse and the pulse produced from the MCP by the emitted photon.  TAC after 
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being started by the reference PD charges a capacitor with constant current and generates 
linearly rising voltage.  The output pulse created by the first fluorescence photon in MCP is 
used to stop the clock (i.e., charging of the capacitor is stopped).  The single-photon output 
pulse from MCP may have considerable amplitude jitter due to random amplification 
mechanism in the detector.  The reference pulse from PD may also change because of 
intensity fluctuation of the laser source.  The exact positions in time of a pulse from MCP 
(representing time of the photon event) or the timing of the reference signal are crucial.  In 
order to avoid timing jitter arising from amplitude jitter of the detectors, the out put pulses 
are directed to constant fraction discriminator (CFD) before they start-stop TAC.  The 
accumulated voltage in the TAC is proportional to the time delay between excitation pulse 
(start pulse) and the pulse produce by the photon (stop pulse).  The amplitude of the voltage 
from TAC is measured by an analog-to-digital converter (ADC) to determine into which of 
the time slot on the time axis of the decay curve this photon should be recorded.  It sends the 
time slot number to multi-channel analyzer (MCA).  This number is then interpreted as a 
channel number in MCA. MCA has a memory—a multichannel array, which divided into N 
channels.  Each channel corresponds to a short voltage interval in increasing order.  For 
example, if the intervals are 0.1V and the input signal is 1.0 V, the signal is attributed to 
channel 10 and the value in this channel is incremented by one.35  Of course, the 
measurement of a single photon does not contain any information about the fluorescence 
time course.  If the sample is repeatedly excited by pulses and single photons are counted, 
then a histogram, which corresponds to the decay curve, is built up in the MCA with 
increasing numbers of events.  
TCSPC deals with single photon detection.  It is important that during the detection 
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cycle only one photon is detected, since all other photon but the first will be lost.  This is the 
case when many molecules are excited at the same time.  The lost photons could induce a 
nonlinear distortion in the histogram, known as pile-up.7,37,38  In order to avoid pile-up, the 
average count rate at the detector should be 1-5% of the excitation rate.  Low excitation pulse 
energy (<1 nJ) and low sample concentration are also recommended to ignore pile-up.   
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Figure 2.12.  Illustration of basic principle of time-correlated single photon counting 
method. PD - photodiode, CFD - constant fraction discriminator, TAC - time to amplitude 
converter, MCA - multi-channel analyzer.9  
  
 The time resolution of this technique is limited by the transit time spread of the 
electron response pulse of the detector.  Transit time spread reflects how much the timing of 
the response pulse varies from one pulse to another.  For example, the transit time spread of 
MCP detector (Model R3809U-50) from Hamamatsu is 25 ps. One can get ≤ 40 ps 
instrument response function using this detector in TCSPC.7,37,38  
The recorded fluorescence profile f(t) is the convolution of instrument response 
function i(t) and the sample’s response to delta pulse excitation g(t), is given by2 
tdtgttitf ′′′−= ∫
∞
)()()(
0
    (2.54) 
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The instrument response function, i(t), is measured by scatting the excitation pulse using 
nondairy coffee creamer.  The g(t) can be obtained by deconvolution of f(t) using known i(t).   
 Let us assume that the actual fluorescence, g(t), is represented by sum of exponential 
decays as 
g(t) = aie
−
t
τ i
i
∑      (2.55) 
where ai and τi are the amplitude and decay time, respectively, of the ith decay component.  
In order to extract g(t), one generally start with trial values of ai and τi and a calculated fc(t) is 
obtained after convoluting with the instrument response function, i(t), according to eq 2.54.  
The difference between fc(t) and f(t) is then minimized by least square fitting, in which ai and 
τi are varied.  The goodness of the fit is represented by χ2, is expressed as 
χ 2 =
g(t) − gc (t)[ ]
2
g(t)2i
∑      (2.56) 
 TCSPC Setup    
An optical layout of the TCSPC instrument used for the experiments is shown in 
Figure 2.13.  A homebuilt mode-locked Ti:sapphire oscillator pumped by a Nd:VO4 laser 
(Millennia, Spectra Physics) producing femtosecond pulses tunable from 780 to 900 nm with 
a repetition rate of 88 MHz is used as the laser source.  The fundamental wavelength at 814 
nm from the Ti-sapphire oscillator is modulated by a Pockels cell (Model 350-160, Conoptics 
Inc.) to reduce the repetition rate to approximately 8.8 MHz and is subsequently frequency 
doubled or tripled by using a harmonic generator (Model TP-2000B, U-Oplaz Technologies).  
The resulting blue (~ 407 nm) or UV (~ 266 nm) light provides the excitation source.  The 
excitation pulses are passed through a half-wave plate and a polarizer before reaching the 
 69 
sample in order to make the polarization of the excitation light vertical with respect to the 
laser table.  The fluorescence is collected at a 90o geometry, and passes through an analyzer 
set at the magic angle (54.7o) with respect to excitation polarization.  The fluorescence is 
generally collected at the magic angle in order to avoid the influence of orientational motions 
of the fluorophores on the temporal behavior of the fluorescence.  A microchannel plate, 
MCP (Hamamatsu) is used for the fluorescence detection.  The detector output is amplified 
and fed to the Becker & Hickl photon counting module Model SPC-630.  The module 
contains the usual building blocks (CFDs, TAC, ADC) together with a large histogram 
memory integrated on one board.  The full-width-at-half-maximum (FWHM) of the 
instrument response function is ~40 – 45 ps. 
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Figure 2.13.  Schematic diagram of TCSPC instrument.  M - mirror, L - lens, C - crystal, OC 
- output coupler, P - prism, BS - beam splitter, PD - photodiode, WP - wave plate, MCP - 
microchannel plate. 
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Fluorescence Upconversion 
Ultrafast dynamics in the femtosecond time range cannot be resolved using TCSPC 
owing to the limiting factor of the detector response, even if femtosecond excitation pulses 
are used.  But fluorescence spectroscopy can be performed in the ultrafast regime by optical 
gating of the fluorescence emission using a nonlinear crystal with a technique popularly 
known as fluorescence upconversion. With this method, time resolution comparable to laser 
pulse width is obtained.   
Principle  
The fluorescence upconversion technique2,35,36,38-42 is based on nonlinear  effect of 
sum frequency mixing in a nonlinear birefringent crystal.  Typically, the sample is excited 
with femtosecond light pulses and the emitted fluorescence (νf) is collected, and focused 
along with the gate pulses (νg) onto a nonlinear crystal.  The combined electric fields of the 
two pulses interact with electrons of the nonlinear crystal to generate a new radiation field at 
the sum frequencies (νs) of the incident radiation.  Since the output photons, νs= νf +νg, are 
upconverted to a higher frequency by the gate pulse, this technique is known as fluorescence 
uoconversion (Figure 2.14a).  The upconverted signal (νs) is separated with a monochromator 
and sent to subsequent light detection and data acquisition devices.  The detector response 
may be slow because it only measures the signal intensity at sum frequency, not its time 
course.  A necessary condition for upconversion is that the two fields (gate pulse and 
fluorescence) be present in the crystal at the same time because polarization of electrons is 
essentially instantaneous.  If the gate pulse is not present, the fluorescence alone cannot 
produce a sum signal (νs).  Thus the gate pulse opens an optical gate to measuring the 
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fluorescence intensity at a certain instant after excitation.  Usually, the arrival time of the 
gate pulse is controlled with a motorized delay stage consists of a retro-reflecting mirror, and 
is swept across the time profile of the fluorescence.  The reverse method can also be carried 
out, i.e., the arrival time of fluorescence photons is controlled by delaying the excitation 
pulse and scanned with respect to the gate pulse that is fixed in time.  Our upconversion 
instrument follows this method.  Based on the speed of light (c) in air and folded path of 
excitation beam along the delay stage, a delay of ∆t = 1 fs is generated by a displacement d = 
c∆t/2 = 1.5 µm in translation line.  Moving the translational line with small steps, one can 
scan the whole decay profile. 
The important point here is the width of pulse because the time resolution of this 
method is limited by the width of gate and excitation pulse.  Both the pulses get broaden 
when they pass through the solvent, sample cell window, detection optics and nonlinear 
crystal because of group velocity dispersion (GDV).  In order to achieve good time resolution 
it is better to use the sample cell, crystal and lenses in the optical scheme as thin as 
possible.35,38      
 The intensity output photons (Is) at sum frequency is proportional to the product of 
intensity of gating (Ig) and fluorescence (If) photons, and is given by2,41 
∫
′
∞−
′−=′
t
gfs dttIttItI )()()(     (2.57) 
Eq 2.57 also clearly indicates that the signal at sum frequency is not obtained when the gate 
and fluorescence photons are simultaneously coincident on the crystal.  The gate photons 
slice out only those photons of fluorescence, which are overlapped with the gate photons 
(Figure 2.14b).  Thus the time course of the fluorescence at a particular frequency, νs, is 
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mapped out by scanning the delay line for excitation pulse causing fluorescence from sample. 
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Figure 2.14.  Principle of fluorescence upconversion.  (a) The sum frequency signal is 
generated in the crystal when both the gate pulse and fluorescence is present at the same 
time.  (b) The intensity of sum frequency signal is proportional to the product of gate pulse 
and fluorescence intensity.  Thus, sum frequency signal obtained with delay time is accurate 
representation of time-resolved fluorescence decay.38,40,42,43 
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The instrument response function is obtained from cross-correlation function of gate 
pulse Ig(t) and excitation pulse Iex(t) using the same optics and crystal that are used for the 
sample.  The cross-correlation function (C′) is given by39 
∫
′
∞−
′−=′′
t
gex dttIttItC )()()(     (2.58) 
The cross-correlation function is used for the deconvolution of optically gated fluorescence 
data because experimentally measured fluorescence intensity is the convolution of true 
fluorescence decay and excitation pulse.  
Fluorescence Upconversion Setup     
A schematic diagram of fluorescence upconversion setup is displayed in Figure 2.15.  
The laser source is a homebuilt mode-locked Ti:sapphire oscillator.  The fundamental 
wavelength and repetition rate of the femtosecond output are 814 nm and 88 MHz, 
respectively.  The fundamental output from the oscillator is frequency-doubled by a type-I 
LBO crystal (2 mm).  The frequency-doubled pulses (407 nm) are separated from residual 
fundamental light using a dichroic mirror, and used to excite the sample.  The residual of the 
fundamental is used as the gate pulse to upconvert the fluorescence signal.  A filter is used to 
block trace 407 nm light with the fundamental.  The gate pulses pass through a λ/2 plate, 
turning the polarization by 90o with to plane of laser table.  The exciting pulses also pass 
through a λ/2 plate, which is adjusted at the magic angle (54.7o).  In our upconversion 
system, the excitation pulse is delayed with respect to gate pulse using a motorized delay 
stage.   
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Figure 2.15.  Schematic diagram fluorescence upconversion system.  M - mirror, L - lens, C 
- crystal, OC - output coupler, P - prism, BS - beam splitter, BBO - β-barium borate, PMT - 
photomultiplier tube. 
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The sample is contained in a glass rotating cell of path length 1 nm mounted 
perpendicularly to the exciting beam and spins about an axis parallel to the beam.  First, the 
frequency-doubled blue pulses (407 nm) are focused on the sample and the fluorescence 
signal is collected using a 10x objective lens.  Then, the gate pulse and fluorescence signal 
are focused onto a 0.4 mm type-I BBO crystal to generate the sum frequency light, which is 
detected by a photomultiplier tube mounted on a monochromator.  The upconverted signal is 
usually weak. In order to pick up the upconverted signal from the background noise, an 
optical light chopper is settled in the excitation beam line.  The light is chopped at 1000 Hz, 
and the signal is counted at this rate using a lock-in amplifier connected to the PMT.  The 
full-width-at-half-maximum (FWHM) of the instrument response function is 300 fs, obtained 
by the cross-correlation function of the frequency doubled and the fundamental light.   
Fluorescence Quenching   
Fluorescence quenching refers to any process that decreases the fluorescence intensity 
or lifetime of a sample.  Fluorescence quenching has been a common experiment to 
determine the location of fluorescent probes in macromolecules based on the accessibility of 
fluorophores to quenchers.1  There are two basic types of quenching: static and dynamic 
(collisional).  Both types of quenching mechanism require an interaction between the 
fluorophore and the quencher.  In the case of static quenching, a ground-state nonfluorescent 
complex is formed between the fluorophore and the quencher.  In the case of dynamic 
quenching, the quenchers diffuse to fluorophores during its excited-state lifetime.  The 
fluorophore returns to the ground state without emission of a photon after a diffusive 
encounter with a quencher during its excited-state lifetime.  It is known that the fluorescence 
of dyes is quenched by a wide variety of external quenchers.  Excited-state electron transfer, 
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energy transfer, proton transfer, exiplex formation (excited-state complex) and spin-orbit 
coupling (heavy atom effect) have been proposed as possible quenching mechanisms for 
various quenchers.1,44   Mechanism of quenching varies with the fluorophore-quencher pair.  
For example, for halide ions such as Br– and I–, fluorescence quenching are thought to be a 
result of enhanced intersystem crossing to an excited triplet state because of efficient spin–
orbit coupling of the excited (singlet) fluorophore and the halide upon contact.45  Since 
molecules usually have a longer triplet state lifetime, the triplet emission is quenched by 
collisions with surrounding solvents at room temperature.  Acrylamide is a quencher that 
quenches fluorescence of tryptophan possibly due to electron transfer from tryptophan in 
excited state to acrylamide.1  Other quenchers, such as Cu2+, Pb2+ are though to cause the 
donation of an electron from the fluorophore in the excited state.  
Bimolecular fluorescence quenching mechanism can usually be described by the 
following kinetic scheme46 
*AhA →+ ν  
ν ′+→ hAA rk*  
∆+→ AA nrk*  
∆++→+ QAQA qk*  
In the absence of quenchers, the rate of relaxation of an excited fluorophore, A*, can 
be written as47 
d[A*]
dt
= −(kr + knr )[A
*]    (2.59) 
Solution of eq 2.59 with respect to initial conditions, at t = 0, [A*] = [A*]0 is 
0/
0
** ][][ τteAA −=      (2.60) 
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where )/(10 nrr kk +=τ , is the fluorescence lifetime in the absence of any quencher.  If a 
quenching agent (Q) is present in solution, the rate of relaxation of A* becomes 
d[A*]
dt
= −(kr + knr + kq[Q])[A
*]    (2.61) 
If [Q]>>[A*], which means [Q] can be treated as a constant (the quencher concentration is 
orders of magnitude larger than [A*] in practice), then eq 2.61 can be integrated to obtain 
[A*] = [A*]e− t /τ      (2.62) 
with ])[/(1 Qkkk qnrr ++=τ .  From the ratio of lifetimes in absence and presence of 
quencher, we have 
τ 0
τ
=1+ kqτ 0[Q]      (2.63) 
The fluorescence quantum yield in the absence of quencher is 
Φ0 =
kr
kr + knr
= krτ 0      (2.64) 
whereas in the presence of quencher, it is given by 
Φ =
kr
kr + knr + kq[Q]
=
kr
1/τ 0 + kq[Q]
    (2.65) 
Eqs 2.63, 2.64 and 2.65 can be grouped together to obtain 
][1][1 0
000 QKQk
F
F
SVq +=+===Φ
Φ
τ
τ
τ
   (2.66) 
where F0 and F are the steady-state fluorescence intensities in the absence and presence of 
quencher, respectively.  The relation (eq 2.66) between fluorescence intensity and quencher 
concentration is known as Stern-Volmer equation.  If the fluorescence intensity (F) (or 
lifetime, τ ) in the absence of quencher and in the presence of incremental amounts of 
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quencher are measured, and then the resulting ratio of fluorescence intensities (F0/F) (or τ0/τ) 
is plotted as a function of quencher concentration, [Q], the resulting graph (a Stern-Volmer 
plot) will have an intercept of one, and a slope known as Stern-Volmer constant, KSV.  
Since KSV = kqτ 0 , knowing the slope and the lifetime in the absence of quencher, τ0, it allows 
easy calculation of the quenching rate constant kq.   
For dynamic quenching, all fluorophore are affected by the quenching process as 
there is the possibility of collision with a quencher during the excited state lifetime.  Thus, 
both fluorescence intensity (F) and lifetime (τ) are reduced with increasing concentration of 
the quencher.  For static quenching, only fluorophore-quencher associations result in 
reduction in fluorescence intensity because unassociated fluorophores are free to fluoresce.  
Increasing quencher concentration affects fluorescence intensity, because there are more 
associations, but not the fluorescence lifetime because the unassociated fluorophores can 
fluoresce with its normal fluorescence lifetime.  Therefore, the diagnostic test for assigning if 
a quenching mechanism is dynamic or static is to compare how the fluorescence intensity and 
lifetime change as a function of increasing quencher concentration.  In the case of dynamic 
quenching, plots of F0/F and τ0/τ with [Q] will be the same.  For static quenching, only a plot 
of F0/F will change with [Q] whereas τ0/τ  plot will have slope close to zero (Figure 2.16). 
Modified form of Stern-Volmer equation is often used when there are two types of 
populations of fluorophores present in the system, one being accessible to quenchers, a, and 
the other inaccessible or buried, b.1  The total fluorescence intensity in the absence of 
quencher can be written as   
F0 = F0
a + F0
b       (2.67) 
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The quenchers affect only fluorescence intensity of accessible fluorophore according to 
Stern-Volmer equation.  This leads to observed fluorescence intensity, F, as    
b
a
SV
a
F
QK
F
F 0
0
][1
+
+
=      (2.68) 
where KSV
a  is the Stern–Volmer quenching constant of the accessible fraction.  Substraction 
of eq 2.68 from eq 2.67 results 
F0 − F = ∆F = F0
a KSV
a [Q]
1+ KSV
a [Q]
 
 
 
 
 
    (2.69) 
The eq 2.69 can also be expressed as 
F0
∆F
=
1
faKSV
a [Q]
+
1
fa
     (2.70) 
with fraction of initial fluorescence accessible to the quencher, fa = F0
a /(F0
a + F0
b ) .  Plot of 
F0/∆F against 1/[Q] produces the intercept as1/fa and slope 1/ faKSV
a .   
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Figure 2.16.  Model plots to distinguish between dynamic and static quenching.  In dynamic 
quenching, increasing quencher concentration increases the probability of collisions with 
fluorophore during its fluorescence lifetime while incase of static quenching increasing 
quencher concentration increases probability of association with the fluorophore in the 
ground state.  
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Fluorescence Resonance Energy Transfer 
Resonance energy transfer (RET) is an important mechanism by which an excited 
molecule (donor) can return to its ground state by transferring the excitation energy to 
another molecule (acceptor).  If the donor molecule is fluorescent, then RET is referred to as 
fluorescence resonance energy transfer, FRET.  The acceptor however may or may not be 
fluorescent.  FRET is the non-radiative transfer of energy from a donor molecule to the 
acceptor molecule, therefore the signature of FRET is quenching of the high energy donor 
emission followed by emission from the acceptor of relatively low frequency of light.  When 
donor and acceptor are to close (< 10 Å), energy transfer occurs by exchange of electrons due 
to overlapping of their electron cloud known as Dexter mechanism of energy transfer.48  In 
this thesis we will deal with Förster energy transfer.49  In principle for Förster energy transfer 
to occur several major criteria must be satisfied.  First, the donor emission spectrum must 
overlaps with the absorption spectrum of acceptor.  A second criterion that needs to be 
satisfied is that the donor to acceptor distance must be within 10-100 Å of each other.  The 
third criterion that must be met is that the excited state lifetime of the donor molecule must 
be of sufficient duration to allow energy transfer to occur.      
Theodore Förster provided a quantitative idea in 1946 by developing non-radiative 
transfer rate equation that relates to the inter-chromophore distance and the spectroscopic 
properties of the chromophores, known as “Förster theory of energy transfer”.49  He showed 
that the efficiency of energy transfer decreases with sixth power of the distance between 
donor and acceptor.  Stryer and Haugland have verified this theory critically in 1967.50  
Förster theory is based on very weak dipole-dipole interaction between the donor and 
acceptor.  Thus spectroscopic properties like absorption of donor and acceptor should not be 
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altered in the presence of each other.  In resonance energy transfer process; first the donor 
(D) molecule gets excited by absorbing light energy.  As a consequence of this, an induced 
dipole is formed in the donor molecule.  When D* (excited donor) and A (acceptor) 
molecules come close to each other in solution, they feel each other’s presence due to long-
range Coulomb forces.  As D* and A approach, the D* dipole starts interacting with the A 
dipole.  As a result of this dipole-dipole interaction, the electron in the HOMO (highest 
occupied molecular orbital) of A will also be induced to oscillate more violently.  This 
violent oscillation can cause the excitation of the electron into the LUMO (lowest 
unoccupied molecular orbital) of A, along with a de-excitation of the excited electron on D.  
The ultimate result of this interaction is that D* has become de-excited to the ground 
electronic state with simultaneous excitation of A to A* (Figure 2.17).51  This dipoles 
interaction and exchange of energy is similar to two oscillating pendulums that are 
mechanically coupled.  If two pendulums have a spring connecting their rods then when one 
pendulum is set swinging (the donor molecule absorbs a photon) the other pendulum of 
couple will begin swinging (the acceptor molecule emits a photon).52  
D* A D A*
Initial State Final State
Energy Transfer
 
Figure 2.17.  Energy level diagram showing electron movements in long-range Coulombic 
energy transfer. 
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The rate of energy transfer from the donor to an acceptor is given by  
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where N is the Avogadro’s number, c is the velocity light, φD is the quantum yield of donor in 
the absence of acceptor, τD is the donor lifetime in the absence of acceptor, n is the refractive 
index of the medium, R is the distance between donor and acceptor, fD is the flurescence 
emission spectrum of donor normalized to unity, εA is the absorption spectrum of the 
acceptor, and ˜ ν  is the wavenumber in cm-1.  The integrated part of eq 2.71 is known as 
overlap integral (Figure 2.18).  κ is known as orientation factor which is expressed as  
κ = sinθ1 sinθ2 cosφ12 − 2cosθ1 cosθ2    (2.72) 
θ1, θ2 and φ12 are the angles designated in Figure 2.19.  The maximum, minimum and the 
average value of κ2 are 4, 0 and 2/3. 
DemAabs
ν (cm-1)
ε FF
 
Figure 2.18.  Overlap integral of donor emission and absorption spectra is shown by series of 
horizontal lines. 
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Figure 2.19.  Orientation for dipole-dipole coupling.   
 
From eq 2.71 it is clear that rate of energy transfer energy decreases with sixth power 
of the distance between donor and acceptor.  kET  is expressed as   
6
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R0 is known as Förster distance that represents the distance at which the efficiency of energy 
transfer is 50%, and is expressed as 
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In an alternative way at R = R0, kET is equal to the decay rate of the donor ( τ D
−1) in the absence 
of acceptor.  At this distance, one half of the donor molecules decay by energy transfer and 
the other half decay by the usual radiative and non-radiative processes. 
The efficiency can be defined in many ways like in term of lifetime of donor, 
fluorescence intensity of donor and also in term of D-A distance.  τDA and τD are the lifetime 
donor in presence and absence of acceptor respectively.  Similarly, fDA and fD are the 
fluorescence of donor in presence and absence of acceptor  
 84 
E =1−
τ DA
τ D
=1−
fDA
fD
=
R0
6
R0
6 + R6
   (2.75) 
The distance dependence of resonance energy transfer process provides the basis of 
its usefulness in the study of molecular interactions.  Förster distance 10-100 Å is especially 
convenient of studying interactions biological macromolecules.  These distances are 
comparable to the diameter of many proteins, the thickness of biological membrane and 
distance between the sites on multi-subunits proteins.  Any phenomenon, which affects the 
D-A distance, will also affect the rate of energy transfer, allowing the phenomenon to be 
quantified.  Also this technique is important because measurement can be done under 
physiological (or other) with near angstrom resolution.  For this reason resonance energy 
transfer has found to be widely useful in polymer science, biochemistry and structural 
biology.53-59 
Time-Resolved Fluorescence Anisotropy  
Absorption of a photon by a molecule takes place on the order of 10-15 s.  The average 
fluorescence lifetime is in the range of 10-9 s for many fluorophores.1  Therefore, there is a 
significant time delay between absorption and fluorescence, and a molecule or its constituent 
parts can undergo significant angular displacement in the time between absorption and 
emission.60  In the time-resolved fluorescence anisotropy experiment (Figure 2.20), an 
ensemble of dyes is excited using a polarized laser pulse.  In a solution of randomly oriented 
fluorophores (isotropic solution), an incident beam of polarized light preferentially excites 
molecules with a probability proportional to cos2θ, where θ is the angle between the 
transition dipole moment of the dye and the polarization of the incident light.  This process is 
known as photoselection.61  The orientational anisotropic distribution of the excited dye 
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molecules relaxes by rotational diffusion during their fluorescence lifetime and emits the 
fluorescence in a possibly changed orientation.  The resulting rotation in the plane of 
fluorescence polarization is usually detected by using a polarizer before the detector at 
parallel and perpendicular orientation with respect to excitation polarization.  This yields two 
fluorescence intensity signals; I||(t) and I⊥(t) as the parallel and perpendicular part of the 
fluorescence, respectively.  The I||(t) and I⊥(t) of the same sample are different because the 
time evolution of fluorescence intensity at a fixed plane of polarization is the superposition of 
rotational diffusion and excited state population decay.  For a single rotational correlation 
time, τr , I||(t) and I⊥(t) can be written as37  
)21()( /0
/
||
rf tt eretI ττ −− +=     (2.76) 
)1()( /0
/
||
rf tt eretI ττ −− −=     (2.77) 
τf  is fluorescence lifetime of the probe.  The r0 is anisotropy value at t = 0, and is related to 
the θ  by the relation given as1,37 
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The value of r0 varies between 0.4 and -0.2 because the angle θ changes between 0o to 90o.  
When the θ = 54.7o, there is a complete loss of anisotropy.  The total fluorescence intensity, 
F(t), according to eq 2.76 and 2.77 is 
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 The fluorescence anisotropy r(t) at time t after the excitation of the fluorophore is 
defined as2,37,62 
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If the fluorophore behaves in solution as a rigid rotator, the τr depends mainly on the size and 
shape of the molecule.  The Stokes-Einstein-Debye1,63 relation can estimate the τr for a 
fluorphore in solution 
Tk
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where η is the solvent viscosity, kB is the Boltzman constant, T is temperature, and V is the 
molecular volume of the fluorophore.  This equation is based on classical hydrodynamics and 
requires the hypothesis of a continuous and homogeneous solvent.  If the rotational motion of 
a fluorophore is restricted in an environment in such way that the anisotropy r(t) never (on 
the time scale of fluorescence) decays to zero, then a residual anisotropy r∞ is observed as 
given by64 
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For more complex motions or nonsperical molecules, the r(t) must be described by multi-
exponential functions.  In this case, a general description of the anisotropy is given by1 
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Time-resolved depolarization of fluorescence of dye molecules in liquids is one of the 
powerful techniques for the investigation of the tumbling or rotational motion of the 
molecule on the picosecond to nanosecond time scale.2  Information about the microscopic 
motions is contained in the time-dependent fluorescence anisotropy r(t).  The fluorescence 
anisotropy decay for a number of organic dye molecules in pure solvents is usually single 
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exponential, and the rotational dynamics of the molecule resembles that of an ellipsoid or a 
sphere.65-69  There are also a few reports where the anisotropy decay of dye molecules in 
liquids is biexponential.70-72  In microheterogeneous media such as micelles and membranes, 
the rotational dynamics of the dye is different from that in homogeneous media due to the 
existence of an aqueous/nonaqueous interface that leads to an orientationally nonrandom 
equilibrium distribution of the molecules, and highly restricted dynamics of the molecules.73  
For example, the fluorescence anisotropy decay of a dye molecule in a spherical micelle is 
best described by a model of restricted rotational motion of the dye (wobbling-in-cone) 
coupled with the rotational motion of the whole micelle (tumbling motion of the micelle), 
leads to a biexponential anisotropy decay with two widely separated rotational correlation 
time constants.73 
I I
I⊥
I⊥
Rotation during
lifetime
 
Figure 2.20.  Schematic model of fluorescence anisotropy.  The dye is first excited by a 
polarized laser pulse.  During fluorescence lifetime the dye undergoes rotational diffusion.  
Finally, the dye emits a photon in a possibly changed orientation.  A polarizer (before the 
detector) at the parallel (I||) and perpendicular (I⊥) orientation with respect to polarization of 
excitation yields (I||) and I⊥(t), respectively.  
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Solvation Dynamics 
 The area of solvation dynamics has attracted much attention in the past several years 
because of its influence on various chemical reactions, especially on charge transfer 
processes.74-78  The time scale of the response of surrounding solvent to electronic 
rearrangement of solute molecule can play a deterministic role in the rates of chemical 
reaction.75,79-82  In particular, for a reaction, if the solvents cannot respond quickly enough to 
the electronic rearrangement as the reactant passes through the transition state, the evolving 
product may re-cross the free-energy barrier; hence rate of the reaction is reduced.83-87  
Theoretical, experimental and molecular dynamic simulation studies reveal that the rates of 
both activated and activationless electron transfer are most affected by the fastest part of the 
solvent response, hence the dynamics of solvation on a femtosecond timescale is critical.88-93  
The central question in liquid-phase chemistry is: how do solvents affect the rate, 
mechanism and outcome of chemical reactions?  The term “solvation” refers to the 
thermodynamically stable state of the local system consisting of a solute and its surrounding 
solvents.  Understanding the rate of solvent reorganization in response to a perturbation in 
solute-solvent interactions (solvation dynamics) is an essential step in answering this central 
question.  Time-resolved fluorescence spectroscopy has been of great importance probing the 
dynamics of the solvent.80,81,94-99  The dynamics of solvent relaxation around the solute 
molecules, which are perturbed from equilibrium solvation is often followed by measuring 
the time-dependent fluorescence Stokes shift of the solute molecule.  In a typical solvation 
dynamics experiment, a chromophore that is in equilibrium with surrounding solvent 
molecules is electronically excited with ultrafast optical pulse.  An abrupt change of 
electronic charge distribution of the probe molecule is induced by the electronic excitation 
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from the electronic ground state to the excited state.  The formation of the excited state 
occurs on 10-15 s time scale much faster than any nuclear rearrangement of the environment 
according to Franck-Condon principle.  This indicates that the nuclear solvent coordinates 
are “frozen” (although the solvent’s electronic charge distribution can follow the photo-
induced change in the chromophore’s electronic charge distribution).  As a result, the 
excited-state solute-solvent configuration is in highly non-equilibrium situation.  Usually the 
fluorescence lifetime of the probe molecule is long compared to solvation time scale.  
Consequently, the solvent molecules around the new excited-state charge distribution of the 
solute respond by reorientation in order to minimize the free energy of the system (Figure 
2.21).  During this process of adjustment of free energy, the energy of excited state is 
lowered.  This results in a red shift of the fluorescence spectrum as the solvation proceeds, 
known as dynamic Stokes shift.81,100   
It is important to use a relatively structurally rigid chromophore, so that most of the 
changes in the fluorescence spectrum can be ascribed to changes in the solvent environment 
rather than changes in the molecular geometry.  Selection of the probe is crucial in order to 
obtain correct information from solvation dynamics experiment.  For example, Coumarin 153 
(C153) is a standard fluorescence probe that has been used in solvation dynamics 
studies.80,94,96,101  C153 is a reasonably rigid molecule with high fluorescence quantum yield 
and undergoes a large change in its dipole moment on photoexcitation.94  Only a single 
excited state (S1 state) of intramolecular charge transfer character is responsible for the 
fluorescence of this dye.94  Thus, complications arising due to the participation of multiple 
fluorescent states, as happens with many probe molecules, can be avoided with C153. 
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Figure 2.21.  A schematic representation of electronic transition involved in a typical time-
resolved fluorescence experiment measuring solvation dynamics.  A short laser pulse excites 
the probe molecule from S0 to S1.  Since the electronic transition is fast compared to nuclear 
motions of the solvent, an excited state with a solvent environment that is characteristic of 
equilibrium in S0 is initially prepared.  The solvents reorganize over time along the solvation 
coordinate in order to lower the solvation energy in the excited state.  This relaxation can be 
followed by measuring the fluorescence of the probe as a function of time after excitation.  
 
The observed dynamic Stokes shift is represented by a correlation function, C(t), 
defined as81 
C(t) =
ν (t) −ν (∞)
ν (0) −ν(∞)
     (2.84) 
where ν(t), ν(0) and ν(∞) are the emission maxima at time t, zero and infinity, respectively.  
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It is clear from eq 2.84 that C(t) equals to 1 at t = 0 and decays to 0 as t → ∞.  Thus, the time-
dependent behavior of C(t) provides a means of quantifying the relaxation of the surrounding 
environment on a microscopic level.  The solute-solvent interaction energy as function of 
time, E(t), fluctuates rapidly about some average value <E>.  The time dependence of these 
fluctuations is δE(t) = E(t) − <E>.  Thus, one can follow the “solvation dynamics” by 
calculating the time correlation function, <δE(0)δE(t)>, which is the ensemble averaged (“< 
>”) behavior of these fluctuations.  When the solvent response is linear to the external 
perturbation, the non-equilibrium correlation function, C(t), is equivalent equilibrium 
correlation function, C∆E (t):
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C(t) ≅ C∆E (t) =
< δ∆E(0)δ∆E(t) >
< δ∆E 2 >
=
< δν(0)δν(t) >
< δν 2 >
   (2.85) 
 The solvation correlation function, C(t) is typically not a single exponential.  Details 
of molecular motions are important in order to understand the multi-exponential relaxation.  
Solvation of newly created charge distribution in the excited state of a solute molecule 
surrounding dipolar molecules involves primarily librational (hindered rotation, a high 
frequency mode), rotational and translational motion (including intermolecular vibrations) of 
the dipolar solvent molecules.  All these motions generally determine the final organized 
structure of solvent molecules around the excited dipole of solute.  Contribution from 
electronic polarization that can be estimated from polarizibility of the solvent molecules may 
also be significant part of the total solvation energy.  Therefore, the time scales of solvation 
dynamics can be very wide.  For example, the electronic, high frequency vibration and 
libration motions are very fast (≤ 100 fs).  However, translational (low frequency vibration, 
diffusive translation) and rotational (diffusive rotation) motions can be significantly 
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slower.102 
 Jimenez et al.95 reported excited-state solvation dynamics of Coumarin 343 (dye) in 
water.  The experimental C(t) in water is fitted by C(t) = age
−
1
2
ωg
2t 2
+ a1e
−
t
τ 2 + a1e
−
t
τ 3  with a 
Gaussian component (ωg = 38.5 ps-1, 48% of the total amplitude) and a slower biexponential 
decay with τ2 = 126 fs (20%) and τ3 = 880 fs (35%).  The ultrafast solvation is attributed to 
the high frequency intermolecular vibrational or librational motions of water.  The solvation 
dynamics of methanol is also nonexponential and shows an ultrafast component of 30 fs with 
a contribution of 20% to C(t).103  It was concluded that the OH librational motion is 
responsible for the initial 30 fs decay.  Molecular dynamic simulations of solvation dynamics 
water and methanol have also shown that the relaxation contains a large contribution (~50%) 
from a very rapid (sub ~100 fs) underdamped, inertial response.83,103 
C(t) can also be calculated theoretically using the frequency-dependent dielectric 
response ε(ω) of the solvent.  Briefly, in dielectric continuum model, the solvent is treated as 
structureless fluids with a frequency-dependent dielectric constant, ε(ω), represented in the 
Debye equation104-106 as   
ε(ω) = ε∞ +
ε0 −ε∞
1+ iωτ D
     (2.86) 
where ε0 and ε∞ are the static and optical frequency dielectric constants of the liquid, 
respectively.  τD is Debye relaxation time, which is a measure of the time it takes for the 
polarization of a macroscopic sample of liquid to decay to zero after the electric field has 
been turned off.  In this model the C(t) is given by94 
C(t) = e− t /τ L      (2.87) 
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This shows that C(t) decays single-exponentially with a lifetime of τ L = ε∞τ D /ε0.  The 
assumption of Debye form of the frequency-dependent dielectric response ε(ω) may over 
simplify the solvent.  Majority of the solvents show complex dielectric response than given 
in eqs 2.88 to 2.90.  In practice, one can use one of the following three forms of ε(ω) to 
describe the experimental data.42  
ε(ω) = ε∞n +
ε0 j −ε∞j
1+ iωτ Djj
n
∑  Multiple Debye  (2.88) 
ε(ω) = ε∞ +
ε0 −ε∞
(1+ iωτ 0)
β  Davidson-Cole  (2.89) 
ε(ω) = ε∞ +
ε0 −ε∞
1+ (iωτ D )
1−α  Cole-Cole   (2.90) 
For instance, dielectric response of normal alcohols is generally expressed in terms of 
multiple Debye form94 and C(t) is represented by multi-exponential decay function 
C(t) = a j
j
∑ e− t /τ Fj     (2.91) 
with τ Fj =
2ε∞j + εc
2ε0 j + εc
 
 
  
 
 
  τ Dj  and relative amplitude, a j ∝
(ε0 j −ε∞j )
(2ε∞j + εc )(2ε0 j + εc )
.  Here εc is 
dielectric constant of the cavity surrounding the probe. 
Data Analysis 
Construction of Time-Resolved Emission Spectra (TRES)   
Determination of time-resolved emission spectra (TRES) is the most general and 
precise way to quantitatively describe the solvation response function, C(t).  The TRES at a 
given time t is calculated from wavelength-dependent time-resolved fluorescence decays by 
relative normalization to the steady-state spectrum.  Deconvoluted fluorescence decay using 
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instrument response function at each wavelength is represented by multiexponential 
function107,108 
D(λ,t) = ai(λ)e
−
t
τ i (λ )
i
∑     (2.92) 
where a(λ) and τ(λ) are the pre-exponential factor and time constant at a particular 
wavelength λ.  The wavelength-dependent steady-state normalized fluorescence decay 
function, S(λ, t) is defined as 
S(λ, t) = A(λ)D(λ,t)     (2.93) 
where A(λ) is the normalization constant.  The pre-exponential factors (ai) in eq 2.92 are 
relative to each other, but not absolute.  Absolute pre-exponential factor is obtained when 
they are normalized to steady-state intensity S0(λ).  S0(λ) is given by 
S0(λ) = S(λ,t)dt
0
∞
∫ = A(λ) D(λ,t)
0
∞
∫ = A(λ) ai(λ)τ i(λ)
i
∑   (2.94) 
This leads to the normalization constant, A(λ) 
A(λ) =
S0(λ)
ai(λ)τ i(λ)
i
∑
     (2.95) 
Thus, the fluorescence emission intensity at any wavelength (λ) and time (t) can easily be 
calculated using the eq 2.96.83,94 
S(λ, t) =
S0(λ)
D(λ,t)dt
0
∞
∫
D(λ,t) =
S0(λ)
ai(λ)τ i(λ)
i
∑
ai(λ)e
−
t
τ i (λ)
i
∑   (2.96) 
Log-Normal Fitting Equation   
The emission maximum frequencies, ν(t) are usually determined by fitting the points 
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in TRES at different times to the log-normal line shape function, G(ν).  The G(ν) is defined 
as94 
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where α =
2b(ν −ν p )
∆
.  Here, G0, b and νp denote the peak height, asymmetry factor and peak 
frequency, respectively.  The full width at half maximum (FWHM) Γ, and the width, ∆ of 
this function are related by 
Γ = ∆
sinh(b)
b
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 
 
     (2.98) 
Estimation of the Time Zero Spectrum  
The time-zero spectrum is the hypothetical spectrum that would be observed for a 
solute that has completely relaxed vibrationally but before any relaxation of the solvent has 
occurred.109  This is based on the fact that intramolecular vibrational relaxation occurs on 
much faster time scale (sub 100 fs) compared to solvent relaxation.  This indicates that the 
shift between absorption and emission spectra of a solute before solvation takes place should 
be equal to the Stokes shift of the same solute in a non-polar solvent. 
 The basic idea is that a molecule has an intrinsic spectral absorption g(ν) and an 
emission line-shape f(ν).  These line shapes are related to the absorption (Anp) and emission 
spectra (Fnp) of the molecule in a non-polar solvent by 
g(ν) ∝ν −1Anp (ν)     (2.99) 
f (ν) ∝ν −3Fnp (ν)      (2.100) 
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These line shapes functions can be used to calculate the absorption and emission spectra of 
the molecules in an inhomogenously broadened environment.  The solvent molecules, 
distributed around the solute molecule, cause a broadening (σ) and a shift (δ0) of the line 
shape function due to solvent-solute interactions.  Assuming a Gaussian distribution p(δ) of 
solvent molecules, these effects can be described as a convolution of the line shape function 
g(ν) with the solvent distribution function p(ν).  Based on this assumption, the absorption 
spectrum in a polar solvent can be written as 
∫ −∝ δδδννν dpgAp )()()(     (2.101) 
where p(δ) = (2πσ 2)−1/ 2 exp[−(δ −δ0)
2 /2σ 2].  Similarly, the time-zero emission spectrum 
immediately after monochromatic excitation (νex) in a polar solvent can be expressed as 
∫ −−∝= δδδνδδννννν dkfpgtF radexexexp )()()()();0,( 3   (2.102) 
Here, νexg is essentially proportional to the measured absorption spectrum; ν3f is proportional 
to the emitted quantum distribution over wavenumbers.  The krad is the radiative constant.  
The terms, f(ν−δ)krad(δ) leads to emission intensity function and g(ν-δ)p(δ) to convolution of 
the solvent distribution initially transferred to the excited state. g(ν) and f(ν) are obtained 
from the absorption and emission spectra in a non-polar solvent.  The broadening and shift by 
the solvent which define distribution function, p(δ), are determined as a set that yields closest 
match with the absorption spectra in an polar solvent of interest when convoluted with g(ν).  
The radiative rate function is calculated with shift using 
∫
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 Construction of Solvation Correlation Function  
Solvation dynamics are analyzed and quantified by means of the solvation correlation 
function, C(t), 
)()0(
)()(
)(
∞−
∞−
=
νν
νν t
tC      (2.104) 
where ν (0), ν (t) and ν (∞) denote the peak frequency of the emission spectra at time zero, t 
and infinity.  The “zero time” emission spectrum is obtained according to the method of Fee 
and Maroncelli.109  The ν (∞) is taken as the peak frequency of the steady-state fluorescence 
spectrum.  The ν (t) is determined by taking the maxima from the log-normal fits as the time-
resolved emission maximum which is constructed according to the procedure described by eq 
2.96 using steady-state emission spectrum and fitting parameters from wavelength-resolved 
decay traces.  In most cases, however, the broad spectra result in uncertainty in the exact 
position of the emission maxima.  Thus, using the signal-to-noise ratio and width of the 
spectrum (including “zero-time”, steady-state, or time-resolved emission spectrum) as 
guides, we have determined the typical uncertainties as follows: time-resolved emission ~ ± 
200 cm−1, “zero-time” and steady-state ~ ± 100 cm−1.  These uncertainties are used to 
compute error bars for the C(t).  The fractional solvation at any time, t is calculated using  ft = 
1 − C(t). 
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CHAPTER 3.  ACCUMULATION AND INTERACTION OF HYPERICIN IN LOW 
DENSITY LIPOPROTEIN (LDL) — A PHOTOPHYSICAL STUDY 
 
A paper published in the Photochemistry and Photobiology 
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and Pavol Miskovsky3,* 
 
Abstract 
The accumulation and interaction of hypericin with the biologically important 
macromolecule, LDL, is investigated using various steady-state and time-resolved 
fluorescence measurements.  It is concluded that multiple hypericins can penetrate 
considerably deeply into the LDL molecule.  Up to ~ 20 nonaggregated hypericin molecules 
can enter LDL; but upon increasing the hypericin concentration, the fluorescence lifetime of 
hypericin decreases drastically, suggesting most likely the self quenching of aggregated 
hypericin.  There is also evidence of energy transfer from tryptophans of the constituent 
protein, apoB-100, to hypericin in LDL.  The results demonstrate the ability of LDL to 
solubilize hypericin (a known photosensitizer) in nonaggregated form, which has  
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implications for the construction of drug delivery systems. 
Introduction 
 Hypericin (Figure 3.1) is a major component of the botanical dietary supplement, St. 
John’s Wort.  It is a widely spread, naturally occurring perylene quinone pigment that is of 
great interest because of its broad spectrum of light-induced biological activities.1-4  Here, we 
investigate the interaction of hypericin with the biologically important complex, low density 
lipoprotein (LDL).  LDL is the main carrier of cholesterol in the human circulatory system.  
It can be characterized as a spherical particle having three different regions:  the outer surface 
layer, the core region, and an interfacial region between these two.  The surface monolayer 
mainly consists of phospholipid molecules and a single molecule of the protein, apoB-100, 
(one of the largest monomeric proteins known) which consists of 4536 amino acid residues, 
and the core of LDL is enriched with triglycerides and cholesteryl esters.5,6  The biological 
activity of hypericin and its analogs depends on light.  This activity and the underlying 
photophysics have been the subject of numerous reviews.1,4,7-12   
In the biological context, we have extensively studied the interaction of hypericin 
with proteins such as human serum albumin (HSA) 13 and two different isoforms of 
glutathione S-transferase (GST), HA1-1 and HP1-1.14  These studies reveal that hypericin 
forms a rigid complex with these proteins. Upon its incorporation in the blood, it interacts 
mainly with LDL and to a lesser extent with HAS.15 There are also numerous examples of 
interactions of photosensitizers with serum proteins and LDL.16-24  Miskovsky and coworkers 
have studied hypericin binding to LDL using steady-state fluorescence measurements.25  
They concluded that multiple hypericins interact with LDL, most likely through a 
nonspecific interaction with the lipid part of LDL.  The quenching of tryptophan fluorescence 
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emission with increase in hypericin concentration prompted the authors to conclude that the 
hypericin molecules reside somewhere near the apoB-100 part of the LDL;  and, based on 
these observations, they proposed that hypericin accumulates at the interfacial region of the 
LDL molecule:  i.e., between the surface and the core regions.  In this work, we continue the 
investigation of the location of hypericin in LDL by exploiting fluorescence quenching and 
time-resolved fluorescence measurements.  Our results are consistent with theirs. 
 
Figure 3.1.  Structure of hypericin (7,14 normal form). 
 
Materials and Methods 
Hypericin was purchased from Molecular Probes (Eugene, Oregon, USA) and used 
without further purification.  Low density lipoprotein (LDL) (purity > 95 % of total 
lipoprotein content by electrophoresis) was purchased from Calbiochem.  
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Steady-State and Time-Resolved Measurements.  Steady-state absorption spectra 
were obtained on Hewlett Packard 8453 UV-visible spectrophotometer with 1-nm resolution.  
Steady state fluorescence spectra were obtained on a Spex Fluoromax-2 with a 3-nm 
bandpass and corrected for lamp spectral intensity and detector response.  For both 
fluorescence and absorption measurements, a 3-mm path-length quartz cuvette was used.  All 
experiments were done at room temperature. 
The apparatus for time correlated single photon counting is described elsewhere.26  
Briefly, the fundamental from the home-made mode-locked Ti-sapphire oscillator was 
modulated by a Pockels cell (Model 350-160, Conoptics Inc) to reduce the repetition rate.  
The excitation source (266 nm) was generated by sum frequency generation of the 
fundamental red light (~ 800 nm) and the second harmonic blue light (~ 400 nm) using U-
Oplaz Technologies (Model TP-2000B).  Fluorescence decay traces were recorded by 
exciting the sample at 266 nm or at 407 nm and collecting the emission of tryptophan or 
hypericin using appropriate cut-off filters.  For fluorescence lifetime measurements typically 
~ 3000 - 5000 counts were collected at the peak channel.  The polarized fluorescence traces 
of hypericin were used to obtain fluorescence anisotropy decay parameters collected to a 
maximum of ~ 10000 counts at the peak channel.  For LDL/buffer system ~ 6000 counts 
were collected at the peak channel.  Fits were considered acceptable for χ2 ≤ 1.3.  
Sample preparation.  A hypericin stock solution in DMSO was used for sample 
preparation.  The total organic content of the final sample solution was kept < 1% for all 
solutions containing LDL in phosphate buffer (pH 7.0).  The hypericin/LDL solutions were 
equilibrated for about 12 hours in the dark prior to steady state and time resolved 
experiments.  For steady state fluorescence measurements, the solutions were prepared 
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having [LDL] ~ 1 × 10−7 M with varying amounts of hypericin corresponding to [Hyp] ~ 1 × 
10−7 M (1:1  LDL to hypericin) - 3 × 10−6 M (1:30 LDL to hypericin).  For time-resolved 
fluorescence studies, [LDL] was maintained at ~ 5 × 10−7 M and [Hyp] was varied from ~ 5 
× 10−7 (corresponding to 1:1 LDL to hypericin) to 1.5 × 10−5 M (corresponding to 1:30 LDL 
to hypericin).  
Preparation of solutions for Stern-Volmer quenching experiments.  For 
quenching of hypericin in DMSO, two stock solutions were prepared of concentrations 1 × 
10−5 M hypericin in DMSO and 2 M potassium iodide in DMSO.  For all measurements, 
hypericin concentrations were kept constant at 1 × 10−7 M.  Nine solutions were prepared 
with increasing quencher concentration from 0 to 1.2 M.  Similar quenching experiments 
were performed in LDL:Hyp = 1:1 complex by preparing three stock solutions of 
concentrations 1 × 10−5 M, 1 × 10−5 M and 2 M, of hypericin in DMSO, LDL in pH 7 
phosphate buffer and potassium iodide in water.  For experiments with LDL:Hyp = 1:30 
complex the concentration of stock solution of hypericin in DMSO was changed to 3 × 10−4 
M.  For all measurements, hypericin and LDL concentrations were kept constant at 1 × 10−7 
M (for the 1:1 complex) or 3 × 10−6 M (for the 1:30 complex) and 1 × 10−7 M.  Six or seven 
solutions were prepared with increasing quencher concentration from 0 to 1.6 M for 
LDL:Hyp = 1:1 and from 0 to 1 M for LDL:Hyp = 1:30.  Samples were excited at 550 nm for 
taking the emission spectra.       
Results and Discussion 
 
Steady-state experiments  
Hypericin in aqueous physiological solution is aggregated 27,28, and binding with 
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biological macromolecules helps to solubilize it in monomeric form, which is believed to be 
important for virucidal action.  For example, Burel and Jardon have noted that the 
photodynamic properties of hypericin are greatly diminished when it is aggregated.29  Upon 
interacting with LDL, the emission intensity of hypericin increases drastically and the 
emission spectrum closely resembles that of hypericin in bulk organic solvents—e.g., the 
peak maximum is only ~2 nm blue shifted with respect to that of DMSO.  In the following 
sections we discuss the results obtained from different experiments which help us to predict 
the possible location of hypericin in LDL.   
Stern-Volmer quenching by I
−
 ion  
The quenching of hypericin fluorescence by I− is shown in Figure 3.2.  The very 
inefficient quenching in LDL/Hyp = 1:1 complex (Ksv = 0.25 M−1) as compared to 
Hyp/DMSO (Ksv = 5 M−1) indicates that hypericin is not exposed to the surface of LDL and 
is buried sufficiently deeply inside the LDL molecule so as to become inaccessible by I− ion.  
To evaluate the possibility of incorporation of multiple hypericin inside one LDL molecule 
we undertook similar quenching experiment in LDL:Hyp = 1:30 complex.  Most interestingly 
for this complex the KSV value was found to be 0.75 M−1, larger than that for the 1:1 
complex, suggesting that some of the accumulated hypericins are nearer to the surface than in 
the 1:1 complex.  To the extent that the data for the 1:30 complex are genuinely nonlinear, as 
they seem to be from Figure 3.2, they may be analyzed in terms of a nonlinear Stern-Volmer 
plot 30 which provides the fraction of fluorophores, which are initially accessible to the 
quencher, fa, and the intrinsic Stern-Volmer quenching constant.  Using such an approach, we 
obtain 0.42 and 9.2 M−1, respectively, which is consistent with our analysis since the 
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quenching constant obtained in this manner is similar to that obtained in bulk DMSO. 
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Figure 3.2.  Stern-Volmer quenching plot of hypericin in DMSO (solid circles), 
LDL:hypericin = 1:1 complex (open circles) and LDL:hypericin = 1:30 complex (solid 
squares) by I− ion.  KSV values for hypericin/DMSO, LDL:hypericin = 1:1 and 
LDL:hypericin = 1:30 complexes were found to be 5 M−1, 0.25 M−1 and 0.75 M−1,  
respectively.  The very inefficient quenching in LDL/hypericin complexes indicates that 
hypericin is not located at the LDL surface and that it is inaccessible to iodide.  All samples 
were excited at 550 nm. 
 
Energy transfer from tryptophan to hypericin 
There is significant overlap of tryptophan emission and hypericin absorption spectra 
(Figure 3.3).  This facilitates energy transfer from tryptophan to hypericin molecules.  Energy 
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transfer is well-documented for the HSA-hypericin complex.13  There are 37 tryptophan 
molecules in LDL, clearly rendering such a process plausible in this system as well.  To 
evaluate the relative position of hypericin molecules with respect to apoB-100, we studied 
the energy transfer from tryptophan molecules in apoB-100 to hypericin molecules.  With 
increasing hypericin concentration (going from 0 to 30 molecules of hypericin for each LDL 
molecule), there is a decrease in tryptophan emission.  Consequently, it is reasonable to 
conclude that there is efficient energy transfer between tryptophan and hypericin.  In order to 
quantify this observation, however, it is necessary to correct the tryptophan emission spectra 
since hypericin’s absorption spectrum overlaps that of tryptophan. Corrected steady-state 
fluorescence emission spectra of tryptophan and hypericin are shown in Figure 3.4.  The 
decrease of the tryptophan fluorescence quantum yield (10 % decrease in the 1:10 LDL:Hyp 
complex) and corresponding increase in the hypericin quantum yield (20 % increase in 1:10 
LDL:Hyp complex) points toward energy transfer from tryptophan to hypericin molecules.  
However, for the 1:20 complex the decrease in tryptophan fluorescence quantum yield is 
more pronounced (20 % decrease for tryptophan).  We observe a corresponding increase in 
hypericin emission when complexed to LDL in LDL:Hyp = 1:20 complex (37 % increase in 
hypericin emission with respect to that of in DMSO).  This suggests that the efficiency of 
energy transfer increases with increasing hypericin content. The fluorescence quantum yields 
of tryptophan and hypericin in different systems are shown in Figures 3.4a and 3.4b 
respectively.  Its value in the 1:30 complex is smaller than in the 1:20 complex, suggesting 
self quenching among hypericin aggregates.  
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Figure 3.3.  Spectral overlap between hypericin absorption and tryptophan emission in the 
LDL-hypericin complex, suggesting the possibility of energy transfer from tryptophan to 
hypericin.  The calculated R0 for LDL-hypericin complex is 27 Ǻ (see text).  The 
corresponding value for HSA-hypericin complex is 28 Ǻ, which was incorrectly calculated 
elsewhere.13  The donor spectrum was obtained using a solution of LDL in buffer and its 
fluorescence quantum yield (for the computation of R0) was obtained in the absence of 
hypericin.  For the acceptor spectrum we have used the excitation spectrum of hypericin in 
DMSO, converted to molar extinction coefficient. 
 
Time-resolved fluorescence measurements   
Fluorescence lifetime parameters of tryptophan and hypericin with an excitation 
wavelength of 266 nm are compiled in Tables 3.1 and 3.2.  Representative decays are shown 
in Figure 3.5.  There is a decrease in tryptophan fluorescence lifetime with increasing 
hypericin concentration.  This effect is more pronounced in the LDL:Hyp = 1:20 complex 
than in LDL in buffer (1.2 ns as opposed to 2.3 ns).  The decrease in tryptophan lifetime in 
the presence of hypericin is consistent with energy transfer from tryptophan to hypericin.   
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Figure 3.4.  Corrected steady-state fluorescence emission spectra of (a) tryptophan and (b) 
hypericin in different systems.  The decrease in tryptophan emission and the corresponding 
increase in hypericin emission suggest energy transfer from tryptophan to hypericin.  For all 
experiments, samples were excited at 266 nm.  The fluorescence quantum yield of tryptophan 
and hypericin are given in parentheses in the figure.     
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Table 3.1.  Fluorescence lifetime parameters of tryptophan in different systems 
 
System
a
 
 
 
a1 
 
τ1 (ps) 
 
a2 
 
τ2 (ps) 
 
τ3 (ps)
b
 
 
〈τ〉 (ps)c 
 
LDL/Buffer 
 
 
0.44 ± 
0.02 
 
600 ± 100 
 
0.56 ± 
0.02 
 
3600 ± 
300 
 
---- 
 
2300 ± 
300 
 
LDL:Hyp = 
1:10 
 
0.47 ± 
0.01 
 
560 ± 100 
 
0.53 ± 
0.01 
 
3200 ± 
200 
 
 
---- 
 
2000 ± 
200 
 
LDL:Hyp = 
1:20 
 
0.23 ± 
0.02 
 
 
130 ± 20 
 
0.46 ± 
0.03 
 
620 ± 100 
 
3000 ± 
300 
 
1200 ± 
400 
 
LDL:Hyp = 
1:30 
 
0.32 ± 
0.02 
 
 
120 ± 20 
 
0.40 ± 
0.03 
 
600 ± 100 
 
2800 ± 
200 
 
1100 ± 
300 
 
aλex = 266 nm, λem = 300-410 nm.   
bThe absence of τ3 indicates that the decay was fit to two decaying exponentials.   
cThe average lifetime was calculated according to i i
i
<τ> = a τ∑ .  The pre-exponential 
factors sum to unity.  The error bars are based on the average of three measurements. 
 117 
 
Table 3.2.  Fluorescence lifetime parameters of hypericin in different systems 
 
System
a
 
 
 
a1 
 
τ1(ps) 
 
τ2 (ps)
b
 
 
〈τ〉 (ps)c 
 
Hyp/DMSO 
 
 
1.0 
 
---- 
 
5600 ± 200 
 
5600 ± 200 
 
LDL:Hyp = 1:10 
 
 
1.0 
 
---- 
 
7400 ± 300 
 
7400 ± 300 
 
LDL:Hyp = 1:20 
 
 
1.0 
 
---- 
 
7600 ± 300 
 
7600 ± 300 
 
LDL:Hyp = 1:30 
 
 
0.20 ± 0.01 
 
1200 ± 100 
 
5400 ± 200 
 
4600 ± 300 
 
aλex = 266 nm, λem ≥ 500 nm.   
bThe absence of τ1 indicates that the decay was fit to a single decaying exponential.   
cThe average lifetime was calculated according to i i
i
<τ> = a τ∑ .  The pre-exponential 
factors sum to unity.  The error bars are based on the average of three measurements. 
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Figure 3.5.  Representative fluorescence lifetime decays of (a) tryptophan and (b) hypericin. 
All samples were excited at 266 nm.  There is a decrease in fluorescence lifetime of 
tryptophan and an increase in hypericin lifetime when complexed to LDL.  Fitting parameters 
are given in Tables 3.1 and 3.2.   Data on the 11.9-ns time scale are collected with a 
resolution of 23.3 ps/chan. 
 
Hypericin absorbs light directly at 266 nm and, as indicated above, is also an acceptor 
for energy transfer from tryptophan.  Thus, 266-nm excitation will induce hypericin 
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fluorescence:  the lifetime decay of hypericin is single exponential up to LDL:Hyp = 1:20.  
Also, there is an increase in fluorescence lifetime of hypericin compared to that of in bulk 
solvents (~ 7.5 ns in LDL as opposed to ~ 5.6 ns in DMSO).  The question then arises 
whether this lengthening of the hypericin lifetime is a result of interactions with tryptophan 
or induced by local environment of hypericin in LDL.  To attempt to differentiate between 
these two possibilities we measured the lifetimes exciting hypericin directly.  Lifetime 
parameters are given in Table 3.3.  Here too, a similar trend is observed.    
This lifetime lengthening is clearly a result of multiple hypericins in the LDL 
molecule.  There are two explanations that seemed likely for its presence.  There is the 
possibility that it arises from energy transfer from the tryptophans:  the latter acting as a 
relatively long-lived pulse source that artificially seems to lengthen the hypericin lifetime.  
This idea was tested by convoluting tryptophan lifetimes from 100 ps to 3 ns with the 
“standard” hypericin lifetime of ~5.6 ns.  This clearly induced a rise-time in the simulated 
hypericin transient, but it did not produce any significant lengthening of the lifetime and 
produced nothing like that we measured experimentally.  This possibility can definitively be 
eliminated by noting that direct excitation into hypericin produces similar effects (Figure 
3.6).  Consequently, it seems most likely to us that the observed lifetime is a result of 
hypericin-hypericin interactions, possibly excimer-like interactions.   We note that similar 
fluorescence lifetimes (i.e., longer than that observed in bulk solvent) have been observed in 
other systems as well.31   We also note that our earlier investigation of hypericin in reverse 
micelles in heptane indicated that there is a slight lengthening of the fluorescence lifetime to 
~5.9 ns.32 
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Table 3.3.  Fluorescence lifetime parameters of hypericin in different system  
 
aλex = 407 nm, λem ≥ 500 nm.  
bThe absence of τ1 indicates that the decay was fit to a single decaying exponential.  
cThe average lifetime was calculated according to i i
i
<τ> = a τ∑ .  The pre-exponential 
factors sum to unity.  The error bars are based on the average of three measurements.  
 
 
 
 
 
 
 
System
a
 
 
 
a1 
 
τ1 (ps)
 
 
τ2 (ps)
b 
 
<τ> (ps)c 
 
Hyp/DMSO 
 
 
1.0 
 
------ 
 
5600 ± 200 
 
5600 ± 200 
 
LDL:Hyp = 1:10 
 
 
1.0 
 
----- 
 
6600 ± 300 
 
6600 ± 300 
 
LDL:Hyp = 1:10 
 
0.14 ± 0.01 
 
 
200 ± 50 
 
7000 ± 200 
 
6000 ± 600 
 
LDL:Hyp = 1:20 
 
0.09 ± 0.01 
 
 
600 ± 100 
 
6500 ± 200 
 
6000 ± 700 
 
LDL:Hyp = 1:30 
 
0.24 ± 0.02 
 
 
900 ± 100 
 
4800 ± 200 
 
3900 ± 500 
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Figure 3.6.  Plot of average fluorescence lifetime of tryptophan with 266 nm excitation (solid 
circles), hypericin with 266 nm excitation (open circles) and hypericin with 407 nm 
excitation (solid squares) with respect to the ratio of concentration of LDL to hypericin in 
different LDL-hypericin complexes studied.   
 
In order to determine the efficiency of the tryptophan-hypericin energy transfer, we 
estimated the critical distance for the LDL-hypericin complex.  The efficiency of the 
nonradiative energy transfer in a Förster energy transfer mechanism is given by, among other 
things, R0, the critical distance at which the rate of energy transfer is equal to the inverse of 
fluorescence lifetime of the donor.   
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In the above equations kET is the rate of energy transfer, τF is the average lifetime of the 
tryptophan donor, R is the distance between the donor and acceptor, n is the refraction index 
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of the medium (considered as 1.4), N is Avogadro’s number, ΦD is the fluorescence quantum 
yield of the tryptophan donor (0.10) which was calculated with respect to standard value for 
tryptophan in pH 7 buffer (0.18)13,33,34, FD( ν ) is the donor emission spectrum on a  
wavenumber scale and εA( ν ) is the molar extinction coefficient of the acceptor (in M−1cm−1) 
on a wavenumber scale.  The calculated R0 for LDL-hypericin complex is 27 Å.  Considering 
the apoB-100 is mainly located on the surface of LDL this distance might indicate that the 
hypericin molecules are mainly localized near the apoB-100.  
 The presence of multiple donors and acceptors in LDL-hypericin complex (37 
tryptophans and 10-30 hypericins), however, clearly obviates any concrete interpretation of 
this “distance,” since with the current experiments it is impossible to specify which of the 
donor-acceptor pairs are participating in the energy transfer process.   
Time resolved anisotropy measurements 
Fluorescence anisotropy decay parameters are given in Table 3.4.  Representative 
polarized fluorescence decays are presented in Figure 3.7.  Tryptophan molecules in LDL 
show two rotational time constants, which are widely separated.  The shorter component (~ 
400 ps) can be attributed to local motion of tryptophan molecules; the very long component 
(> 40 ns), to the tumbling motion of the LDL molecule.  
For LDL:Hyp = 1:1 complex, exciting hypericin directly at 407 nm, we observed a single 
rotational time constant of ~ 10 ns for hypericin, indicating that it is rigidly bound and 
consequently, probably not attached to the LDL surface, where more flexibility might be 
expected.  Similar behavior is observed in other hypericin/protein systems that we have 
investigated (Table 3.4).   
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Table 3.4.  Fluorescence Anisotropy Decay Parameters in Different Systemsa 
System r0
b
 rF τF
(r)
 (ns) rS τS
(r) 
(ns) 〈τ〉 (ns) 
LDL/bufferc 0.22 ± 0.02 0.08 ± 0.02 0.4 ± 0.1 0.14 ± 0.02 > 40 ----- 
LDL:Hyp = 1:1d −0.07 ± 
0.01f 
----- ----- −0.07 ± 
0.01 
10.3 ± 0.5 10.3 ± 0.5 
LDL:Hyp = 1:10d −0.06 ± 
0.01f 
−0.02 ± 
0.01 
0.9 ± 0.2 −0.04 ± 
0.01 
10.3g 7.2 ± 1.2 
LDL:Hyp = 1:30d −0.06 ± 
0.01f 
−0.03 ± 
0.01 
1.6 ± 0.3 −0.03 ± 
0.01 
10.3g 6.0 ± 1.0 
HSA:Hyp = 1:1e 
13 0.32 ------ ------ 0.32 31 31 
GST (HA1-
1/HP1-1):Hyp = 
1:1e 14 
0.30 ----- ------ 0.30 ≥ 20 ≥ 20 
 
aThe subscripts “F” and “S” denote the fast and slow depolarizing events, the latter which is 
attributed to overall protein tumbling. 
bThe error bars are based on the average of three measurements.  An average anisotropy 
decay time is not computed for the LDL/buffer system, since the longer decay component 
could not be accurately determined on the time scale used, 24-ns full scale.  For all systems 
χ2 ≤ 1.3.  
cλex = 266 nm, λem ≥ 300 nm.  d  λex = 407 nm, λem ≥ 500 nm.  e λex = 580 nm, λem ≥ 610 nm.   
fThe negative r0 value for hypericin is due to excitation at 407 nm.  See Das et al. 35 for a 
discussion of the wavelength dependence of the limiting anisotropy of hypericin and related 
pigments.  
gFor LDL complexes with multiple hypericins, the longer rotational time component was 
considered as a fixed global parameter. 
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For complexes having multiple hypericins, we have fit the polarized fluorescence 
decays to two decaying exponentials.   Here we take the longer time component as a fixed 
global parameter having a 10.3-ns rotational time constant, as determined for the LDL:Hyp = 
1:1 complex.  Shorter “nontumbling” time constants are observed:  ~ 900 ps and ~ 1600 ps 
for 1:10 and 1:30 complexes, respectively.  The possibility of surface exposure of hypericin 
is unlikely given the results of the Stern-Volmer experiments cited above.  Two possibilities 
thus present themselves:  some hypericins are nearer to the surface (i.e., farther to the surface 
in the interfacial zone, but not surface exposed) and have more latitude of movement; all 
hypericins are bound rigidly, but there are depolarizing events due to energy transfer (self-
quenching) among hypericin molecules, whose presence seems likely given the data in 
Tables 3.3 and 3.4.  Most likely, a combination of both is possible.    
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Figure 3.7.  Representative polarized fluorescence decay of hypericin in 1:1 LDL:Hyp 
complex.  λex = 407 nm, λem ≥ 500 nm.  Anisotropy parameters indicate that hypericin is 
rigidly bound to LDL (see the text and Table 3.4).   
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Conclusions 
 
We have studied the interaction of hypericin with the biologically important 
macromolecule, LDL. Based on various steady-state and time-resolved fluorescence 
measurements, we conclude that multiple hypericins can penetrate considerably deeply into 
the LDL molecule and most likely span the interfacial region.  In particular, the anisotropy 
data indicate that a single hypericin is rigidly held, and thus probably resides fairly deeply in 
LDL.  Energy transfer is efficient, suggesting that hypericin can be moderately close to the 
surface, where apoB-100 is located.  Both results taken together suggest that the hypericin 
lies in an intermediate location between surface and core—i.e., the interfacial region. The 
accommodation of multiple hypericins in LDL should not be surprising considering the 
diameter of LDL (~ 220 Å) and the dimensions of hypericin:   major axis, 10.5 Å; minor 
axis, 9.6 Å.  
 Up to ~ 20 nonaggregated hypericin molecules can enter one LDL; but upon 
increasing the hypericin concentration, the fluorescence lifetime of hypericin decreases 
drastically, suggesting most likely the self quenching of aggregated hypericin.  The ability of 
LDL to solubilize hypericin is significant because hypericin has been reported to be most 
active in its monomeric form.36  
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CHAPTER 4.  SOLVATION DYNAMICS OF THE FLUORESCENT PROBE, 
PRODAN, IN HETEROGENEOUS ENVIRONMENTS:  CONTRIBUTIONS FROM 
THE LOCALLY EXCITED AND CHARGE-TRANSFERRED STATES 
 
A paper published in The Journal of Physical Chemistry B  
 
Ramkrishna Adhikary, Charles A. Barnes, and Jacob W. Petrich* 
 
Abstract   
The coexistence of different excited states with different properties of the same 
chromophores could have significant consequences for the accurate characterization of 
solvation dynamics in a heterogeneous environment, such as a protein.  The purpose of this 
work is to study the contributions of the locally-excited (LE) and charge-transferred (CT)  
states of the fluorescent probe molecule, 6-propionyl-2-(N,N-dimethylamino)naphthalene 
(PRODAN), PRODAN to its solvation dynamics in the heterogeneous environment provided 
by reverse micelles formed by sodium 1,4-bis-(2-ethylhexyl) sulfosuccinate (AOT)/n-
heptane/water.  We have found that the LE and CT states of PRODAN solvate on different 
time scales in reverse micelles (2 and ~0.4 ns, respectively), consistent with results suggested 
in the literature, and have concluded that PRODAN’s use as a probe of heterogeneous
____________________________________ 
Reprinted with permission from The Journal Physical Chemistry B 2009, 113(35), 11999-
12004. Copyright (2009) American Chemical Society. 
Department of Chemistry, Iowa State University, Ames, Iowa 50011. 
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environments must be used with caution and that, more importantly, the same caution must 
be exercised with any chromophore capable of emitting from different excited states.  
Introduction  
Fluorescent molecules sensitive to environmental polarities have been used 
extensively as probes in the studies of physicochemical properties of solvents, surfaces, 
proteins, membranes, cells etc.1-5  It is critical to understand the photophysical properties of 
the fluorescent probe molecule, especially if it can emit from more than one state.  6-
Propionyl-2-(N,N-dimethylamino)naphthalene (PRODAN) (Figure 4.1) is a highly 
fluorescent, hydrophobic molecule, first synthesized and characterized by Weber and Farris 
in 1979.6    Its absorption and emission spectra are strongly dependent upon the polarity of its 
environment 6, and it has a long history of use in probing biological systems.7-14  It has been 
used as an optical probe of the function and dynamics of proteins and membranes.7-14  
Recently it has also been used to study solvation dynamics in polar liquids, ionic liquids, and 
supercritical fluids.15-19   
PRODAN is a push-pull, charge-transfer chromophore that produces a substantial 
change in its excited-state dipole moment upon photoexcitation owing to the presence of an 
electron-donating dimethylamino group and electron-withdrawing propionyl group 
connected to the aromatic spacer by a single bond.  The excited-state kinetics of PRODAN 
are complex, and the origins of its solvatochromatic nature have been debated.20-26  
Theoretical calculations suggest a planar structure in the ground state.  But the geometry of 
its charge-transferred emissive state has not yet been confirmed.20,27  Several theoretical 
studies have been performed to determine the possible conformational changes in its excited- 
state geometry:  for example, whether the emissive state is twisted intramolecular charge 
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transfer (TICT) or planar intramolecular charge transfer (PICT).20,23-35   
(a) (b)
(c)  
Figure 4.1.  Structure of (a) 6-Propionyl-2-(N,N-dimethylamino)naphthalene (PRODAN), 
(b) 2′-(N,N-dimethylamino)-6-naphthoyl-4-trans-cyclohexanoic acid (DANCA) and (c) 
Aladan.   
 
Lakowicz and Balter 36,37 studied PRODAN in n-butanol and suggested that its 
spectral relaxation requires at least two steps.  Later Heisel et al. 28 explained the time-
resolved fluorescence experimental results of PRODAN in n-butanol in terms of a 
nonradiative intramolecular reaction from a locally-excited state to an energetically lower 
charge-transferred state and to solute-solvent interactions.  Chapman et al. 15 and Chapman 
and Maroncelli 16 discussed the spectral relaxation of PRODAN in terms of a continuous 
solvation process.  It is generally agreed that, PRODAN undergoes excited-state 
intramolecular charge-transfer following excitation from the ground state.  The charge-
trasferred state, CT, is formed from an initially excited state referred to as the locally-excited 
state (LE).38  In nonpolar environments, emission is from the LE state, while in polar 
environments the emission is from the CT state (Figure 4.2).38  
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PRODAN has a single broad emission spectrum with a dramatic solvatochromatic 
shift (~130 nm) of its maximum, ranging from 401 nm in cyclohexane to 531 nm in water.6  
Weber and Farris 6 first reported a change in dipole moment, ∆µ ~ 20 D,  upon excitation, 
and concluded that this was responsible for its  large Stokes shift.  Balter et al. modified this 
value to 10 D and suggested that solvent-specific interactions (e.g., hydrogen bonding) may 
cause a large Stokes shift in polar protic solvents.29  Recently Samanta et al. 32 have 
suggested this value to be 4.4-5.0 D based on transient dielectric loss measurements.  
Recently ground and excited Frank-Condon state dipole moment of PRODAN was also 
reported from electrooptical absorption measurements.39   
hυ
LE CT  
Figure 4.2. The charge-transferred (CT) state is created via the locally-excited (LE) state in 
polar environments.   
 
PRODAN has a single-exponential fluorescence lifetime decay in nonpolar solvents 
(e.g., cyclohexane:  ~ 0.2 ns; heptane:  ~ 0.14 ns) and in polar aprotic solvents (e.g., 
acetonitrile:  ~3.3 ns).22,40  However, it exhibits a biexoponential lifetime in polar protic 
solvents such as methanol and water.  The reported lifetime components in methanol are ~2.0 
ns (75%) and 3.4 ns (25%).22  The fluorescence behavior is more complex in water than in 
other solvents:  Balter et al. 22 observed an additional, weak emission band around 430 nm. 
They also reported a biexponential fluorescence lifetime (τ1~0.5 ns and τ2~1.9 ns) with an 
additional small contribution from a long-lived component of ~ 13 ns at the blue edge of 
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emission spectrum, exciting at 337 nm.  The faster lifetime component in protic solvent was 
interpreted in terms of a solute-solvent complex formation via hydrogen bonding.  Later, 
Bunker et al. 29 noticed a stronger blue emission band exciting at 280 nm, and they suspected 
that the blue emission was the consequence of water-soluble impurities present in 
commercial PRODAN.  Sun and coworkers 41 resolved this ambiguity.  They showed that the 
extra blue-edge shoulder and the small contribution from the additional long-lived 
component (~ 13 ns) in the fluorescence decay were the result of  PRODAN-PRODAN  
intermolecular interactions in a supersaturated solution of PRODAN in water.                  
Our work here is motivated by previous studies using PRODAN to study the 
environments of reverse micelle.40,42-48  While most of these studies attributed PRODAN 
fluorescence to only the LE state and rationalized the observed emission to partitioning of the 
fluorophore in different regions of the reverse micelle 42-47,  Novaira et al. 40,48 have reported 
dual fluorescence from both LE and CT in reverse micelles  arising from both the LE and CT 
states by using time-resolved area normalized emission spectroscopies.     
The coexistence of different excited states with different properties of the same 
chromophores could have significant consequences for the accurate characterization of 
solvation dynamics in a heterogeneous environment, such as a protein.  Therefore, the 
purpose of this work is to study the contributions of LE and CT states of PRODAN to its 
solvation dynamics, in particular, in reverse micelles formed by sodium 1,4-bis-(2-
ethylhexyl) sulfosuccinate (AOT)/n-heptane/water (Figure 4.3).  We have found that the LE 
and CT states of  PRODAN solvate on different time scales and concluded that PRODAN’s 
use as a probe of heterogeneous environments must be used with caution.    
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Figure 4.3.  PRODAN in the 1,4-bis-(2-ethylhexyl) sulfosuccinate (AOT)/n-heptane/water 
reverse micellar environment.  LE and CT are the locally-excited and charge-transferred 
emissive states of PRODAN, respectively.     
 
Experimental Section 
Materials.  6-Propionyl-2-(N,N-dimethylamino)naphthalene (PRODAN) (purity ≥ 
98%) and sodium 1,4-bis-(2-ethylhexyl) sulfosuccinate (AOT) (purity > 99%) were obtained 
from Sigma-Aldrich and used as received.  n-Heptane was obtained from Acros, 
Spectragrade. Methanol and acetonitrile (purity 99.9%) were purchased from Fisher 
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Scientific and used without further purification.  
Sample Preparation. Stock solutions of PRODAN (0.05 M) in acetonitrile and AOT 
(0.8 M) in n-heptane were prepared.  The reverse micelle system was prepared through 
volumetric dilution from the stock solutions.  The final AOT concentration was 0.2 M.  The 
concentrated PRODAN in acetonitrile solution was used to introduce the probe into the 
system.  The final concentration of PRODAN was 5×10-5 M with an organic content of < 
0.1%.  An appropriate amount of nanopure water was then added to obtain w = 20 (w = 
[H2O]/[AOT] ).  All samples were allowed to equilibrate for 24 hrs before subsequent steady-
state and time-resolved measurements.  To prepare a PRODAN/water solution, 45µL of a 
solution of 1×10-3 M PRODAN in methanol (Fisher Scientific, HPLC) was added to 5 mL of 
water:  i.e., 9×10-6 M PRODAN/water was prepared with an organic content < 0.9%.  This 
freshly prepared solution was then used for the steady-state and time-resolved measurements.   
Steady-State Measurements. Steady-state absorption spectra were obtained on a 
Hewlett Packard 8453 UV-visible spectrophotometer with 1-nm resolution.  Steady-state 
emission spectra were obtained on a Spex Fluoromax-4 with a 3- or 4-nm bandpass and 
corrected for lamp spectral intensity and detector response.  For absorption and emission 
measurements, 5-mm and 1-cm path-length quartz cuvettes were used, respectively.  All 
experiments were done at room temperature. 
Time-Resolved Measurements.  Measurements of excited-state lifetimes were 
performed with the time-correlated single-photon counting (TCSPC) technique.  The 
apparatus for time- correlated single-photon counting is described elsewhere.49  The 
fundamental from a home-made mode-locked Ti-sapphire oscillator was modulated by a 
Pockels cell (Model 350-160, Conoptics Inc) to reduce the repetition rate to 8.8 MHz.  All 
  
136 
experiments were performed using either the 407-nm or 266-nm excitation obtained from the 
814 nm fundamental by means of a U-Oplaz Technologies (Model TP-2000B) 
doubler/tripler.  Recent modifications in the experimental set-up include the replacement of 
NIM-style electronics by a Becker & Hickl photon counting module (Model SPC-630).  With 
this modified system, the full-width at half-maximum of the instrument-response function is 
~40 – 50 ps.  A cuvette of 5-mm or 1-cm path length was used for the time resolved 
measurement depending upon the system.  
To construct the time-resolved spectra, a series of decays were collected typically 
from 370 nm to 560 nm at 10 nm intervals.  Transients were fit to sums of exponentials, and 
time-dependent spectra were reconstructed from these fits by normalizing to the steady-state 
spectra:  
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D(λ,t) is the wavelength-resolved fluorescence decay, and S0(λ) is the steady-state emission 
intensity at a given wavelength.  We have employed the traditional approach of fitting the 
time-resolved spectra to a log-normal function, from which we extract the peak frequency, 
ν(t), as a function of time.   
Results and Discussion 
The absorption and emission spectra of PRODAN in AOT/n-heptane/water (w = 20) 
are shown in Figure 4.4.  The emission spectrum of PRODAN in AOT/n-heptane/water 
exciting at 266 nm consists of two bands.  This result is consistent with the dual emission 
obtained previously exciting at 330 nm in AOT/n-heptane/water reverse micelles 40 from a 
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locally-excited state (LE) at λem max = 411 nm and from a charge-transferred state (CT) at λem 
max = 507 nm.  Upon excitation at 407 nm, only one emission band was obtained, with λem max 
= 508 nm.  Thus, it is possible to observe PRODAN emission from both the LE and CT 
states in the same sample; and its emission can be tuned with excitation energy.   
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Figure 4.4. Normalized absorption (solid line) and emission spectra (dashed line) of 
PRODAN in AOT/n-heptane/water (w = 20).  The emission spectrum was fit with two log-
normal equations to obtain individual emission spectra for the CT (dashed-dotted line) and 
LE states (dotted line).  The sample was excited at 266 nm and emission was collected using 
a 345 nm long-pass filter.   
 
Fluorescence lifetime decays of PRODAN in water, n-heptane and AOT/n-
heptane/water (w = 20) at different excitation wavelengths are displayed in Figure 4.5.  
Figure 4.5A presents the decay traces of PRODAN in n-heptane and water exciting at 266 
nm.  The lifetime parameters are given in Table 4.1.  PRODAN has a single-exponential 
lifetime with a time constant of 0.15 ns in n-heptane.  The decay of PRODAN in water is 
well described by a biexponential function with time constants of 0.70 ns (60%) and 2.0 ns 
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(40%).  There is a significant change in the decay kinetics of PRODAN in AOT/n-
heptane/water (w = 20) depending on whether the excitation wavelength is 266 or 407 nm 
(Figure 4.5B).  The trace obtained with 266 nm excitation was best fit with a biexponential 
function with time constants of 0.16 ns (70%) and 2.3 ns (30%).  The trace obtained with 407 
nm, however, was best fit by a single exponential with a time constant of 2.6 ns.  The 
absence of a risetime of the CT emission band (Table 4.1, Figure 4.5B) suggests that in such 
a polar environment the LE→ CT reaction rate of PRODAN is too fast to be resolved under 
the present experimental conditions.  4-N,N-dimethylaminobenzonitrile (DMABN) is a well 
studied molecule which emits from both LE and CT states and shows dual emission bands in 
polar solvents.50,51  It is important to note that DMABN also leads to a complete cutoff of the 
LE emission band and shows only the CT emission band upon red-edge excitation of its 
absorption spectrum in polar solvent.52 The charge-transferred time found for DMABN in a 
polar acetonotrile solution was ~4-6 ps.53,54 
To investigate the solvation of the LE and CT states, wavelength-resolved lifetime 
measurements were carried out at 20 different wavelengths from 370 to 560 nm for 
PRODAN in AOT/n-heptane/water (w = 20) and were fit to a sum of two decaying 
exponentials.  Representative wavelength-resolved fluorescence decay traces are displayed in 
Figure 4.6.  To evaluate the spectra and dynamics of the LE and CT states separately, the 
emission spectrum in Figure 4.4 was decomposed into two bands using log-normal functions.  
Time-resolved emission spectra were constructed according to eq 4.1 for each using the 
fitting parameters for the 20 wavelength-resolved decay traces.  Representative time-resolved 
emission spectra for the LE and the CT states are given in Figure 4.7.  Plots of peak 
frequencies as a function of time are given in Figure 4.8 for the LE and CT states.  The peak 
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shift was fit to a single exponential of time constant 2.0 ns for LE and to two exponentials 
with time constants of 0.40 ns (91%) and 4.0 ns (9%) for CT.    
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Figure 4.5. (A) Fluorescence decay traces of PRODAN in (a) n-heptane and (b) water, 
exciting at 266 nm.  (B) Fluorescence decay traces of PRODAN in AOT/n-heptane/water (w 
= 20) exciting at (a) 266 nm and (b) 407 nm.   
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Table 4.1.  Lifetime parameters of PRODAN in different environments 
System a1 τ1 (ns) a2 τ2 (ns) 
a n-heptane 1.0 0.15 ---- ---- 
a water 0.60 0.70 0.40 2.0 
a AOT/n-heptane/water (w = 20) 0.70 0.16 0.30 2.3 
b AOT/n-heptane/water (w = 20) 1.0 2.6 ---- ---- 
 
a λex = 266 nm, λem ≥ 300 nm 
b λex = 407 nm, λem ≥ 425 nm  
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Figure 4.6. Representative wavelength-resolved decay traces of PRODAN in AOT/n-
heptane/water (w = 20) at (a) 370 nm, (b) 400 nm, (c) 430 nm, (d) 460 nm, (e) 490 nm, and 
(f) 560 nm, exciting at 266 nm. 
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Figure 4.7. Representative normalized time-resolved emission spectra of the locally-excited 
state (LE) and the charged-transferred state (CT) at 0.05, 0.2, 0.4, 0.6, 0.8, 1.0, 2.0, 5.0, and 
10.0 ns.  
 
These results clearly demonstrate that the solvatochromic probe, PRODAN, can emit 
from different states in a heterogeneous environment and that, owing to the different natures 
of these states (i.e., charge-transferred or not), their solvation dynamics can occur on 
different time scales and they can have significantly different Stokes shifts.  This, 
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consequently, introduces another level of complication into the interpretation of the data 
when fluorescence is observed from chromophores capable of emitting from more than one 
excited state.  If the properties of each state are known, it is possible to take them into 
account.  We have recently discussed and compared two methods of performing such an 
analysis.55   
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Figure 4.8.  Plots of the maxima of the time-resolved emission spectra for the locally-excited 
(LE) state (solid circles) and the charge-transferred (CT) state (empty circles).   Peak 
frequencies were obtained by fitting the time-resolved emission spectra to log-normal 
functions.   The peak shift was fit to a single exponential of time constant 2.0 ns for LE and 
to two exponentials with time constants of 0.40 ns (91%) and 4.0 ns (9%) for CT.  
 
There are other factors, however, that are more difficult to account for, namely the 
effects of slow conformational changes or aggregation, which is possible at the high 
concentrations (~ 1 mM) 56,57 at which some of these experiments are performed.  We now 
refer to a few examples.  As illustrated in Figure 4.1, more elaborate fluorescent probes of 
biological systems are based upon the PRODAN chromophore, namely, DANCA 58 and, 
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more recently, a nonnatural amino acid analog, Aladan 59.   Boxer and coworkers 56 have 
incorporated the latter at different buried and exposed sites of the immunoglobin binding 
domain, B1, of protein G (GB1) and measured the time-dependent Stokes shift.   All the sites 
showed a bimodal relaxation with an inertial ultrafast response of ~80-140 fs followed by a 
much slower relaxation on the timescale of several picoseconds to several nanoseconds, 
depending upon the location of the probe.  This experimental work forms the basis for a good 
comparison with simulations performed by Golosov and Karplus.60   In the context of their 
study, an interesting observation was that the time-resolved emission spectra of Aladan at 
fully and partially exposed sites of the protein showed a blue shift at long times (> 1 ns).  The 
authors suggested that this blue shift could be attributed either to different chromophore 
populations having different lifetimes and solvation dynamics or to aggregation effects.   
 Based on our above results for the PRODAN photophysics and solvation dynamics, 
we suggest a model that can produce a blue shift of time-resolved spectra at long times.  In 
this model we assume that the LE state is formed from CT states.  In particular, we assume a 
slow ground-state conformational change or aggregation that perturbs the environment of 
the chromophore in such a manner that CT states are no longer predominantly favored and 
thus increases the population of LE states.  As LE is gradually formed in this manner, it will 
undergo its characteristic solvation dynamics, which must be convoluted with the LE 
formation and decay in order to obtain the complete spectral response of this newly formed 
species.  The spectrum at any given time will then have contributions from both CT and LE. 
Thus, the time course of production and decay of LE, L(t) is given by   
                                                      )()( 0 LE
f
tt
eeItL ττ
−−
−=                                                     (4.2) 
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where I0 is fraction of the protein population that undergoes the conformational change 
discriminating against the formation of CT and instead favoring the production of LE.   In 
our simulation, we took I0 = 0.1 (~20% of the CT population, as given by the spectral 
decomposition of eq 4.1). The time of formation, τf, of LE from CT was chosen as 5.0 ns. 
The fluorescence lifetime of LE, τLE, was found experimentally to be 0.15 ns.  The evolution 
of time-resolved spectra of LE is 
                                                       LE
m tt
eAetI τσ
λλ
λ
−
−
−
=
2
2))((
2
1
),(                                             (4.3) 
where A = 2.4 and was obtained by spectral decomposition using eq 4.1 and σ = 1280 cm-1 , 
as obtained from the time-resolved emission spectrum at the instrumental time-zero.  The 
peak frequency of the time-resolved spectra is given by ∞
−
∞ +−= λλλλ
τ sol
t
m e)( 0 , where λ0 
and λ∞ were taken from the experimental data as  24675 cm-1 and 20292 cm-1, respectively. 
The solvation time, τsol, of LE is 2.0 ns  (Figure 4.8).  The convolution of L(t) with I(λ, t) is 
                                                     ∫ ′′−′=
t
tdttItLtLE
0
),()(),( λλ                                          (4.4) 
and yields the time-resolved emission spectrum induced by the slow conformational change 
or aggregation postulated above (Figure 4.9).  The time-resolved spectra for LE and CT were 
then summed to generate the total time-resolved spectra.  Those at t = 0, 1.0, and 10.0 ns are 
shown in Figure 4.10.  At t = 0 ns, there is virtully no contribution from LE in the total time-
resolved spectrum; but with increasing time, LE contributes significantly to the total time-
resolved spectrum.  Other variations of this model are clearly possible.   
Given, however, that the LE state was not accessed with 400 nm excitation (Table 
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4.1), the excitation wavelength used by Boxer and coworkers, and that their steady-state 
spectra showed no evidence of the LE state, the blue shift they observed is likely to have 
other origins.  On the other hand, it is useful to consider three different investigations carried 
out to study the solvation response of myoglobin using various chromophores to replace the 
heme.  These chromophores are:   the PRODAN derivative, DANCA 58; another charge-
transfer molecule capable of emitting from dual states, aniline-2-aminonaphthalene-6-
dimethylsulfonamide (ANSDMA) 61, and coumarin 153 57.   Each probe of solvation 
dynamics exhibited a different response.  DANCA yielded a complicated solvation response 
with significant contributions into the nanosecond regime.  ANSDMA provided a single-
exponential response of ~ 9 ns (although rapid components might have been neglected 
because of the time resolution of the experiment).  Using coumarin 153, it was found that 
almost 60 % of the solvation is complete within the time resolution of the experiment (300 
fs) and that this initial response is followed by a slower one.  Most importantly, there was 
excellent agreement between the solvation correlation function, C(t) , from fluorescence 
upconversion experiments and those obtained from molecular dynamics simulations.  While 
some of these differences may be attributed to how 55 or whether a solvation correlation 
function was actually constructed, it is legitimate to inquire whether some of the discrepancy 
might not also be attributed to the nature of the fluorescent probes employed.  While 
DANCA and ANSDMA are both capable of charge transfer in the excited state, coumarin 
153 is exquisitely inert, which is one of the reasons it has been so extensively employed as a 
probe of solvation.57,62-73   (The DANCA experiments used an excitation wavelength of 345 
nm.  Novaira et al. have observed that both LE and CT emission can be observed in reverse 
micelles at 330 nm.  While the DANCA work 58 does not mention a blue-shift at long times, 
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it is feasible that some of the long-time dynamics observed are a result of the possible 
behavior we have suggested above.) 
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Figure 4.9.  Schematic diagram illustrating the assumptions underlying the simulation 
described in the text.  As noted in the Introduction and in the caption to Figure 4.2, it is 
generally agreed that in all cases, regardless of solvent or environment, the LE state is 
formed immediately upon excitation and that whether the LE state decays into the CT state 
does, however, depend on environment.  The purpose of the simulation, whose results are 
illustrated in Figure 4.10, is to suggest a mechanism by which blue shifts in the dynamic 
Stokes shift may be observed at long times.  We propose that they may arise from a system 
that emits completely from an ensemble of CT states initially, but that after several 
nanoseconds, for example, a small but nonnegligible population of protein assumes 
conformations where LE, not CT, is the emissive state.  It must be noted that in the time 
required for the conformational change or aggregation to occur, the same protein sample is 
being used for the experiment (~ 2 hours for single wavelength decay measurement).  It is 
not being suggested that the lifetime of CT is 5 ns, nor that there is an excited-state pathway 
converting CT to LE on this time scale. 
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Figure 4.10.  Simulation of the total time-resolved emission spectra at 0, 1, and 10 ns as 
described in the text.  The black line is the time-resolved emission spectrum for LE; the red 
line, for CT.  The sum of the two time-resolved spectra is shown in green.  Note that the scale 
of the ordinate changes with time. 
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Conclusions 
Stimulated by the work of Novaira et al. 40,48, we have studied the solvation dynamics 
of PRODAN in a heterogeneous environment (reverse micelles) that permits a distribution of 
the chromophores to emit from both the LE and the CT states.  We have studied the solvation 
dynamics of both states and found them to be very different, as suggested by the work of 
Novaria et al.   This result consequently leads to the question of whether PRODAN-based 
chromophores or, more generally, any chromophore capable of undergoing excited-state 
photochemistry, can induce artifacts into the interpretation of solvation dynamics in 
heterogeneous environments—in particular, those provided by biological systems such as 
proteins.  Considerable care in choosing and characterizing the system is required in order to 
analyze the results fully.  
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CHAPTER 5.  EXCITED-STATE INTRAMOLECULAR HYDROGEN ATOM 
TRANSFER AND SOLVATION DYNAMICS OF THE MEDICINAL PIGMENT 
CURCUMIN 
 
A paper published in The Journal of Physical Chemistry B 
 
Ramkrishna Adhikary,1 Prasun Mukherjee,1 Tak W. Kee2* and Jacob W. Petrich1* 
 
Abstract  
The potential use of the naturally occurring yellow-orange pigment curcumin as a 
photodynamic therapy agent is one of the most exciting applications of this medicinal 
compound.  Although sub-nanosecond spectroscopy has been used to investigate the 
photophysical processes of curcumin, the time resolution is insufficient to detect important 
and faster photo-induced processes, including solvation and excited state intramolecular 
hydrogen atom transfer (ESIHT).  In this study, the excited state photophysics of curcumin is 
studied by means of ultrafast fluorescence upconversion spectroscopy.  The results show two 
decay components in the excited-state kinetics with time scales of 12-20 ps and ~100 ps in 
methanol and ethylene glycol.  The resulting prominent isotope effect in the long component
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upon deuteration indicates that curcumin undergoes ESIHT in these solvents.  The short 
component (12-20 ps) is insensitive to deuteration, and multi-wavelength fluorescence 
upconversion results show that this decay component is due to solvation of excited-state 
curcumin.  
Introduction 
Curcumin, 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, is a 
naturally occurring yellow-orange pigment derived from the rhizomes of Curcuma longa 
(turmeric).  It has been traditionally used as a spice and food coloring in Indian cooking and 
medicine.1  Currently, it is the subject of a large number of investigations in the fields of 
biology, medicine, and pharmacology owing to its profound effects on human health.  
Curcumin exhibits a variety of biological and photochemical properties, including 
antioxidant, anti-inflammatory, and anticancer activity.2-6  Recently, it was also established 
that curcumin has the ability to prevent protein aggregation in debilitating diseases such as 
Alzheimer’s and Parkinson’s.7,8  Curcumin has two tautomeric forms, namely the β-diketone 
and keto-enol.  It has been shown that curcumin exists predominantly as a keto-enol tautomer 
in a number of solvents with various polarities using results from NMR spectroscopy.9  It 
follows that strong intramolecular hydrogen bonding is present in the keto-enol tautomer of 
curcumin, of which the chemical structure is shown in Figure 5.1, providing a favorable 
interaction for stabilization of this tautomeric form. 
Recent research shows that curcumin has great potential to be an effective 
photodynamic agent.10-17  In particular, studies have demonstrated the use of curcumin to 
treat melanoma.18-24  It was shown that the photodynamic action is greatly enhanced in the 
presence of light for destruction of tumor cells.15-17  It has been shown that stable 
  
156 
photoproducts are not responsible for the medicinal effects of curcumin.10  Photolytically 
produced active oxygen species such as singlet oxygen, hydroxyl radical, superoxide or 
hydrogen peroxide are mainly suggested for its activity.10,11,25-29  In addition, Slobodan et al. 
demonstrated that H-atom transfer is a preferred antioxidant mechanism of curcumin by laser 
flash photolysis and pulse radiolysis.30  Currently, there are significant interests in developing 
a detailed level of understanding in the photophysics and photochemistry of curcumin in 
order to further exploit its medicinal effects. 
 
Figure 5.1. Structure of the keto-enol form of curcumin.  
 
Several studies have focused on using time-resolved fluorescence spectroscopy to 
investigate the excited state photophysics of curcumin in organic solvents on the sub-
nanosecond time scale, aiming to provide fundamental understanding to elucidate the 
medicinal properties of curcumin.12,18,31-33  In all cases, these studies focused on excited state 
intramolecular hydrogen atom transfer (ESIHT) of curcumin because this phenomenon has 
been associated with the medicinal properties of other pigment molecules, including 
hypericin and hypocrellin.34-38  For instance, two of these studies agree that the fluorescence 
lifetime of curcumin in methanol has a dominant component with a time constant of roughly 
130 ps.  This decay component, however, was assigned to different molecular processes, i.e. 
solvation33 and ESIHT,31 in the two studies.  Here, we perform ultrafast fluorescence 
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upconversion studies to address this issue in the literature.  Using a time resolution of 300 fs 
and deuterated curcumin, we show unambiguously that ESIHT occurs with a time scale of 
approximately 100 ps.  Furthermore, the similarity between the time scale of ESIHT and the 
measured fluorescence lifetime indicates that ESIHT is a major photophysical process in the 
deactivation of the excited state. 
Owing to femtosecond time resolution of ultrafast fluorescence upconversion, in 
addition to the ESIHT component, a short-lived fluorescence decay component with a time 
scale of 12 ± 2 ps was also detected at 520 nm for curcumin in methanol.  In ethylene glycol, 
the short-lived component has a time constant of 20 ± 3 ps.  This fast decay component was 
previously unobserved because of the insufficient time resolution used.  Solvation is 
expected to be present in the relaxation dynamics due to the substantial change in dipole 
moment reported for curcumin.31  In the present work, using results from multi-wavelength 
fluorescence upconversion measurements, we definitively assign this decay component to 
solvation dynamics.  The solvation correlation function C(t), which provides a quantitative 
measure of the time scale of solvation dynamics, has a fast component which is shorter than 
the instrument response function of 300 fs, and a slow component of 12 ± 2 ps in methanol 
and 30 ± 5 ps in ethylene glycol.  These results strongly support the assignment of the 12 – 
20-ps component observed in the fluorescence upconversion results to solvation. 
Experimental Section 
Materials.  Curcumin (purity ~ 70% HPLC) was purchased from Sigma Aldrich and 
used without further purification.  High purity curcumin (≥ 98.5%) was obtained from Alexis 
Biochemicals.  This highly purified product is virtually free of the other two closely related 
curcuminoids (~ 30%) which are also found in turmeric, namely demethoxy- and bis-
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demethoxycurcumin.  While the experiments performed in this work involved using 
curcumin from the first source, fluorescence upconversion and time correlated single photon 
counting measurements were repeated using high purity curcumin to ensure the roles of 
demethoxy- and bis-demethoxycurcumin are negligible.  Methanol, ethylene glycol and 
chloroform were obtained from Fisher Scientific and used without further purification.  In 
addition, chloroform was also dried over type 4A molecular sieves prior to use.  Methanol-d4 
(purity 99.8%) and ethylene glycol O,O-d2 (purity 98%) were purchased from Cambridge 
Isotope Laboratories, Inc. and used without further purification.  For the experiments on 
curcumin in deuterated solvents, curcumin was allowed to equilibrate in these solvents for 48 
hours to ensure complete exchange of the enolic hydrogen with deuterium.  
Steady-state measurements.  Steady-state absorption spectra were obtained on 
Hewlett Packard 8453 UV-visible spectrophotometer with 1-nm resolution.  Steady state 
fluorescence spectra were obtained on a Spex Fluoromax-4 with a 3-nm bandpass and 
corrected for lamp spectral intensity and detector response.  All the samples were excited at 
407 nm for steady state fluorescence measurement.  For both fluorescence and absorption 
measurements, a 5-mm path-length quartz cuvette was used.  All experiments were done at 
room temperature. 
Time-resolved measurements.  The apparatus for fluorescence upconversion is 
described in detail elsewhere.39  Briefly it is based on a homebuilt mode-locked Ti:sapphire 
oscillator producing femtosecond pulses at a fundamental wavelength of 814 nm with a 
repetition rate of 82 MHz.  Frequency doubled pulses (407 nm) were used to excite the 
sample and the residual of the fundamental was used as the gate pulse to upconvert the 
fluorescence signal.  First, the fluorescence signal was collected using a 10× objective lens.  
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Then, the gate pulse and fluorescence signal were focused onto a 0.4 mm type-I BBO crystal 
to generate the sum frequency light, which was detected by a photomultiplier tube mounted 
on a monochromator.  The full-width-at-half-maximum (FWHM) of the instrument response 
function is 300 fs, obtained by the cross-correlation function of the frequency doubled and 
the fundamental light.  A rotating sample cell was used and all experiments were performed 
at room temperature. 
Solvation dynamics are analyzed and quantified by means of the solvation correlation 
function, C(t), 
)()0(
)()(
)(
∞−
∞−
=
νν
νν t
tC      (5.1) 
where ν(0), ν(t) and ν(∞) denote the peak frequency of the emission spectra at time zero, t 
and infinity.  The “zero time” emission spectrum has been approximated using the emission 
spectrum of curcumin in hexanes, according to the method of Fee and Maroncelli.40  The 
ν(∞) is taken as the peak frequency of the steady-state fluorescence spectrum.  ν(t) is 
determined by taking the maxima from the log-normal fits as the time-resolved emission 
maximum which is constructed according to the procedure described by Fee and Maroncelli41 
using steady-state emission spectrum and fitting parameters from wavelength-resolved decay 
traces.  In most cases, however, the broad spectra result in uncertainty in the exact position of 
the emission maxima.  Thus, using the signal-to-noise ratio and width of the spectrum 
(including “zero-time”, steady-state, or time-resolved emission spectrum) as guides, we have 
determined the typical uncertainties as follows: time-resolved emission (~ ± 200 cm−1), 
“zero-time” ~ steady-state (~ ± 100 cm−1).  These uncertainties are used to compute error 
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bars for the C(t).  The fractional solvation at 300 fs was calculated using f300fs = 1 − C(t = 300 
fs). 
Time-resolved fluorescence lifetime anisotropy data were collected using the time-
correlated single photon counting (TCSPC) technique.  Our apparatus has been described 
elsewhere.39  Recent modifications in the experimental set-up include the replacement of 
NIM-style electronics by the Becker & Hickl photon counting module Model SPC-630.  
With this modified system, the full-width-at-half-maximum of the instrument-response 
function is ~40 – 45 ps.  The acquisition time window had a width of 3.33 ns with 1024 
channels, corresponding to 3.25 ps per channel.  All experiments were performed using 407 
nm excitation obtained by frequency doubling of 814 nm fundamental light.  For anisotropy 
measurements, 65,000 counts were collected at the peak channel for parallel polarization.  A 
normalization factor was then applied to the TCPSC trace such that the maximum count was 
10,000 due to requirement of the analysis software.  A cuvette of 1-cm path length was used 
for the time-resolved anisotropy measurement.  The anisotropy measurement involved 
collecting two fluorescence signals with polarizations parallel (I║) and perpendicular (I⊥) to 
the excitation polarization in order to determine the anisotropy decay r(t), as follows. 
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The anisotropy data were obtained from simultaneous fitting of parallel and perpendicular 
decays.42  The decay of the anisotropy reflects the time scale of orientational relaxation. 
Results and Discussions 
UV-Vis absorption and fluorescence spectra of curcumin.  Figure 5.2 illustrates 
the absorption and fluorescence spectra of curcumin in methanol, ethylene glycol, the 
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corresponding deuterated solvents, and chloroform.  The spectra obtained in methanol and 
chloroform were found to be in agreement with the previous results with respect to the 
spectral shape and peak position.32  While the UV-Vis absorption spectra are relatively 
insensitive to the solvent used, the fluorescence spectra exhibit a strong solvent effect.  The 
strong dependence of the Stokes shift on solvent polarity indicates that the excited state 
dipole moment of curcumin is considerably larger than that of its ground state.  This property 
also implies that solvation dynamics play an important role in the excited state relaxation of 
curcumin, as will be discussed further. 
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Figure 5.2. Normalized absorption and fluorescence spectra of curcumin in (a) methanol 
(MeOH), deuterated methanol (MeOH-d4), (b) ethylene glycol (EG), deuterated ethylene 
glycol (EG-d2) and (c) chloroform (CHCl3). 
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Fluorescence upconversion and excited state intramolecular hydrogen atom 
transfer of curcumin.  The excitation and probe wavelengths in the fluorescence 
upconversion experiments are 407 nm and 520 nm, respectively, as shown in Figure 5.2.  
While having the excitation wavelength at 407 nm efficiently promotes curcumin from the 
ground state to the excited state, monitoring the time resolved fluorescence at 520 nm, which 
is on the blue side of the fluorescence spectrum, provides the good signal-to-noise ratio and 
sensitivity to record early time events in the excited state relaxation process. 
Figure 5.3a shows the fluorescence upconversion signals of curcumin in methanol 
and deuterated methanol as a function of time.  The time-resolved fluorescence signal of 
curcumin in methanol (red) was fitted with a bi-exponential function with time constants of 
12 ± 2 ps and 70 ± 10 ps with nearly equal amplitudes, see Table 5.1.  In order to 
demonstrate the effect of deuteration, fluorescence upconversion of curcumin in deuterated 
methanol was investigated.  In deuterated methanol (blue), while the first decay component 
remains identical within experimental error, a prominent isotope effect is observed in the 
second component.  The decay time constant of this component is increased to 120 ± 20 ps 
upon deuteration.  Fluorescence upconversion experiments were also performed with pure (≥ 
98.5%) curcumin in methanol and the same fast and slow components were obtained as 
mentioned above. 
The appearance of this prominent isotope effect of 1.7 requires equilibration of 
curcumin in deuterated methanol for a period of approximately 48 hours.  Exchange of the 
enolic hydrogen of curcumin with the deuterium of methanol-d4 is expected to occur on this 
time scale, which is consistent with deuteration of a similar system.43  In contrast, the inset of 
Figure 5.3a shows the fluorescence upconversion results of curcumin in methanol and 
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deuterated methanol with an equilibration time of only 15 minutes.  The two traces are 
identical within experimental error, clearly showing the absence of an isotope effect at early 
equilibration time.  The results shown in Figure 5.3a and the inset yield the following 
important insights.  First, the observed isotope effect correlates with the enolic H/D exchange 
of curcumin, supporting the excited state hydrogen atom transfer character of the kinetics.  
Second, the lack of isotope effect at early equilibration time indicates that the hydrogen atom 
transfer process is intramolecular in nature, as opposed to a consequence of intermolecular 
hydrogen bonding with the surrounding solvent molecules.  Additionally, this result also 
indicates that the observed isotope effect is unrelated to suppression of radiationless 
deactivation of excited state curcumin in deuterated methanol.  Therefore, these results 
clearly indicate that ESIHT, which occurs with a time constant of 70 ps in methanol, is a 
major pathway of non-radiative decay in curcumin. 
The effect of solvent on the fluorescence upconversion signal is shown in Figure 
5.3b.  In ethylene glycol (red), the time-resolved fluorescence signal also exhibits a bi-
exponential decay, similar to methanol.  However, the time scales of the decays are longer; 
the time constants of the decays are 20 ± 3 ps and 105 ± 15 ps, with nearly equal amplitudes.  
Deuteration of ethylene glycol produces a similar isotope effect, i.e., the time constant of the 
short-lived decay component remains unchanged but that of the long-lived component is 
increased by a factor of 2.1, see Table 5.1.  The presence of this notable effect further 
supports our assignment of the long-lived decay component to ESIHT.  The ESIHT time 
constants of curcumin reported in this study are comparable to those of 7-azaindole in 
methanol.44 
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Figure 5.3. Fluorescence upconversion decays of curcumin in (a) methanol (MeOH), (b) 
ethylene glycol (EG) and (c) chloroform (CHCl3); corresponding decays in the deuterated 
analogs in (a) and (b) show a prominent isotope effect. The inset in (a) shows the virtually 
identical traces prior to the H/D exchange (equilibration time of ~15 minutes), which 
indicates that the isotope effect observed after equilibration (48 hours) is independent of 
solvent effects. While the decays in (a) and (b) exhibit bi-exponential nature, the trace in (c) 
is single-exponential. All samples were excited at 407 nm and fluorescence was collected at 
520 nm. 
 
  
165 
The ESIHT for curcumin in methanol and ethylene glycol occurs, within 
experimental error, on the same time scale: 70 ± 10 ps and 105 ± 15 ps, respectively (Table 
5.1).  While the solvent viscosity differs by a factor of ~30 between methanol and ethylene 
glycol (0.59 cP and 16.1 cP, respectively, at 20oC), the lack of dependence of the ESIHT 
time scale on viscosity indicates that ESIHT occurs through small amplitude molecular 
motions, which do not heavily involve the surrounding solvent molecules.  In this regard, 
ESIHT in curcumin is similar to that in hypericin, for which the rate of ESIHT is 
uncorrelated to solvent viscosity.37,38  In another related species, 2-hydroxyacetophenone, it 
was determined that small amplitude molecular vibrations are responsible for the initial 
events in ESIHT and the O–H vibration is unaffected in this process.45  Therefore, our results 
indicate that ESIHT in curcumin is similar to that of the systems in which ESIHT has a weak 
dependence on solvent viscosity. 
Table 5.1. Fluorescence upconversion decay parameters for curcumin in different solvent 
systemsa 
 
Solvent a1
b
 τ1 (ps) τ2 (ps) 
Methanol 0.45 12 70 
Methanol-d4 0.45 12 120 
Ethylene glycol 0.45 20 105 
Ethylene glycol O,O-d2 0.45 20 220 
Chloroformc 1.0 130 - 
 
a The fluorescence upconversion traces, f(t), were fitted with the multi-exponential function  
f(t) = a1 exp (-t/τ1) + a2 exp (-t/τ2).  The a1, a2 and τ1 were kept constant during the fitting 
process.  All parameters have a relative error of ± 15%. 
b a1 + a2 = 1. 
c Chloroform was dried over molecular sieves prior to use.  Water content was assessed with 
a coulometric Karl Fischer Titration (Mettle Toledo DL 36).  % wt H2O=0.002 
 
Chloroform is a polar aprotic solvent with which curcumin is not involved in 
intermolecular H-bonding.  Care was taken to exclude water in chloroform because it has 
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been reported that water quenches the fluorescence by forming a non-fluorescent stable 
complex with excited state curcumin.46  In addition, the presence of a hydrogen-bonding 
impurity might complicate the excited state dynamics.47  The fluorescence upconversion 
decay trace of curcumin in chloroform is shown in Figure 5.3c.  The decay trace is best fitted 
with a single exponential decay function with a time constant of 130 ± 20 ps.  This decay 
component is assigned to ESIHT for the following reasons.  First, the decay trace is unrelated 
to solvation dynamics of curcumin in chloroform since solvation in chloroform occurs with 
time constants of 0.285 ps and 4.15 ps, as determined by Horng et al.48  Consequently, 
because intermolecular hydrogen bonding with the solvent is impossible between curcumin 
and chloroform, the observed kinetics are attributed to an intramolecular interaction, which 
we assign to an intramolecular process, namely ESIHT.  While the ESIHT time of a related 
molecule, 3-hydroxyflavone, is 240 fs in methylcyclohexane,47 the absence of such a short 
component in Figure 5.3c indicates that ESIHT in curcumin does not occur as rapidly as in 3-
hydroxyflavone.  In fact, the 130-ps ESIHT time constant of curcumin in chloroform shows 
good agreement with those of curcumin in methanol and ethylene glycol.  
Early time solvation dynamics.  In addition to ESIHT, the fluorescence 
upconversion results also reveal that there is a short-lived component with a time scale of 12 
ps in methanol, which is likely to be undetectable in TCSPC because of insufficient time 
resolution.  Solvation, in addition to ESIHT, is expected to play a role in the excited state 
relaxation dynamics due to the significant dipole moment change reported for curcumin: ∆µ 
= 6.1 D.31 Such a ∆µ is comparable to that of Coumarin 153 (∆µ ≈ 8 Debye),41,48 which is a 
standard probe molecule for solvation dynamics.  Additionally the fluorescence spectra 
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exhibit a Stokes shift that is largely dependent on solvent polarity, implying that solvation 
may play a major role in the relaxation of the excited state in addition to ESIHT. 
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Figure 5.4. Representative normalized wavelength resolved fluorescence upconversion 
traces of curcumin in (a) methanol and (b) ethylene glycol.  Time-resolved emission spectra 
were constructed by collecting upconversion traces over a range from 500 to 600 nm at 
intervals of 10 nm.  The time resolved traces at the red end (600 nm) show a growing 
component, which is the signature of solvation dynamics. 
 
To demonstrate the presence of solvation, we performed fluorescence upconversion 
experiments on curcumin at up to 11 wavelengths spanning the range of 500 – 600 nm in 
methanol and ethylene glycol.  Representative decay traces are shown in Figure 5.4.  For 
curcumin in methanol, all the transients are well fitted to a bi-exponential function with a 
fixed long decay component of 140 ps (fluorescence lifetime).  In methanol, at the blue end 
of the emission spectrum (500 nm), the result shows a fast decay component of 10 ps (56%).  
At 530 nm, the time constant of the fast portion becomes 17 ps (41%).  At 560 nm, a rising 
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components is observed with a rise time of 1.6 ps.  The time constant of this rising 
component becomes 6.9 ps at 600 nm.  The wavelength dependent behavior of the fast 
component is the signature of solvation dynamics.  As shown in Figure 5.4, a similar 
behavior is also observed for curcumin in ethylene glycol, where the long decay component 
was also fixed at its lifetime of 210 ps.  These results clearly indicate the major role of 
solvation in the relaxation of the excited state. 
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Figure 5.5. Normalized time resolved emission spectra of curcumin in methanol (MeOH) 
and ethylene glycol (EG).  Steady-state (ss) and “zero-time” (t = 0 ps) spectra are included.  
Almost 70 % of the solvation is complete in both systems within the time resolution of our 
instrument (300 fs). 
 
In Figure 5.5a, the emission spectra of curcumin in methanol at 0 ps, 0.3 ps, 20.3 ps 
and steady state (t → ∞) are shown.  For curcumin in ethylene glycol, the trend of emission 
spectral shift is similar to methanol but it occurs at a slower rate.  For instance, it takes the 
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emission spectrum approximately 40 ps to almost fully recover to the steady state spectrum, 
as shown in Figure 5.5b. 
Table 5.2. Solvation correlation function decay parameters for curcumin in different solvent 
systems 
 
 
Solvent 
 
 
f300fs
a
 
 
a
1
 
 
τ1(ps)
b
 
 
τ2 (ps) 
 
〈τ〉 (ps) 
 
Methanol 
 
 
0.75 ± 0.04 
 
0.71 ± 0.02 
 
0.05 
 
12 ± 2 
 
3.5 
 
Ethylene glycol 
 
 
0.75 ± 0.05 
 
0.73 ± 0.02 
 
0.05 
 
30 ± 5 
 
8.2 
 
a f300fs: fractional solvation at 300 fs 
b The faster component was fixed at 0.05 ps during fitting. 
 
The C(t) of methanol and ethylene glycol are presented in Figure 5.6 and the 
solvation parameters are shown in Table 5.2.  In particular, the f300fs values show that more 
than 70% of solvation is completed in both the solvents within the time resolution (300 fs) of 
the instrument.  The solvation correlation function shows an initial fast response (50 fs, 
fixed) followed by a slow response.  As shown by previous studies on similar systems, this 
fast response is attributed to ultrafast librational motion of the solvents.48-50  The time 
constants of the other component are 12 ± 2 ps and 30 ± 5 ps in methanol and ethylene glycol 
respectively.  These time scales are highly consistent to the fast component in the 
fluorescence upconversion results at 520 nm of curcumin in these solvents, see Figure 5.3 
and Table 5.1.  Based on the results from the studies on solvation dynamics, the short-lived 
component in the fluorescence upconversion results for curcumin in methanol and ethylene 
glycol at 520 nm has been assigned to solvation.  In addition, the average solvation time in 
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methanol and ethylene glycol are 3.5 ps and 8.2 ps respectively, which are in excellent 
agreement with previous studies using Coumarin-153 as the probe molecule.48 
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Figure 5.6. The solvation correlation function, C(t) of curcumin in methanol and ethylene 
glycol obtained from fluorescence upconversion experiments.  Solvation correlation function 
is fitted with bi-exponentials decay function.  Both the solvent showed a same initial fast 
component of 50 fs but a different slow component of 12 ps (methanol) and 30 ps (ethylene 
glycol). 
 
Fluorescence Anisotropy of Curcumin.  The effects of solvation and ESIHT on the 
rotational motion of curcumin are examined with fluorescence anisotropy studies.  To gain 
insight into the sensitivity of orientation of curcumin to the environment, anisotropy 
experiments were carried out in methanol and ethylene glycol.  The anisotropy parameters 
are shown in Table 5.3; the anisotropy decays are single exponential, which are well 
described with the equation ]/exp[)( )(0
rtrtr τ−= , where r0 and τ(r) are the initial anisotropy 
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value and molecular rotational time, respectively.  The anisotropy results reveal that r0 has 
values of 0.37 and 0.36 in methanol and ethylene glycol, respectively, very close to the 
theoretical limit of 0.4. 
The anisotropy results also reveal that τ(r) of curcumin is 200 ps in methanol and 5080 
ps in ethylene glycol.  The difference between the τ(r) of methanol and ethylene glycol can be 
understood by taking into account the Debye-Stokes-Einstein relation, which states that 
τ(r)DSE = Vη/kBT.  Using ηmethanol = 0.59 cP, ηethylene glycol = 16.1 cP (with T = 20oC) and the 
estimated hydrodynamic radius of curcumin of 8.5 Å,51 τ(r)DSE of methanol and ethylene 
glycol are estimated to be 375 ps and 10200 ps, respectively.  Although the Debye-Stokes-
Einstein relation overestimates τ(r) of curcumin for both methanol and ethylene glycol, the 
ratio between the predicted τ(r) agree very well with the experimental results, indicating, as 
expected, that viscosity is the determining factor for the molecular rotational time of 
curcumin. 
The comparison between the time scales of molecular rotation and other processes 
including solvation and ESIHT can provide important insight into the coupling between 
molecular processes.  In the case of curcumin in methanol, we have established that solvation 
and ESIHT occur on the time scales of 12 ps and 70 ps, respectively.  Relative to the time 
scale of molecular rotation of 200 ps, the results indicate that the coupling between rotation 
and either of solvation and ESIHT is weak.  On the other hand, the coupling is negligible for 
curcumin in ethylene glycol.  This phenomenon is clearly demonstrated by comparing the 
molecular rotation time of 5080 ps to the time scales of solvation of 30 ps and ESIHT of 105 
ps. 
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Figure 5.7.  Polarized fluorescence traces and residuals of fits for curcumin in methanol 
(MeOH) and ethylene glycol (EG).  Fitting parameters are given in Table 5.3.  The upper 
trace represents that emission is collected parallel and the lower trace is collected 
perpendicular to the excitation polarization.  λex= 407 nm, λem≥ 500 nm.  
 
Table 5.3. Time-resolved fluorescence anisotropy data of curcumin in different systems 
 
System 
 
r0 τ(r) (ps) τ(r)calc. (ps) 
Curcumin/MeOHa 0.37 ± 0.01 200 ± 20 375 
Curcumin/EGa 0.36 ± 0.02 5080 ± 1100 10200 
 
a The errors are based on the average of three measurements.  Fluorescence anisotropy 
decays are fit to the form: ]/exp[)( )(0
rtrtr τ−= .  In all cases χ2 ≤ 1.3.   
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Conclusion 
In summary, we have demonstrated with fluorescence upconversion that curcumin 
undergoes excited state intramolecular hydrogen atom transfer (ESIHT) and it plays a major 
role in the photophysics of curcumin.  Photoexcitation of curcumin produces a fluorescence 
signal which decays with a bi-exponential fashion on the order of 12-20 ps and 70-105 ps. 
The long-lived signal, which exhibits a prominent isotope effect in deuterated solvents, is 
attributed to ESIHT. Additionally, the results show that ESIHT is insensitive to solvent 
viscosity, implying that only small amplitude motions are coupled to ESIHT of curcumin.  
We have also presented results from the studies on multi-wavelength fluorescence 
upconversion of curcumin.  The results show that only decay components are present in the 
fluorescence upconversion signals on the blue side of the emission spectrum.  A rising 
component, however, appears on the red side of the emission spectrum, clearly indicating the 
presence of solvation in the relaxation dynamics.  We have shown that curcumin exhibits a 
long solvation component of ~12 ps in methanol and ~30 ps in ethylene glycol.  Results from 
fluorescence anisotropy studies show that curcumin in methanol and ethylene glycol have τ(r) 
of 200 ps and 5080 ps, respectively.  By comparing the time scales of solvation and ESIHT 
with τ(r), we conclude that the coupling between molecular rotation to other molecular 
processes is weak for curcumin in methanol.  Additionally, in the case of curcumin in 
ethylene glycol, the coupling is essentially negligible. 
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Appendix 
Origin (and Lack) of Isotope Effect   
 The kinetic isotope effect (KIE) arises from the difference in zero-point energies 
(ZPE) of the ground state and the transition state (TS) among the different isotopes.52 ,53  The 
ZPE is calculated by 
νhZPE
2
1
=      (5.3) 
where h is the Planck constant and ν is the frequency of the vibrational mode being 
considered.  The vibrational frequency can be estimated by using an equation that accounts 
the simple harmonic motion of the bond 
ν =
1
2π
k f
µ
      (5.4) 
where the reduced mass, )/( 2121 mmmm +=µ .  Eq 5.4 shows that ν is directly proportional to 
the square root of the force constant kf and inversely proportional to the square root of the 
reduced mass, µ.  As isotopic substitution has no effect on the electron density of the bond, kf 
remains essentially same for both isotopic bonds.  The vibrational frequency (ν) of the bond 
is lowered when a lighter atom is replaced by its heavier isotope because of the higher 
reduced mass µ and hence, the ZPE is lowered (Figure 5.8).  If we consider transition state 
(TS) theory, it can easily be shown that the isotope effect originates from the exponentiated 
activation energies.54  If we consider hydrogen (H) versus deuterium (D) transfer, the isotope 
effect can be expressed as54 
]/)(exp[ RTGG
k
k TS
D
TS
H
D
H ∆−∆−≈     (5.5) 
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where ∆GH
TS − ∆GD
TS ≈ ZPE H
TS − ZPE H
R − ZPED
TS + ZPED
R .  The reactant ZPER difference is 
larger for H than D, i.e., (ZPED
TS − ZPED
R ) > (ZPE H
TS − ZPE H
R ).  This type of KIE is ~2-10 at 
room temperature and follows the Arrhenius temperature dependence.   
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Figure 5.8.  Different activation energies for H and D resulting from their different zero-
point energies (ZPE) at the ground and transition state.  
 
Sometimes a KIE of 50 or larger is observed for comparisons of H versus D.52 ,53  
Such type of dramatic isotope effect has been attributed to quantum mechanical tunneling.  A 
deviation of Arrhenius plot from linearity at low temperature is also a common observation 
for tunneling.  Tunneling is the phenomena by which a particle transfers through the reaction 
barrier rather than over it due to its wave-like properties.53,55  The de Broglie wavelength is 
λ=h/(2mE)1/2, where m is the particle’s mass and E is its energy.  This wavelength for 
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hydrogen with energy of 20 kJ/mol is thereby calculated to be 0.63 Å for 1H (protium, H) and 
0.45 Å for 2H (deuterium, D).55  These wavelengths are comparable to the molecular 
dimension.  Uncertainty relation of Heisenberg (
  
∆x ∆p ≈ h) predicts ∆x ≈ λ /4π , which is 
equivalent to saying that there is an appreciable probability of barrier penetration when λ 
becomes comparable with the width of the barrier.55   
Let us qualitatively discuss some useful concepts of tunneling for a collinear reaction 
AH……A ↔ A……HA, of proton transfer between two “heavy” atoms A taking place in 
condensed phase.  We can generalize the proton transfer by considering transition between 
two harmonic oscillator’s potentials for two AH.  We will restrict our discussion on the 
ground state vibrational wavefunction of a covalently bound proton harmonic oscillator 
because the typical vibration quanta for AH covalent bond is order of ~ 3000 cm-1, while 
kT ~ 200 cm-1 at room temperature.56  The wavefunction at the ground state is represented by  
))/)(2/1(exp(
1 2
04
0
0 ax
a
−=
π
ψ     (5.6) 
where x is the reduced coordinate and a0 is the amplitude of the vibration.  The tunneling 
transition probability is proportional to the resonance integral ∫ dvV fifi ψψ , where ψ’s are the 
wavefunction of the initial (i) and final state (f), and Vif is the potential of their interaction.56  
This shows that the tunneling probability is higher for stronger overlap of the wavefunctions.  
When the oscillator’s reduced mass is small (for AH) and the ZPE (1/2 hν) is large; 
correspondingly, the amplitude a0 is large too, and the wave functions decay slowly.  
Therefore, the wave functions overlap is substantial already for the ground level, and the 
tunneling probability is high too (Figure 5.9).  When the reduced mass of the oscillator (for 
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AD) is higher, ZPE is lower, so the amplitude a0, and the overlap are poor and tunneling 
probability is low.  Thus tunneling also results in a KIE.  A similar concept also explains why 
the distance between the reactant and product wells affects the tunneling probability.  
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Figure 5.9.  Schematic potential energy curves of AH and AD for ground-state nuclear 
tunneling.  The wave function overlap is substantial for the AH oscillator than that of 
AD because of higher zero-point energy (ZPE).  More overlap between the reactant and 
product wavefunctions results in higher tunneling probability.  
    
It is important to note that tunneling becomes possible only in the case where the 
energy levels of initial and final states are equal because transition at this situation does not 
violate the energy conservation law.  Electrostatic interactions through reorganization of 
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surrounding solvents with the proton plays an important role in order to equalize these levels, 
that, generally, are not equal from the beginning.54    
Influence of the Potential Energy Surface 
  Zero-point energy and the energy barrier are affected by the strength of the hydrogen 
bonds.57-60  Whether the zero-point energy is below or above the barrier in the proton 
coordinate is critically determined by the separation of the heteroatoms (AA).  The 
separaion is dependent on the strength of the hydrogen bond.    
(a) Weak (b) Strong (c) Very Strong
AH…………A A…H……A A…H…A
D
H
D
H
D
H
RAA  
Figure 5.10.  Zero-point energy and barrier height among three types of hydrogen bonds: (a) 
weak, (b) strong and (c) very strong. 
    
Figure 5.10 illustrates how a zero-point energy and activation energy barrier changes 
for a weak, strong and very strong hydrogen bond.  The potential energy of hydrogen-bonded 
complex, AH……A, can be represented by a symmetric double-well potential generated 
from the superposition of the potential wells of each species, AH and HA.  In a weak 
hydrogen bond (large AA distance, RAA), zero-point energies of hydrogen and deuterium 
lie near the bottom of the well and separated by a high barrier.  When the hydrogen bond is 
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strong, the two heteroatoms are partially covalently bonded to the proton.  In this case, the 
zero-point energy of the hydrogen is close or above the barrier but is lower when H is 
replaced by D and leads to an isotope effect.  This hydrogen bond is categorized as the low-
barrier hydrogen bond.  In case of very strong hydrogen bond, the heteroatoms are so close to 
each other (small AA distance, RAA) that they almost equally share the hydrogen 
resulting a very low barrier, and the zero-point energies of hydrogen and deuterium both lie 
well above the barrier.  In this case, the zero-point energy effects do not support the same 
isotope effect but allow cross over and modestly opposite isotope effects.60,61  
Effect of Environment   
Intermolecular interactions can also influence the potential of proton in a hydrogen-
bonded system.52  The molecular complex AH……B exhibits a small permanent electric 
dipole moment, which changes as it passes through a transition state [Aδ−……H……Bδ+]‡ to the 
product A−……HB+.  This indicates that the reacting pair can interact with surrounding 
polar environment and the potential energy surface can be modulated.  Proton potential 
energy curves with proton and solvent coordinates for a model symmetric proton transfer 
reaction in a linear hydrogen-bonded complex are shown in Figure 5.11.  This shows how 
configurational changes in the surrounding environment distort potential from being initially 
asymmetric favoring residing the proton on A through the transition state where a proton 
symmetric double well is established, and on to an asymmetric potential now favoring the 
proton residing on B.  The motion of the solvent is critical because of the coupling between 
the evolving charge distribution of the reacting pair and the polarization field of the solvent.  
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Figure 5.11.  Illustration of proton potential energy curves with proton (in the circle) and 
solvent coordinates for a model symmetric proton transfer reaction in a linear hydrogen-
bonded complex.  
 
Adiabatic and Nonadiabatic Proton Transfer  
Hynes and coworkers58,59 developed nontraditional theories on acid-base proton 
transfer reaction AH……B→ A−……HB+ in solution.  The important nontraditional 
aspects are quantum mechanical character of proton’s nuclear motion and solvent coordinate 
as the reaction coordinate.  The two regimes for the proton’s motion are adiabatic and 
nonadiabatic proton transfer.  In the adiabatic proton transfer regime, the high frequency 
quantum proton vibration adiabatically follows the solvent fluctuations as the reaction 
proceeds from reactant to product, and at the transition state the zero-point level is above the 
barrier in the proton coordinate.  Thus, the reaction coordinate is solvent coordinate rather 
than proton coordinate.  This is in contrast to the common conception that if tunneling does 
not occur, there is classical motion of the proton over the barrier in the proton coordinate.  
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The second regime is nonadiabatic, where the lowest proton vibrational level is below the 
proton barrier when solvent has rearranged to establish a symmetric potential in the proton 
coordinate and the reaction is exclusively tunneling.  Again the reaction coordinate is 
solvent.  In adiabatic limit, an isotope effect is not obtained because lowest vibrational 
energy level of the proton stretch mode lies above the barrier whereas the opposite is true in 
nonadiabatic limit. 
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CHAPTER 6.  EXCITED-STATE INTRAMOLECULAR HYDROGEN ATOM 
TRANSFER OF CURCUMIN IN SURFACTANT MICELLES 
 
A paper published in The Journal of Physical Chemistry B 
 
Ramkrishna Adhikary,1 Philip J. Carlson,1 Tak W. Kee2* and Jacob W. Petrich1* 
 
Abstract 
Femtosecond fluorescence upconversion experiments were performed on the 
naturally occurring medicinal pigment, curcumin, in anionic, cationic, and neutral micelles.  
In our studies, the micelles are composed of sodium dodecyl sulfate (SDS), dodecyl trimethyl 
ammonium bromide (DTAB) and triton X-100 (TX-100).  We demonstrate that the excited-
state kinetics of curcumin in micelles have a fast (3 – 8 ps) and slow (50 – 80 ps) component.  
While deuteration of curcumin has a negligible effect on the fast component, the slow 
component exhibits an pronounced isotope effect of ~1.6, indicating that micelle-captured 
curcumin undergoes excited-state intramolecular hydrogen atom transfer.  Study of solvation  
dynamics of curcumin in 10 ps time-window reveals a fast component (<300 fs) followed by 
a 8, 6 and 3 ps component in the solvation correlation functions for TX-100, DTAB and SDS 
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micelles respectively. 
Introduction 
Curcumin, 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, has 
received considerable attention owing to its numerous medicinal properties.1-9  Curcumin, 
whose structure is shown in Figure 6.1, is the major ingredient of the yellow pigments 
(curcuminoids) in the Indian spice plant turmeric.  While curcuminoids are composed of 
approximately 77% curcumin, demethoxy curcumin (17%) and bisdemethoxy curcumin (3%) 
constitute most of the remaining portion.  In addition, cyclocurcumin, which was isolated in 
1993, is also present at a trace level.10  A large number of studies have shown that curcumin 
possesses anticancer,3,4 anti-Alzheimer,6 anti-cystic fibrosis,7 and other desirable medicinal 
benefits.1,8,9  Of particular interest are the prospects of curcumin or curcumin-like nontoxic 
agents to exhibit anticancer effects without side effects,3,4 unlike conventional chemotherapy 
drugs.  Several clinical trials are either underway or have recently been completed with 
curcumin as the treatment agent.11,12  The preliminary results from these trials are highly 
promising. 
Two major challenges in the application of curcumin as an effective treatment agent 
are lack of bioavailability and severely limited stability in aqueous environments.  Because of 
the low aqueous solubility, curcumin tends to aggregate and precipitate in water, limiting its 
bioavailability.13-16  In addition, curcumin undergoes rapid degradation in water and buffer 
solutions, with a reaction half-life of 9.5 minutes at pH 7.2.17  It has been demonstrated that 
the degradation is mostly due to deprotonation of curcumin, producing the degradation 
products: vanilin, ferulic acid, and feruroyl methane.17,18  It is interesting that most of these 
products have medicinal properties as well.  Previous studies have shown that encapsulation 
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of curcumin in surfactant micelles and binding to proteins resolve these two major issues.14-16 
 
Figure 6.1.  Structure of keto-enol form of curcumin. 
 
Micellar systems may potentially play an important role in leading to improved 
clinical use of curcumin.  It is established that micelle-captured curcumin is well dispersed in 
aqueous solutions, thereby increasing the bioavailability significantly.13,15,16  Moreover, 
curcumin is trapped in the regions of the micelle where the presence of free water molecules 
is relatively limited, preventing alkaline hydrolysis, which is the major mechanism for 
degradation.17,18  It is therefore plausible that association to micelles plays a considerable role 
in enabling curcumin to exhibit its medicinal characteristics.  Apart from preventing 
degradation, micelles also serve as well defined model systems for biomembranes.  It has 
been shown that a large portion of curcumin is membrane bound in a biological 
environment.19  Investigations on the behavior of curcumin in micelles may provide valuable 
insight into the properties of curcumin in biomembranes. 
Curcumin exists predominantly as the keto-enol tautomer in a number of solvents.20  
It is capable of executing excited state intramolecular hydrogen atom transfer (ESIHT) due to 
the presence of strong intramolecular hydrogen bonding between the proton donor and the 
acceptor atom, as indicated in Figure 6.1.  Although there is a general agreement that ESIHT 
is a major photophysical event of curcumin,21-23 the exact time scale of this phenomenon was 
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not well established until our recent work.23  Using deuteration of curcumin and time-
resolved fluorescence upconversion as a technique for probing ESIHT, our work has shown 
that the time constant of ESIHT of curcumin is 70 ps in methanol and 120 ps in ethylene 
glycol.23  It has been proposed that the presence of a labile hydrogen as a result of ESIHT 
plays a role in the medicinal effects of other naturally occurring pigments such as hypericin 
and hypocrellin.24-31  As for curcumin, it is possible that ESIHT results in partial 
deprotonation, which induces fragmentation to yield the medicinal degradation products 
mentioned earlier.  While ESIHT of curcumin in polar organic solvents has been 
established,23 it remains unclear if micelle-captured curcumin also undergoes this 
photoinduced process.  It is known that intramolecular proton transfer processes are affected 
in confined environment due to the structure, various interfaces and dynamics of the 
environment.32 
Here we present unambiguous results demonstrating that ESIHT is a major 
photophysical event of curcumin in micelles.  The well studied micellar systems composed of 
sodium dodecyl sulfate (SDS), dodecyl trimethyl ammonium bromide (DTAB) and triton X-
100 (TX-100), which are anionic, cationic and nonionic in nature, respectively, were chosen 
for our investigations.  These micelles not only serve as model systems for biomembranes, 
but also enable photophysical investigations as a function of the polarity of the headgroup.  
By comparing the excited-state decay kinetics of the deuterated and nondeuterated species 
obtained by fluorescence upconversion spectroscopy, we show that the time constant of 
ESIHT of curcumin in these micelles ranges from 50 – 80 ps.  In addition to ESIHT, a fast 
component of 3 – 8 ps was also observed.  Results from multiwavelength studies reveal that 
the fast component is due to solvation dynamics of curcumin in the micellar media.  In short, 
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the present studies offer the first insights into the photophysical events of curcumin in 
micelles, which may lead to further understanding of the behavior of curcumin in 
biomembranes.  
Experimental Section 
Materials.  Curcumin (purity ~ 70% HPLC) and high purity curcumin (≥ 98.5%) 
were purchased from Sigma Aldrich and Alexis Biochemicals, respectively.  High purity 
curcumin was used for all experiments except in the solvation dynamics studies.  We 
confirmed that curcumin from the two sources produces identical fluorescence upconversion 
results at 520 nm.  Triton X-100 (TX-100, reduced), dodecyltrimethyl ammonium bromide 
(DTAB, ~99%) and sodium dodecyl sulfate (SDS, ~99%) were obtained from Sigma Aldrich 
and used without further purification.  Tris-d11 solution (1 M in D2O, 98 atom %D), 
deuterium chloride (35 wt% solution in D2O, 99 atom %D) and D2O (99.9 atom %D) were 
purchased from Sigma Aldrich.  The nondeuterated tris (>99.8% purity) was acquired from 
AMRESCO.  Methanol and Methanol-d4 (purity 99.8%) were obtained from Fisher Scientific 
and Cambridge Isotope Laboratories, Inc., respectively, and used as received.  All solutions 
were prepared with water from a Millipore Milli-Q NANOpure water system. 
Sample preparation.  A 20 mM buffer solution was prepared at either pH or pD = 
7.4 for all the experimental work in these studies using tris or tris-d11, respectively.  The 
concentration of surfactant was maintained at 0.1 M, which is above the CMC for each of the 
micelles, in nondeuterated and deuterated tris buffer.  Two stock solutions of curcumin in 
methanol and methanol-d4 were used for steady-state, time-correlated single photon counting 
(TCSPC) measurements.  A small quantity (2 µL) of the curcumin stock solution (4.5 or 1.5 
mM) was transferred to the micellar solution to yield a solution with a curcumin 
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concentration of 3 or 1 µM for the UV-Vis or fluorescence spectra, respectively.  Care was 
taken to keep the total methanol content of the final sample solution at < 0.1% for all 
solutions.  The solutions were then allowed to equilibrate overnight in either the tris/H2O or 
tris-d11/D2O solution in the dark prior to the optical experiments.  Equilibration was 
particularly important for curcumin in the D2O micellar solutions to ensure a complete 
exchange of the enolic hydrogen of curcumin with deuterium, as indicated below.  For the 
upconversion measurements, the required amount of curcumin (powder form) was directly 
added to the micellar solution to result in a curcumin concentration of 0.5×10–3 to 1×10–3 M.  
This solution was then sonicated for an hour in the dark.  All the solutions for fluorescence 
upconversion measurements were allowed to equilibrate overnight.  In addition, data 
collected with the deuterated samples that were equilibrated for 48 hours are identical to 
those with only overnight equilibration, indicating completion of H/D exchange. 
Steady-state measurements.  Steady-state UV-Vis absorption and emission spectra 
were acquired on a Hewlett Packard 8453 UV-visible spectrophotometer and Spex 
Fluoromax-4 with 1-nm resolution at room temperature.  The emission spectra were 
corrected for lamp spectral intensity and detector response.  The emission spectra were 
obtained with an excitation wavelength of 407 nm with 3-nm bandpass for all the samples.  A 
5-mm path-length quartz cuvette was used for all the absorption and emission measurements. 
Time-resolved measurements.  Excited-state lifetime measurements were performed 
using the TCSPC technique.  A homebuilt mode-locked Ti:sapphire oscillator pumped by a 
Nd:VO4 laser (Millennia, Spectra Physics) producing femtosecond pulses tunable from 780 
to 900 nm with a repetition rate of 82 MHz was used as the laser source.  The fundamental 
wavelength at 814 nm from the Ti-sapphire oscillator was modulated by a Pockels cell 
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(Model 350-160, Conoptics Inc.) to reduce the repetition rate to approximately 8.8 MHz and 
was subsequently frequency doubled by using a harmonic generator (Model TP-2000B, U-
Oplaz Technologies).  The resulting blue light, which had a central wavelength of 407 nm, 
provided the excitation source.  The fluorescence was collected at a 90o geometry, and passed 
through an analyzer set at the magic angle (54.7o) with respect to excitation polarization.  A 
half-wave plate before a vertical polarizer ensured the polarization of the excitation light.  A 
425 nm cut-off filter was placed in front of a multichannel plate, MCP (Hamamatsu).  The 
detector output was amplified and fed to the Becker & Hickl photon counting module Model 
SPC-630.  The full-width-at-half-maximum (FWHM) of the instrument response function is 
~40 – 45 ps.  All the measurements were made in a 3.33 ns time window with a total of 1,024 
channels.  A total of 65,000 counts were collected at the peak channel for all the lifetime 
measurements.  A cuvette of 1-cm path length was used for all the lifetime measurements. 
The apparatus for fluorescence upconversion is described in detail elsewhere.33  In 
short, the laser source was also a homebuilt mode-locked Ti:sapphire oscillator.  The 
fundamental wavelength and repetition rate of the femtosecond output were 814 nm and 82 
MHz, respectively.  The fundamental output from the oscillator was frequency-doubled by a 
type-I LBO crystal (2 mm).  The frequency-doubled pulses (407 nm) were used to excite the 
sample and the residual of the fundamental was used as the gate pulse to upconvert the 
fluorescence signal.  The polarization of the excitation pulse was at the magic angle relative 
to that of the gate pulses.  First, the frequency-doubled blue pulses (407 nm) were focused 
onto a rotating cell containing the sample and the fluorescence signal was collected using a 
10x objective lens.  Then, the gate pulse and fluorescence signal were focused onto a 0.4 mm 
type-I BBO crystal to generate the sum frequency light, which was detected by a 
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photomultiplier tube mounted on a monochromator.  The full-width-at-half-maximum 
(FWHM) of the instrument response function is 300 fs, obtained by the cross-correlation 
function of the frequency doubled and the fundamental light.  All experiments were 
performed at room temperature.  For most fluorescence upconversion experiments, a time 
window of 100 ps was used with a step size of 0.2 ps. 
The solvation correlation function, C(t), was used to analyze and quantify the 
solvation dynamics. 
)()"0("
)()(
)(
∞−
∞−
=
νν
νν t
tC      (6.1) 
The ν(“0”), ν(t) and ν(∞) in eq 6.1 denote the peak frequency (typically in cm-1) of the zero 
time, t and infinity emission spectra.  Using the approach of Fee and Maroncelli,34 the “zero 
time” emission spectrum was approximated by using the emission spectrum of curcumin in 
hexanes.  As for ν(∞), the peak frequency of the steady-state fluorescence spectrum was 
used.  In these investigations, fluorescence upconversion measurements were performed at 
15-16 wavelengths depending upon the system, ranging from 470 – 630 nm, with a time 
window of 10 ps to construct time-resolved emission spectra with sufficient data points to 
reflect the real spectra.  Each of the time-resolved emission spectra was fitted with the log-
normal function and the peak frequency ν(t) was obtained using the procedure outlined by 
Maroncelli and Fleming.35  The relatively large width of the time dependent emission spectra 
typically results in uncertainty in the exact position of the maxima.  Therefore, by using the 
signal-to-noise ratio and width of the spectrum (including “zero-time”, steady-state, or time-
resolved emission spectrum) as sources of uncertainty, we determined the following typical 
uncertainties: time-resolved emission (~ ± 200 cm−1), “zero-time” and steady-state (~ ± 100 
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cm−1).  These uncertainties were used to compute error bars for the C(t).  Finally, the 
fractional solvation at 300 fs was calculated using f300fs = 1 − C(t = 300 fs). 
Results and Discussions 
UV-Vis absorption and emission spectra of curcumin in micelles.  The spectral 
properties of curcumin in three different micelles were investigated systematically to 
examine the influence of micellar environments on spectral features.  Figure 6.2 depicts the 
UV-vis absorption and emission spectra of curcumin in TX-100, DTAB and SDS micelles 
under deuterated (blue) and non-deuterated (red) condition at pD or pH = 7.4 in tris buffer.  
Curcumin exhibits a broad and intense absorption peak at 426 nm, 423 nm and 432 nm in the 
TX-100, DTAB and SDS micelles, respectively.  A small shoulder in the absorption band is 
present at 445 nm and 442 nm in the TX-100 and DTAB micelles, whereas curcumin 
produces a featureless absorption band in the SDS micelle.  The absence of vibronic structure 
in the absorption band of curcumin, as observed in the SDS micelle, is also observed for 
curcumin in water.  This phenomenon indicates that curcumin may interact strongly with 
water molecules in the Stern layer of the micelle, which is the layer between the core/water 
interface and the hydrodynamic shear surface,36 as will be discussed furthering more detail 
forthwith.  Additionally, a broad spectral shoulder is present around 500 nm for curcumin in 
the DTAB micelle.  This extra shoulder, which is absent in the other two micelles, is due to 
the presence of a small population of deprotonated curcumin at pH = 7.4. 
As for the emission spectrum, curcumin shows a broad spectrum peaked at 501 nm, 
498 nm and 548 nm in the TX-100, DTAB and SDS micelles, respectively.  The peak 
positions of the UV-vis absorption and emission spectra of curcumin are affected by the 
isotopic substitution, as shown in Figure 6.2.  While a 3-nm blue shift appears in the UV-vis 
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absorption of curcumin in both the TX-100 and DTAB micelles in D2O, a red shift with the 
same magnitude in the emission maximum emerges in these micelles.  As for the SDS 
micelle in D2O, a 3 nm blue and ~10 nm red shift are found in the absorption and emission 
maxima, respectively.  The changes in absorption and emission peak positions are possibly 
due to changes in zero-point energies in S0 and S1 induced by deuteration.37,38 
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Figure 6.2.  UV-Vis absorption and emission spectra of curcumin in (A) TX-100, (B) 
DTAB, and (C) SDS in H2O (red) and D2O (blue). 
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A comparison between the UV-vis absorption and emission spectra of curcumin in 
micelles with those in a number of organic solvents and water provides valuable insights.  
The UV-vis absorption spectra of curcumin in the TX-100 and DTAB micelles resemble 
those of curcumin in aprotic solvents, including chloroform and toluene,23,39 suggesting 
similarities between the environments.  However, the emission spectra of curcumin in these 
micelles are red-shifted compared to those in the aprotic solvents, potentially due to 
interactions with water molecules at the interface and within the micelle,40-44 as will be 
discussed further in a later section.  It is well established that curcumin exhibits a red-shifted 
emission spectrum in protic solvents including methanol and water, with an emission 
maximum around 550 nm.  The overall results suggest that curcumin is likely to be located in 
the palisade layer of the TX-100 and DTAB micelles, which is consistent with results from 
another study.22  As for the SDS micelle, the positions of the UV-vis absorption and emission 
maxima are identical to those of curcumin in methanol and water, indicating that the micellar 
environment is analogous to the polar environment in these protic solvents.  This suggests 
that curcumin is probably situated near the Stern layer of the SDS micelle, which facilitates 
strong interactions with bulk water. 
The Stokes shifts of curcumin are 75 nm, 75 nm, and 116 nm in the TX-100, DTAB 
and SDS micelles, respectively.  Interestingly, the value of the Stokes shift for TX-100 and 
DTAB micelles are similar to those measured for human and bovine serum albumin (HSA 
and BSA) bound curcumin.14,45-48  It is established that curcumin binds strongly in the 
hydrophobic pocket of these proteins.  The similar Stokes shift values for TX-100 and DTAB 
micelles imply that the micellar environment is similar to the hydrophobic regions of HSA 
and BSA.  In contrast, the sizeable Stokes shift observed in the SDS micelle is virtually 
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identical to that observed in a buffer solution, which reflects that the local environment of 
curcumin in the SDS micelle may have a significant bulk water content, which further 
supports that curcumin is located near the Stern layer of the micelle. 
Fluorescence upconversion and excited-state intramolecular hydrogen atom 
transfer of micelle-captured curcumin.  The fluorescence upconversion results of 
curcumin in the TX-100, DTAB and SDS micelles are shown in Figure 6.3.  The 
fluorescence upconversion decay traces of curcumin in both nondeuterated and deuterated 
micellar environments at pH and pD =7.4, respectively, are illustrated in the figure.  The 
decay kinetics were monitored at 520 nm with an excitation wavelength of 407 nm.  
Collection of time-resolved florescence at 520 nm for the SDS micelle provides early time 
excited-state relaxation information as this wavelength is on the blue side of the emission 
spectrum.  In the case of curcumin in TX-100 and DTAB micelles, since 520 nm is on the red 
side of the emission peak maxima, relaxation processes including solvation could be 
pronounced as curcumin shows a strong solvatochromatic behavior.  All the upconversion 
decays are well fitted with a biexponential function within the 100 ps time window and the 
results are summarized in Table 6.1.  Curcumin in the TX-100/H2O system shows a fast 
component of 8 ± 2 ps and a slow component of 80 ± 10 ps.  Upon deuteration of curcumin 
in the same micelle, a biexponential decay with time constants of 8 ± 2 and 130 ± 20 ps is 
obtained.  It is important to note that while the fast component remains identical within 
experimental error in the two results, the slow component shows a significant isotope effect 
of 1.6.  The isotope effect on the slow component clearly indicates that ESIHT occurs with a 
time constant of 80 ps in TX-100.  In DTAB/H2O and SDS/H2O, the time-resolved 
fluorescence also exhibited a distinct biexponential decay.  The fast component has time 
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constants of 6 ± 2 and 3 ± 2 ps whereas in the slow component 50 ± 5 and 55 ± 3 ps are 
obtained for curcumin in the DTAB and SDS micelles, respectively.  Deuteration of 
curcumin induces a similar isotope effect, i.e., an identical fast component and lengthening of 
the slow component.  The time constants of the long component are 80 ± 5 and 85 ± 6 ps in 
the DTAB/D2O and SDS/D2O media, respectively.  The presence of an isotope effect of ~1.6 
for curcumin in these two micelles reinforces our assignment of the long-lived component to 
ESIHT.  As for the fast component observed in the results, further discussion will be given in 
the following section. 
Several studies have shown that the ESIHT process in curcumin is highly sensitive to 
the presence of hydrogen bonding between curcumin and the solvent.21-23  Nardo et al. and 
Khopde et al. independently reported that there is a ~50 ps decay component in the 
fluorescence lifetime (89 and 64 ps, as measured by the two groups, respectively) of 
curcumin in cyclohexane using TCSPC.21,22  This decay component is, however, limited by 
the time resolution of TCSPC apparatus.  It is accepted that this fast decay component is due 
to ESIHT of curcumin.22  The ESIHT time constant of curcumin in this nonpolar solvent is 
shorter than that in methanol, which has a value of ~ 70 ps.23  The results imply that the 
strength of the intramolecular hydrogen bond of curcurmin is the determining factor in the 
rate of ESIHT.  These authors, furthermore, suggest that in protic solvents, such as methanol 
and ethanol, the keto-enol group of curcumin forms strong hydrogen bonds with the solvent 
molecules, in addition to the intramolecular hydrogen bond within the keto-enol group.21,22  
The interactions between curcumin and the protic solvent molecules interfere with the 
intramolecular hydrogen bond, weakening the bond effectively, thereby decreasing the rate 
of ESIHT.  However, such perturbation in intramolecular hydrogen bonding is absent in 
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nonpolar solvents such as cyclohexane, enabling a strong intramolecular hydrogen bond in 
the keto-enol moiety of curcumin and facilitating a fast ESIHT. 
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Figure 6.3.  Fluorescence upconversion decays of curcumin collected at 520 nm in (A) TX-
100, (B) DTAB and (C) SDS micelles at pH = 7.4 tris buffer (red) with an excitation 
wavelength of 407 nm.  Corresponding upconversion decays in deuterated micellar 
environment at pD = 7.4 (blue) are also included.  Curcumin shows a prominent isotope 
effect in all three micellar media. 
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The ESIHT time constant of curcumin in the TX-100 micelle, with a value of 80 ps as 
measured in this fluorescence upconversion study, is very similar to that of curcumin in 
methanol (70 ps), as reported in our previous study using the same technique.23  Additionally, 
the ESIHT time constant of curcumin reported in this study is comparable to that of 7-
azaindole in methanol.49  The good agreement indicates a substantial level of curcumin-
solvent and curcumin-surfactant intermolecular hydrogen bonding in the micelle.  This result 
is consistent with a previous study, suggesting that curcumin is trapped in the palisade layer 
of the micelle,22 which is a relatively hydrophilic layer of the micelle.50  In addition, studies 
have shown that the C–O groups in TX-100 interact favorably with water, which support that 
there is a substantial level of water in the micelle.51,52  Furthermore, curcumin may also have 
considerable hydrogen bonding with oxygens in the C–O groups in the TX-100 surfactants, 
as will be discussed below.  In short, in the case of the TX-100 micelle, our results indicate 
that hydrogen bonding between curcumin and the micellar environment is similar to that 
between curcumin and bulk methanol, which is consistent with results from a previous 
report.22 
In the DTAB and SDS micelles, the ESIHT time constants are approximately 50 ps, 
as shown in Table 6.1.  It appears that the fast ESIHT times observed in these micelles 
compare well with that in the nonpolar solvent cyclohexane.21,22  However, as indicated 
earlier, the ESIHT process of curcumin in cyclohexane is most likely faster than what was 
measured with TCSPC due to limited temporal resolution.  In comparison to curcumin in the 
TX-100 micelle, the ESIHT process occurs faster in the DTAB and SDS micelles.  It is 
obvious that there is a stronger curcumin intramolecular hydrogen bond, and a weaker 
curcumin-water and/or curcumin-surfactant interaction in these micelles compared to TX-
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100.  To gain insight into the higher rates of ESIHT in the DTAB and SDS micelles relative 
to that of TX-100, we first consider the water content of the micelles.  Studies have suggested 
that the water contents are similar for the DTAB and TX-100 micelles but higher in the SDS 
micelle.53  Therefore, it follows that the curcumin-water hydrogen bonding is likely to play a 
minor role in leading to a higher rate of ESIHT for curcumin in the DTAB and SDS micelles.  
An obvious difference between TX-100 and the other two surfactants is that the presence of a 
high number of C–O groups in the backbone of TX-100, which may interact with curcumin 
through hydrogen bonding.  In contrast, the surfactant backbones of DTAB and SDS are 
composed of the dodecyl group, which only interacts with curcumin through weak van der 
Waals forces.  It is likely that the presence of a considerable hydrogen bonding network for 
curcumin in the TX-100 micelle leads to a slower rate of ESIHT.  In the DTAB and SDS 
micelles, however, the ESIHT rate is higher due to the absence of such hydrogen bonding 
network.  While the results in this study are consistent with the notion of additional hydrogen 
bonding in the TX-100 micelles for curcumin, more work will be necessary to understand 
this effect fully. 
Table 6.1.  Fluorescence upconversion decay parameters for curcumin in different micellar 
systemsa 
 
Micellar system a1 τ1 (ps) τ2 (ps) 
TX-100/H2O 0.30 ± 0.04 8 ± 2 80 ± 10 
TX-100/D2O 0.23 ± 0.03 8 ± 2 130 ± 20 
DTAB/H2O 0.36 ± 0.03 6 ± 2 50 ± 5 
DTAB/D2O 0.22 ± 0.03 6 ± 2 80 ± 5 
SDS/H2O 0.57 ± 0.03 3 ± 2 55 ± 3 
SDS/D2O 0.57 ± 0.03 3 ± 2 85 ± 6 
 
a The fluorescence upconversion traces, f(t), were fitted with the multi-exponential function  
f(t) = a1 exp (-t/τ1) + a2 exp (-t/τ2), where a1 + a2 = 1. 
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Early time solvation dynamics in micelles.  The fluorescence upconversion results 
in Figure 6.3 show that in addition to the component that is attributed to ESIHT, there is an 
early time decay component with a time constant significantly shorter than the ESIHT 
component.  Table 6.1 summarizes the time constant of the fast component, showing that 
values of 8, 6 and 3 ps were obtained for curcumin in TX-100, DTAB, and SDS micelles, 
respectively.  Interestingly, unlikely the ESIHT component which shows an isotope effect, 
the fast decay component is insensitive to deuteration of curcumin.  As shown in Table 6.1, 
the τ1 values are virtually identical for nondeuterated and deuterated curcumin in each of the 
micelles.  In our previous study on curcumin in polar organic solvents, an isotope effect-free 
fast decay component was also observed and we demonstrated that the decay component is 
due to solvation of curcumin in these solvents.23  Using the previous results as a guide, we 
conducted a series of fluorescence upconversion experiments with a time window of 10 ps.  
The results are shown in Figure 6.4.  For curcumin in the TX-100 micelle (Figure 6.4A), the 
fluorescence upconversion traces show a clear decay at 470 nm (blue) and this decay slows 
down considerably at 540 nm (red).  However, at 610 nm (green), the fluorescence decay 
vanishes and a rise component is observed.  The presence of the decay and rise components 
as a function of fluorescence wavelength shown in Figure 6.4 is a key signature of solvation 
dynamics.  As will be discussed further below, water molecules in the micellar structure play 
a major role in solvating curcumin.  For curcumin in the DTAB micelle (Figure 6.4B), an 
almost identical trend in the fluorescence upconversion is shown, with a rise component 
observed at 610 nm.  While a similar behavior of the multiwavelength fluorescence 
upconversion is shown by curcumin in the SDS micelle, the wavelengths at which the decays 
were recorded were set slightly to the red due to a larger Stokes shift observed for curcumin 
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in this micelle.  In short, the results indicate the presence of solvation dynamics for curcumin 
in TX-100, DTAB and SDS micelles. 
Using the method outlined in the experimental section, the solvation correlation 
function, C(t), for curcumin in the three micelles were constructed from 15-17 wavelength-
resolved decay traces depending upon the systems and are shown in Figure 6.5.  First, it is 
clear that for curcumin in each micelle, C(t) shows a rapid decay which is followed by a slow 
decay and an apparent constant offset.  Curcumin shows a fractional solvation at 300 fs, f300 
fs, of 0.25, 0.53, and 0.50, in the TX-100, DTAB, and SDS micelles, as summarized in Table 
6.2.  The C(t) for curcumin in each of the micelles was fitted with a multiexponential 
function, of which the equation is shown as follows, and the fitting parameters are listed in 
Table 6.2. 
)/exp()/exp()( 2211 ττ tatatC −+−=    (6.2) 
Initially, a fit to eq 6.2 was attempted by fixing the τ2 component to 8, 6, and 3 ps for the TX-
100, DTAB, and SDS micelles, respectively and excellent fits were obtained.  For curcumin 
in the TX-100 micelle, the fast decay component in C(t) has a time constant of 0.31 ps, which 
is as short as the instrument response function (IRF) of our apparatus, and an amplitude of 
37%.  In the DTAB and SDS micelles, however, the time constants of the fast component 
have values of 0.12 and 0.15 ps, respectively, which are shorter than the IRF of the 
instrument.  These IRF-limited decay time constants have amplitudes of 56% and 54% in 
these two micelles.  The fast component of C(t) is followed by a slow decay component, of 
which the time constants are fixed as mentioned above.  The amplitudes of this component 
are nearly the same in the three micelles, ranging from 20% to 26%.  In addition to the fast (≤ 
300 fs) and slow (3 – 8 ps) components of C(t), it is obvious that solvation dynamics are 
  
204 
incomplete within the time window of the experiment, giving rise to a constant offset in the 
C(t), as shown in Figure 6.5 and the a3 term in the multiexponential equation in Table 6.2.  
Alternatively, a good fit to eq 2 can also be obtained by fixing the fast component to 0.1 ps 
for the three micelles.  In this case, the slow component has a time constant of 1.8, 2.6, and 
1.9 ps, respectively.  The best-fit curves and fitting parameters are provided in the Supporting 
Information.  The significance of the decay components of C(t) are discussed below. 
Solvation dynamics in micellar media is currently an intense area of research.40-43,54-62  
Surfactant micelles are excellent model systems for more complex biomembranes and 
investigations on solvation dynamics in micelles provide critical insight into the behavior of 
small molecules in biomembranes.  First of all, in our study, it is noteworthy that for each of 
the micelles the value of the time constant τ2 of C(t), as summarized in Table 6.2, is virtually 
identical within experimental error to that of the fast component of the fluorescence 
upconversion results shown in Figure 6.3 and Table 6.1.  The excellent agreement strongly 
indicates that the fast component observed in the fluorescence upconversion results (Figure 
6.3 and Table 6.1) is due to solvation dynamics of curcumin in micellar media.  Second, the 
decay  of C(t) of curcumin in all micelles show a fast component with a time constant that is 
either as fast as the IRF (300 fs) or too short  to be resolved with our apparatus.  This fast 
decay component was also reported for the SDS and DTAB micelles in a study by Dey et al. 
using coumarin 480 as the probe molecule and a time constant of <300 fs was measured.54  
This fast component of solvation dynamics has been previously attributed to motions of 
labile or bulklike water molecules at the interface of the micelle.40-44  As for fast solvation 
dynamics in TX-100, Mandal et al. showed that the fastest component has a time constant of 
2.1 ps,60 which is somewhat longer than our measured value of ~300 fs.  To our knowledge, a 
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~300 fs solvation dynamics component in the TX-100 micelle is previously unobserved, and 
our result is the first demonstration of ultrafast solvation dynamics of the TX-100 micelle.  
Third, it is apparent that curcumin has a shorter time constant of fast solvation dynamics in 
the SDS/DTAB micelles (<300 fs) than in the TX-100 micelle (~300 fs).  This phenomenon 
is likely to originate from the level of interaction of curcumin with the bulklike water 
molecules at the aqueous/micelle interface.  A previous study shows that the hydration layer 
of the SDS and DTAB-like micelles is substantially thinner (6 – 9 Å) than that of the TX-100 
micelle (20 Å).42  This result indicates that curcumin is less shielded from the bulklike water 
molecules in the former two micelles than in the latter and hence faster solvation dynamics 
are observed in the SDS and DTAB micelles.  Fourth, the slow component of C(t), which has 
time constants of 8, 6 and 3 ps, respectively, in the TX-100, DTAB, and SDS micelles, shows 
reasonable agreement with results from previous studies,54,60 which has been assigned to 
solvation of water molecules that are bound to the surface of the micelle by hydrogen 
bonding or the head group-water interactions.40-44  Lastly, the constant offset observed in the 
C(t) of curcumin in the three micelles, which is expressed as a3 in Table 6.2, indicates the 
presence of a decay component with a time constant that is vastly longer than the 10 ps time 
window of the solvation dynamics studies.  Although this decay component of C(t) is too 
long to be resolved with our solvation dynamics investigations, it has been established in 
previous studies that C(t) has a long lived component in micelles, with time constants 
ranging from 165 to 300 ps.54,60 
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Figure 6.4.  Representative normalized wavelength resolved fluorescence upconversion 
decay traces of curcumin at three different wavelengths in (A) TX-100, (B) DTAB, and (C) 
SDS micelles at pH =7.4 tris buffer.  The time-resolved traces at the red end (610 nm for TX-
100 and DTAB and 630 nm for SDS micelles) show a rising component, clearly indicating 
the presence of solvation dynamics. 
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Table 6.2.  Solvation correlation function, C(t), decay parameters for curcumin in different 
micellar systems 
 
Micellar 
system 
f300 fs
a
 a1
b
 τ1 (ps) a2 τ2 (ps)c a3 
TX-100 0.25 ± 0.03 
0.37 ± 
0.02 
0.31 ± 
0.04 
0.22 ± 
0.03 8 
0.41 ± 
0.02 
DTAB 0.53 ± 0.03 
0.56 ± 
0.02 
0.12 ± 
0.02 
0.20 ± 
0.02 6 
0.24 ± 
0.02 
SDS 0.50 ± 0.03 
0.54 ± 
0.02 
0.15 ± 
0.02 
0.26 ± 
0.02 3 
0.20 ± 
0.01 
 
a f300fs: fractional solvation at 300 fs. 
b The C(t) was fitted with the multi-exponential function C(t) = a1 exp (-t/τ1) + a2 exp (-t/τ2) 
+ a3. 
c The τ2 component was fixed at 8, 6, and 3 ps for the TX-100, DTAB, and SDS micelles, 
respectively to demonstrate the agreement with the results in Figure 6.3 and Table 6.1. 
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Figure 6.5.  Solvation correlation function, C(t), of curcumin in TX-100 (red), DTAB (blue), 
and SDS (black) micelles constructed from multiwavelength fluorescence upconversion 
results.  The C(t) is well fitted with a biexponential function.  All three micelles show 
different fast and slow components, refer to Table 6.2.  Note that the slow component in C(t) 
for each micelle is identical to the fast component of the corresponding fluorescence 
upconversion decay at 520 nm within experimental error, see Figure 6.3 and Table 6.1. 
 
Fluorescence Lifetime in Micelles.  The excited-state kinetics of curcumin in 
micelles was also investigated using time-correlated single photon counting (TCSPC).  
Figure 6.6 shows the fluorescence decays of curcumin in the TX-100, DTAB and SDS 
micelles in tris (pH 7.4) and tris-d11 (pD 7.4) buffer with a 3 ns time window, in which 
curcumin produces an isotope effect in each of the micelles.  The decays are 
multiexponential in nature and three exponential functions are necessary to fit the data well.  
The best fit parameters and the average fluorescence lifetimes are summarized in Table 6.3.  
Briefly, in H2O, the fastest decay component has a time constant ranging from 50 – 60 ps, 
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which is followed a slower component of ~200 ps and then a long lived 400 – 900 ps 
component.  In contrast, in D2O, while the two slower components are essentially 
indistinguishable within experimental error, the fastest component increases to 70 – 85 ps, 
exhibiting an isotope effect of 1.4 in the three micelles. 
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Figure 6.6.  Fluorescence decays obtained with time-correlated single photo counting for 
curcumin in (A) TX-100, (B) DTAB and (C) SDS micelle at pH = 7.4 (red) and pD =7.4 
(blue) tris buffer.  The decays were obtained at λex = 407 nm and λem ≥ 425 nm with a full 
time window of 3.33 ns.  The decays are well fitted with a triexponentional decay function.  
The lengthening of the shortest decay component in the deuterated media supports the 
assignment of this decay component to ESIHT, which shows excellent consistency with the 
fluorescence upconversion results. 
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Table 6.3.  Fluorescence lifetime results of curcumin in different micellar systems 
 
Micellar 
system 
 
a1
a
 τ1 (ps) a2 τ2 (ps)b τ3 (ps) 〈τ〉 (ps) 
 
TX-
100/H2O 
 
0.68 ± 0.02 60 ± 5 0.30 ± 0.02 
210 ± 
30 
510 ± 
100 
115 ± 
15 
 
TX-
100/D2O 
 
0.48 ± 0.02 85 ± 5 0.32 ± 0.02 
210 ± 
30 430 ± 20 
195 ± 
12 
 
DTAB/H2O 
 
0.88 ± 0.02 50 ± 5 0.11 ± 0.02 
190 ± 
50 
900 ± 
200 75 ± 12 
 
DTAB/D2O 
 
0.72 ± 0.03 70 ± 5 0.27 ± 0.03 
190 ± 
50 
730 ± 
300 
110 ± 
17 
 
SDS/H2O 
 
0.91 ± 0.01 55 ± 5 0.08 ± 0.01 
185 ± 
10 415 ± 80 70 ± 6 
 
SDS/D2O 
 
0.55 ± 0.02 75 ± 5 0.44 ± 0.02 
185 ± 
10 405 ± 20 125 ± 8 
 
aThe fluorescence decay traces, f(t), were fitted with the multi-exponential function  f(t) = a1 
exp (-t/τ1) + a2 exp (-t/τ2) + a3 exp (-t/τ3), where a1 + a2 + a3 = 1. 
b The τ2 values were limited to the range specified. 
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It is noteworthy that there is a close match between the time constants of the ESIHT 
component, as established in an earlier section on fluorescence upconversion, and the τ1 
component as measured by TCSPC, see Table 6.1 and 6.3.  Furthermore, similar to the 
fluorescence upconversion results, this decay component experiences an isotope effect in the 
deuterated environment.  Therefore, the results strongly indicate that the τ1 component 
measured by TCSPC is due to ESIHT.  Interestingly, the average fluorescence lifetimes of 
curcumin in the TX-100 micelle is close to that of curcumin in methanol (130 ps), suggesting 
the similarities of the two environments, as discussed in a previous section.  The shorter 
average lifetimes of curcumin in the DTAB and SDS micelles imply a greater level of 
intramolecular hydrogen bonding but lesser extent of intermolecular hydrogen bonding, 
which was also discussed in the same section.    
Conclusion 
We have presented unambiguous results to demonstrate that excited-state 
intramolecular hydrogen atom transfer (ESIHT) is a major photophysical process of 
curcumin in the TX-100, DTAB and SDS micelles.  The fluorescence upconversion trasient 
of curcumin in each micelle shows a biexponential decay, with time constants of 3 – 8 ps 
(fast) and 50 – 80 ps (slow).  The slow component exhibits a pronounced isotope effect, 
producing a decay time constant of 80 – 130 ps in the micelles, which is assigned to ESIHT.  
The ESIHT rate of curcumin in the TX-100 micelle is lower than those in the other two 
micellar system.  The hydrogen bonding between curcumin and the TX-100 surfactant may 
contribute to this effect.  The fast decay component, unlike the ESIHT process, is insensitive 
to deuteration of curcumin and has been attributed to solvation dynamics using results from 
multiwavelength fluorescence upconversion studies.  The water molecules in the micellar 
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structure give rise to solvation dynamics of curcumin.  The solvation dynamics observed in 
the micelles are due to water molecules at the micelle interface that are labile or bulklike and 
those that are bound to the surface of the micelles. 
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CHAPTER 7.  A NEW FLUORESCENCE BASED METHOD FOR THE REAL-TIME 
DETECTION OF CENTRAL NERVOUS SYSTEM (CNS) TISSUES ON BOVINE 
CARCASSES BASED ON LIPOFUSCIN 
 
A paper published in Journal of Agricultural and Food Chemistry 
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A. Richt†* and Jacob W. Petrich‡* 
 
Abstract 
The removal of Central Nervous System (CNS) tissues as part of Bovine Spongiform 
Encephalopathy (BSE) risk material is one of the highest priority tasks to avoid 
contamination of the human food chain with BSE. No currently available method enables the 
real-time detection of possible CNS tissue contamination on carcasses during slaughter.  The 
fluorescent pigment lipofuscin is a heterogeneous, high-molecular weight material that has 
been shown to be enriched in high concentrations in neuronal tissues.  In this study, 
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lipofuscin fluorescence was investigated as a marker for real-time detection of CNS 
contamination.  Front-faced fluorescence spectra of brain and spinal cord samples from 11 
cattle gave identical, reproducible fluorescence signal patterns with high intensities.  The 
specificity of these spectra was assessed investigating 13 different non-CNS tissues enabling 
the differentiation of brain and spinal cord by signal intensity and structure of the spectra, 
respectively.  Small quantities of bovine spinal cord were reliably detected in the presence of 
raw bovine skeletal muscle, fat, and vertebrae.  The presented data are the fundamental basis 
for the development of a prototype device allowing real-time monitoring of CNS tissue 
contamination on bovine carcasses and meat cuts. 
Introduction 
Bovine spongiform encephalopathy (BSE) is a fatal, neurodegenerative transmissible 
spongiform encephalopathy (TSE) in cattle that is thought to be the cause of variant 
Creutzfeldt - Jakob disease (vCJD) in humans.1  The oral route of infection is presumptively 
the most likely way of transmission of BSE to humans.2,3 Since most BSE cases were 
diagnosed in the United Kingdom and other European countries, the global nature of BSE 
was highlighted by detection of the disease in cattle in North America4-6 and Japan.7   
Removal of bovine specified risk materials (SRMs, e. g. brain and spinal cord) from 
the human food chain is of critical importance for protecting consumers from BSE.8,9  Brain 
and spinal cord from BSE infected cattle have been shown to contain the highest infectivity 
titer of the causative agent of BSE, the abnormal prion protein PrPBSE.8  As a consequence, 
many countries have banned bovine CNS tissues from meat and meat products.  For instance, 
regulations regarding SRMs are constituted by the European commission in Annex V 
Commission Regulation (EC) No. 999/2001 and for the USA in Docket No. 03-025IF of the 
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USDA-Food Safety and Inspection Service (FSIS). 
So far only laboratory methods for the detection of CNS tissues as part of the BSE 
risk material have been developed.  These include immunochemical detection and enzyme-
linked immunosorbent assays (ELISA)10,11, gas chromatography-mass spectrometry (GC-
MS)12, Western blot analysis13,14, immunohistochemical methods14,15 and a real-time reverse 
transcription (RT)-PCR assay.16,17  None of this method is suitable for the direct real-time 
monitoring of CNS contamination on bovine carcasses during slaughter.  Real-time based 
detection of CNS tissue contamination would allow immediate trimming and removal of 
remaining SRM from the carcass before it enters the food chain.  In addition, meat cuts could 
be monitored after boning to prevent possible contamination with SRM tissues.  
Fluorescence spectroscopy has been commonly used in a variety of biological 
applications due to its high sensitivity and specificity (for a review see refs 18-22).  In 
addition, members of our group have previously demonstrated the potential of fluorescence 
spectroscopy for the detection of fecal contamination on the surface of meat during 
slaughter.23,24  The pigment lipofuscin is a heterogeneous, high-molecular weight fluorescent 
material that has been shown to be enriched in high concentrations in neuronal tissues.25-30 Its 
exact chemical composition is controversial.25  In previous steady-state, front-faced 
fluorescence experiments, spectral features consistent with lipofuscin were found in bovine 
brain and spinal cord.25,31  To investigate the applicability of fluorescence from lipofuscin for 
a real-time detection of brain and spinal cord, spectral shapes and intensities of these two 
most important SRM tissues were investigated and compared to 13 non-CNS tissues.  
Furthermore the detection sensitivity of bovine spinal cord in the presence of skeletal muscle, 
fat and vertebrae was assessed. 
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Materials and Methods  
Collection of bovine tissue samples.  CNS and non-CNS tissue samples were 
collected from healthy male (n=6) and female (n=5) cattle directly after slaughter at local 
abattoirs (n=9) or during necropsy of healthy control animals at the National Animal Disease 
Center (n=2).  All samples were kept frozen at -20°C until processing. Breeds included 
Holstein (n=2), Simmental (n=2), and Angus cross breeds (n=7).  Ages included 2 months 
(n=1), 5-6 months (n=2), 20-24 months (n=4), 48-72 months (n=4) as determined by 
dentition.  Brain and spinal cord were investigated as CNS tissues.  The 13 non-CNS tissues 
were adrenal gland, bone (vertebrae), bone marrow, dorsal root ganglia, fat, heart, kidney, 
liver, lung, lymph node (e.g. iliofemoral ln), peripheral nerve (e. g. sciatic nerve), skeletal 
muscle, and spleen.   
Steady-State Measurements.  Steady-state fluorescence spectra were obtained on a 
SPEX Fluoromax-2 (ISA Jobin-Yvon/SPEX, Edison, NJ) with a 5-nm band-pass and were 
corrected for lamp spectral intensity and detector response.  Fluorescence spectra were 
collected in a front-faced orientation.  To select the appropriate excitation wavelength, brain 
and spinal cord samples from cattle were excited at 350, 410, 470, and 520 nm.  Excitation at 
470 nm was determined to provide optimal measurements.  Therefore, all samples were 
excited at 470 nm with an interference filter on the excitation side; and emission was 
collected at wavelengths greater than 505 nm using a cutoff filter before the detector to 
eliminate scattered light.  Polarized fluorescence spectra were obtained using two polarizers, 
one on the excitation side and another one on the emission side with the appropriate 
excitation interference filter and cut-off emission filter.  Fluorescence spectra were taken in 
horizontal-horizontal (HH) and horizontal-vertical (HV) orientations of the polarizers.  
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Statistical and graphical data analysis was performed by using Origin® V. 7 software 
(OriginLab Corporation, USA).  
Investigation of fluorescence spectra of bovine brain, spinal cord and non-CNS 
tissues.  Ten identically-sized cross and longitudinal sections (five of each) of identical 
regions of the frontal cortex and the cerebellum of each brain and ten spinal cord samples 
from each animal were prepared.  Each sample was placed on a microscope slide and stored 
in a dark moist chamber at < 7°C for 120 minutes until collection of the fluorescence spectra 
at room temperature.  Three cross sections were prepared for the measurement of the 
fluorescence signal from each of the cervical, the thoracic, the lumbar, and the sacral regions 
of the spinal cord from three different animals of 24 months (n=2) and 48 months (n=1) of 
age.  Spinal cord samples from two different animals were kept at -20°C and used for 
collection of fluorescence spectra after 0, 5, 26, 30, 50, 56 hours, and 8 weeks.  Longitudinal 
and cross sections of the non-CNS tissues were prepared as described above. 
Sensitivity of detection of spinal cord by using the front-faced experiment.  The 
lower limit of detection was determined for the optimized setup of the front-faced experiment 
by using spinal cord cross sections from two different animals.  In general, the total surface 
area exposed with the excitation wavelength was 1.0 cm x 2.0 cm. Pieces of each spinal cord 
cross section were prepared in duplicate corresponding to surface areas of 0.4 cm x 0.4 cm 
and 0.1 cm x 0.2 cm and placed on microscope slides.  For each sample, duplicate 
fluorescence spectra were collected and the experiment was repeated.  The lower limit of 
detection is defined by convention as the smallest size of tissue, which could be detected 
typical spectra. 
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Sensitivity of detection of spinal cord in the presence of different background 
tissues.  Bovine skeletal muscle, abdominal fat tissues and vertebrae of two different cattle 
were used for the assessment of the detection sensitivity of spinal cord in the presence of 
background signals.  For the front-faced experiments, six sample sections of similar size and 
height were prepared from these tissues, and were placed on microscope slides.  Skeletal 
muscle and fat were cut into pieces of ~0.2 cm x 0.2 cm.  The slices from vertebrae were kept 
as one piece.  Cross sections were prepared from the spinal cord collected from three 
different animals and prepared as described above.  Fluorescence spectra of all background 
tissue samples and the spinal cord itself were collected.  The surface area of the entire sample 
prepared was of similar size to the area exposed to excitation light.  A piece of spinal cord 
was placed in between the skeletal muscle, fat or on top in case of vertebrae samples, 
respectively.  The sample size of the spinal cord was adjusted to represent fractions of i) 10% 
and ii) 5% of the surface area of the entire sample.  This corresponded to a spinal cord 
section of ~0.1cm x 0.1 cm for a surface area of 5%.  All artificially spiked samples were 
prepared in duplicate and the experiment was conducted twice. 
Semiquantitative measurement of the amount of spinal cord added to the 
different background tissues by means of real time-PCR.  A comparative analysis using 
real-time PCR for the detection of ruminant glial fibrillary acidic protein (GFAP) mRNA was 
performed to i) show that fat and muscle samples used as background tissues were free of 
CNS and ii) show the reproduceability of our spiking experiments by using an alternative 
method as described previously.17  Briefly threshold cycle (Ct-values) obtained for the spiked 
samples were compared with Ct-values from standards of bovine minced meat artificially 
spiked with low amounts of bovine spinal cord to quantify the total amount of CNS tissue in 
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each sample. 
Results 
Selection of the excitation wavelength.  Fluorescence spectra obtained using 
excitation wavelengths of 350 and 520 nm excitation were of low intensity and noisy, 
whereas excitation at 410 nm yielded high-intensity spectra containing few characteristic 
features -namely only one noticeable peak.  On the other hand, by using 470 nm as the 
excitation wavelength, we were able to obtain structured fluorescence spectra with high 
signal-to-noise ratio from bovine brain and spinal cord.  Therefore, we chose to use 470 nm 
as the excitation wavelength for all of the samples considered in this study. This is also 
consistent with the observations reported previously.31  
Fluorescence spectra of bovine CNS and non-CNS tissues.  The solid CNS and 
non-CNS tissues fluoresced over a broader range when excited at 470 nm. Characteristic 
overlaid front-faced fluorescence spectra for CNS (spinal cord and brain) and non-CNS 
(kidney, dorsal root ganglia, liver, lymph node, peripheral nerve, adrenal gland, lung, fat, 
heart, vertebrae, skeletal muscle, bone marrow and spleen) tissues are presented in Figure 
7.1.  Fluorescence spectra from brain and spinal cord exhibited three prominent peaks 
centered at ~ 525 nm, ~555 nm, and 585-600 nm.  There were two small shoulders centered 
at ~625 nm and ~695 nm.  To check whether the peaks shown by spinal cord were not caused 
by the light scattered from the sample, steady-state fluorescence anisotropy experiments 
using polarizing filters were undertaken.  The HV spectra showed a structure very similar to 
that of the HH spectra (data not shown).  This confirmed that the peaks found in spinal cord 
were not artifacts of the detection system. Similar results were obtained for brain and non-
CNS tissues. 
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Figure 7.1.  Representative overlaid fluorescence spectra of spinal cord, brain, kidney, dorsal 
root ganglia, liver, lymph node, peripheral nerve, adrenal gland, lung, fat, heart, vertebrae, 
skeletal muscle, bone marrow and spleen.  The high fluorescence intensity from spinal cord 
enabled the detection of spinal cord in the presence of non-CNS tissue.  All values were 
calculated with respect to the average fluorescence intensity of the spinal cord, which was 
arbitrarily taken as unity.  
 
The spectral features of the CNS tissues were highly conserved in all samples studied 
regardless of age and breed.  No differences in the structure and intensity were seen for brain 
samples taken from cerebrum or cerebellum as well as cervical, thoracic, lumbar and sacral 
spinal cord.  The possible influence of the storage time and tissue consistency on the 
fluorescence signal was determined by measuring the fluorescence spectra at different time 
points and after homogenization, respectively.  Reproducible results were obtained even after 
the storage of spinal cord sections for 0, 5, 26, 30, 50, 56 hours and 8 weeks at -20°C.  A 
bead beater was used for mechanical homogenization of bovine spinal cord.  This did not 
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affect the shape of the spectra, but resulted in decreased signal intensity (data not shown).  
The most apparent difference between the two CNS tissues and all of the non-CNS 
tissues was the much higher fluorescence intensity obtained for spinal cord and brain tissues 
(Figure 7.1).  This observation strongly suggests that fluorescence techniques can be 
exploited to differentiate these two tissues from non-CNS samples. 
The normalized signal intensity obtained for bovine spinal cord was approximately 
three times higher than that from kidney and liver and eight-ten times higher than the 
intensity from skeletal muscle, fat and vertebrae. Standard errors in fluorescence intensity are 
shown in Figure 7.2.  It is obvious that spinal cord can easily be detected in the presence of 
skeletal muscle, fat and vertebrae since the fluorescence intensity from these background 
tissues is very low.  This might not be true in the presence of kidney, liver and lymph node 
tissues. 
Based on the nature of their fluorescence spectra, the non-CNS tissues offered several 
other interesting findings.  Peripheral nerves and dorsal root ganglia, both part of the 
peripheral nervous system, as well as the non-CNS tissues liver, kidney, heart, and lymph 
node showed strong similarities to the spectra of spinal cord (Figure 7.1).  This included the 
localization of the three peaks with similar relative peak intensities.  However, in these non-
CNS tissues, the two small shoulders centered at ~625 and ~695 nm were rarely present.  
Non-CNS tissues like lung, adrenal gland, fat, skeletal muscle, bone marrow, vertebrae and 
spleen showed different fluorescence spectra with regard to relative peak intensity and also 
peak positions from CNS tissues (Figure 7.1).  Lung tissue showed a quite different 
fluorescence spectrum with three peaks centered at ~520 nm, ~555 nm and a high intense 
peak at ~600- 610 relative to the first two peaks.  This intense third peak was not observed in 
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CNS and PNS tissues. For adrenal gland and skeletal muscle, the spectra did show three 
peaks at similar peak maxima like CNS tissues, but the second and third peak had similar 
intensities.  Fat tissue usually showed spectra with a single peak. A sharp peak at ~545 nm 
and sharp shoulder at ~675 nm were detected.  Bone marrow showed the three peaks known 
from CNS tissues, but with a higher intensity for the third peak and an extra broad shoulder 
at ~655-665 nm. Spleen and vertebrae showed almost similar spectra as compared to that of 
bone marrow.  
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Figure 7.2.  Average fluorescence intensities and corresponding standard errors of CNS and 
non-CNS tissues from cattle.  Intensities were normalized with respect to the maximum 
average intensity of spinal cord.  All values were calculated with respect to the average 
fluorescence intensity of the spinal cord, which was arbitrarily taken as unity. 
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Investigation of the detection sensitivity.  The lower limit of detection for bovine 
spinal cord was addressed for the front-faced fluorescence experiment itself.  In addition, the 
possible interference of the presence of skeletal muscle, fat, and vertebrae on the ability to 
detect CNS tissue was investigated.  The front-faced experiment allowed reproducible 
collection of spectra described for spinal cord down to a surface area as small as ~0.1 cm x 
0.1 cm.  Regardless of the presence of skeletal muscle, fat or vertebrae 100% detection 
sensitivity was observed for all of the spinal cord samples representing 10% (n=36) of the 
entire surface area investigated.  By using the experimental setup described above, 70% of all 
samples containing a 5% surface area of spinal cord in the background of fat (n=12) and 
skeletal muscle (n=12) as well as 80% of the samples in the presence of vertebrae (n=12) 
were identified correctly (Table 7.1).  After the addition of 5% spinal cord, the fluorescence 
intensity was ~1.5 times higher and characteristic spectra for spinal cord in presence of 
background tissues were observed (Figure 7.3, Figure 7.4 A-C).  
All fat and skeletal muscle samples used as background tissues for this experiment 
were shown to contain no CNS tissues by using real time-PCR analysis.  Since solid 
vertebrae did not permit the possibility of obtaining a homogenous mixture with spinal cord, 
the outer surface of these bones was removed to assure that only a CNS free background was 
used.  Comparative analysis of the fat and skeletal muscle samples containing a 5% surface 
area of spinal cord by real time-PCR detection of the GFAP mRNA gave concordant results 
for both consecutive experiments.  The CT values for skeletal muscle spiked with spinal cord 
were 25.53 (± 0.71).  Spinal cord in the presence of fat showed CT values of 21.46 (± 1.09) 
(Table 7.1).  
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Table 7.1.  Detection sensitivity (% surface area) of bovine spinal cord in the presence of 
different background tissues investigated in two separate experiments for each background 
tissue. 
 
Detection sensitivity (% [n]) in the 
presence of background tissues 
CT-values ( ± Standard deviations) Surface 
area (%) 
of spinal 
cord 
Skeletal 
muscle Fat Vertebrae Skeletal muscle Fat 
10 100% (n=12) 
100% 
(n=12) 
100% 
(n=12) n. d. n. d. 
5a 70% (n=12) 
70% 
(n=12) 
80% 
(n=12) 25.53 (± 0.71) 21.46 (± 1.09) 
 
a The 5% surface area of bovine spinal cord tissue in muscle and fat corresponded to a total 
amount of 5 % (skeletal muscle) to 7% (fat) of spinal cord in the prepared samples as 
determined by RT real-time PCR amplification of the GFAP mRNA.  Threshold cycle CT-
values are given for each of the two experiments conducted per tissue. Spinal cord in the 
background of solid vertebrae slices was not analyzed by real-time PCR since the solid bone 
did not result in a homogenous mixture the signal obtained from spinal cord would be 
overestimated.  
 
n. d. not done 
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Figure 7.3.  Fluorescence intensities obtained for the background tissues skeletal muscle fat, 
and vertebrae () and in the presence of 5% spinal cord ().  The error bars represent the 
standard errors associated with the measurements.  Note that 5% spinal cord can be detected 
in presence of skeletal muscle, fat and vertebrae as background tissue. 
 
Discussion  
BSE is a zoonotic disease causally associated with vCJD in humans.  BSE epidemic 
in various parts of the world had a severe impact on livestock and meat trade.  Even 20 years 
after the first identification of the disease, the United Kingdom estimated costs in 2005 to 
2006 for its BSE control measures including cohort culls and offspring cull compensation of 
approximately £265 million.  Additional administrative costs for inspection and enforcement 
were estimated to be £64 million as reported for 1999-2000.32  In the U.S., beef exports 
decreased by over 80% in 2004 after the confirmation of only one BSE case and persist 
below pre-2004 levels.33  Total U.S. beef industry losses arising from decreased beef and 
offal exports during 2004 ranged from $3.2 billion to $4.7 billion .34  Resumption of beef 
exports depended on several restrictions made by the important trade partners Japan and 
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South Korea.  This includes the removal of SRM (e.g. brain and spinal cord) and, in the case 
of South Korea, the acceptance of only boneless products, which represented an important 
export product for the South Korean market.33 
Consumer protection from the spread of BSE to the food chain is based on i) testing 
of cattle of particular minimal age for the presence of a BSE infection, ii) ban of SRM (in 
particular brain and spinal cord) from the food chain and iii) the ruminant feed ban.  The 
materials identified as bovine SRM are the brain, skull, eyes, trigeminal ganglia, spinal cord, 
vertebral column (excluding the vertebrae of the tail, the transverse processes, and the wings 
of the sacrum), and dorsal root ganglia (DRG) from cattle of 30 months of age and older, and 
the distal ileum of the small intestine and the tonsils from all cattle.35  The 30-month-and-
older-age classification for SRMs is accepted by the U.S. and several other countries based 
on O.I.E (World Organisation for Animal Health, www.oie.int) requirements. 
Current methods for detecting CNS tissues in meat and meat products are mainly 
based on ELISA and PCR techniques.  The major drawback of the ELISA10,11 or real-time 
PCR16,17 methods are their high costs and the need for varying degrees of access to laboratory 
environments and equipment, making them unsuitable for on-site monitoring during the 
slaughter process.  On the other hand, light-based spectroscopic techniques are rapid and 
noninvasive, requiring no sample preparation.  For example, we have previously developed a 
method and apparatus for the real-time detection of fecal contamination on bovine carcasses 
using fluorescence-based detection of bovine feces containing undesirable bacteria, which 
has been proven to be a reliable technique23,24; it is now being adopted in packing plants in 
the US and France. Using the same principles, we propose to use fluorescent lipofuscin as a 
marker of CNS tissue.36 
  
231 
0.0
0.2
0.4
0.6
0.8
1.0  Skeletal Muscle
 5 % Spinal Cord in Skeletal Muscle
(A)
0.0
0.2
0.4
0.6
0.8
1.0  Fat
 5 % Spinal Cord in Fat
(B)
500 550 600 650 700 750 800
0.0
0.2
0.4
0.6
0.8
1.0
Wavelength (nm)
 Vertebrae
 5 % Spinal Cord on Vertebrae
(C)
A
ve
ra
ge
 F
lu
or
es
ce
nc
e 
In
te
ns
ity
 (a
.u
.)
A
ve
ra
ge
 F
lu
or
es
ce
nc
e 
In
te
ns
ity
 (a
.u
.)
 
Figure 7.4.  Assessment of the detection sensitivity of 5% surface area of bovine spinal cord 
in the presence of (A) skeletal muscle, (B) fat and (C) vertebrae.  Excitation and emission 
conditions are as above.  A surface area of 5 % spinal cord can be detected in presence of 
skeletal muscle, fat and vertebrae based upon fluorescence spectral shape and intensity.  
Detection sensitivity is given in table 7.1.  
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 Lipofuscin is a high molecular weight granular yellow-brown substance which is 
believed to result from “oxidative stress” of many biomolecules particularly polyunsaturated 
fatty acids.  It is heterogeneous, highly fluorescent and undergoes age-related progressive 
accumulation in animal cells, mainly in postmitotic cells, such as neurons, cardiac muscles 
and retinal epithelium.  Lipofuscin is implicated in many aspects of normal health, including 
aging, oxidative stress, macular degeneration, lipid peroxidation, as well as some disease 
processes including atherosclerosis, dementia (Alzheimer’s Disease) and prion diseases.25-
30,37-40
 
We observed in this study, that spectra obtained from all solid bovine CNS and non-
CNS tissue samples were not contaminated by the artifacts of scattered light.  This was 
consistent with previous findings showing the occurrence of lipofuscin in high concentrations 
in brain and spinal cord.31  Our investigation included male and female cattle at the age of 2 
to 72 months. Since 24-month-old bovines represent the largest contingent of slaughtered 
beef cattle in the U.S. 41, special care was taken to include samples of animals of this age in 
every part of the validation studies.  We conclude that the detectability of the fluorescence 
signal is not affected by nonhomogeneous distribution of lipofuscin that might be age or sex 
dependent or be observed in different anatomical regions.  This is consistent with the 
chemical stability of lipofuscin.25  To give a more detailed analysis of possible age related 
variations in signal intensity, experiments are underway investigating a large number of age, 
sex and breed matched samples.  We also found that characteristic CNS tissue fluorescence 
spectra and intensities could be reliably detected after storage at -20°C for at least 8 weeks 
(data not shown) indicating that there is no significant alteration with regard to storage time.  
This observation is of special importance for the analysis of possible CNS contamination on 
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meat cuts processed from frozen beef. 
The shape of the spectra collected from spinal cord and brain were not tissue specific, 
but could also be found in PNS tissues, liver, kidney, heart and lymph node.  In contrast, 
lung, adrenal gland, skeletal muscle, bone marrow, spleen and vertebrae could be clearly 
distinguished with respect to relative peak intensity and in some cases also peak positions.  
However, the average fluorescence signal intensity of PNS and non-CNS tissues (except 
kidney and liver) is at least 4-5 times less than that in CNS tissues, offering the potential for 
the detection of low amounts of spinal cord and brain tissues on bovine carcasses based on 
different intensities.  The presence of spinal cord on skeletal muscle, fat and vertebrae can 
also be determined by the different spectral features.  
We focused on the detection sensitivity of spinal cord and the possible influence of 
different background tissues.  Characteristic spectra of spinal cord were reliably detected 
down to a sample size of ~0.1 cm x 0.1 cm.  It is noteworthy that this low detection 
sensitivity would also enable the detection of the small dorsal root ganglia and peripheral 
nerve cords.  Dorsal root ganglia have been classified as SRM and peripheral nerves have 
been shown to contain low amounts of PrPBSE in BSE affected cattle.42,43  During slaughter, 
spinal cord fragments are easily spread over skeletal muscle, fat and vertebrae, making those 
tissues the most important non-CNS tissues that had to be included in the present study.  It 
should be noted that the fluorescent signal collected from 5% surface area of spinal cord and 
detected in 70% (skeletal muscle, fat) or 80% (vertebrae) of the samples, respectively, was 
not caused by the entire amount of fluorescent substances present in the sample, but only the 
amount in the two-dimensional (2D) area exposed to the excitation light.  This method does 
not allow the comparison with CNS percentage values, which are usually used for semi-
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quantitative measurements by ELISA or real time-PCR methods.  The latter test systems 
refer to the amount of target material contained in the total initial weight and use the three-
dimensional (3D) analysis of the entire sample.  Therefore, the real time-PCR based 
detection of GFAP mRNA16,17 was selected to investigate the quality of the artificially 
contaminated samples.  This method had previously shown its accuracy and robustness in a 
multi-center trial.44 Its high tissue specificity and the potential for accurate quantification of 
CNS tissues were proven recently in direct comparison with two commercially available 
ELISAs.45  Since all skeletal muscle and fat tissues were free of CNS tissues as confirmed by 
PCR analysis, it was proven that the spectra obtained from these tissues were not due to CNS 
contamination.  As indicated by the CT values all artificially spiked samples were 
homogenous preparations containing an entire amount of spinal cord ranging from 5% in 
muscle to 7% in fat.  In comparison, semi-quantitative measurements of spinal cord 
contamination on bovine carcasses varied from 0.5% 46 to more than 1% (data not shown).  
Since the front-faced experiment collects the fluorescence of the CNS tissue located only on 
a sample surface, the detection sensitivity obtained by fluorescence spectroscopy is actually 
lower than the detection sensitivity reported by real time PCR analysis.  
The fluorescence spectra of fat and vertebrae not only differed in signal intensity, but 
also in shape.  As a consequence, the potential to lower the detection sensitivity can be easily 
achieved.  Similarly, the sensitivity for detection of spinal cord in the presence of skeletal 
muscle can possibly be increased by comparing the fluorescence signal intensity ratio 
between the second and the third peak.  The third peak always gave lower signal intensity in 
spinal cord, but a higher intensity in skeletal muscle. 
The present study revealed the potential of fluorescent marker substances, such as 
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lipofuscin, for the real-time detection of spinal cord on bovine carcasses and processed meat 
cuts including bone-in or boneless products.  The front-faced experiments were conducted 
with a well standardized, but technologically simple setup that allowed the detection of small 
amounts of bovine spinal cord in the presence of fat, skeletal muscle and vertebrae.  Our 
future work will focus on the development of industrial prototypes such as a hand-held 
device or entire carcass imaging.  Future focus will be on complex mixtures of CNS tissues 
with background tissues obtained from skeletal muscle, fat and sawdust of vertebrae and 
other bones.  Real-time monitoring for possible CNS contamination during slaughter would 
provide an additional, science-based tool for sanitation procedures for the removal of SRM at 
the abattoir.  A benefit to the beef producing industry would be improved product quality 
assurance and would result in increased consumer protection.  
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CHAPTER 8.  FLUORESCENCE SPECTROSCOPY OF THE RETINA FOR 
DIAGNOSIS OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES 
 
A paper published in Analytical Chemistry 
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Abstract 
The feasibility of exploiting fluorescence spectra of the eye for diagnosis of 
transmissible spongiform encephalopathies (TSEs) was examined.  Retinas from scrapie-
positive sheep were compared with scrapie-negative sheep using fluorescence spectroscopy 
and distinct differences in the fluorescence intensity and spectroscopic signatures were 
observed.  The characteristic fluorescent signatures are thought to be the result of an 
accumulation of lipofuscin in the retina.  It appears that the eye, in particular the retina, is a 
useful tissue for noninvasive examination of some neurological pathologies such as scrapie. 
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The development of procedures based on examinations of the eye that permit the detection of 
neurological disorders in animals holds great promise.  
Introduction  
Neurological disorders of the central and peripheral nervous system are caused by a 
disease, trauma, or injury to the nervous system.  They can be difficult to treat and often are 
debilitating.  Transmissible spongiform encephalopathies (TSEs) are one of many other well 
known neurological disorders such as Parkinson’s disease, Alzheimer’s disease, 
Huntington’s disease, systematic amyloidosis and  maturity-onset diabetes that involve 
accumulation of extracellular aggregates leading to tissue damage and disease.1-4  TSEs are 
slowly progressive, insidiously degenerative diseases that affect the central nervous system 
(CNS) of both humans and animals and are usually accompanied by the production of 
“spongiform” changes in the brain. TSEs are believed to be transmitted by abnormal 
proteins, which are resistant to enzymatic degradation, called prions and in the case of 
scrapie, designated as PrPsc.5   
The TSE of most concern for the food supply is bovine spongiform encephalopathy 
(BSE), a fatal neurodegenerative transmissible disease in cattle.  It is thought to be associated 
with variant  Creutzfeldt-Jakob disease (vCJD) in humans.6  The oral route of infection is 
considered to be the most probable path for transmission of BSE to humans.7,8  In order to 
reduce the risk of human exposure, specified risk material (SRM, e.g. brain and spinal cord) 
from cattle is removed during slaughter and processing.  Prohibition of SRM in the human 
food chain is considered of critical importance for protection of consumers from BSE.9,10  
Regulations regarding SRM have been promulgated by the European Commission (Annex V 
Commission Regulation (EC) No. 999/2001) and for the United States by the Food Safety 
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and Inspection Service (99 CFR 310.22).  Many other countries have also banned bovine 
CNS tissues from meat products and its presence is cause for import rejection and 
international trade disputes.  Developing technology for monitoring CNS tissue in meat and 
other food products as well as for diagnosing animals for TSEs will be increasingly important 
in securing the safety of the world’s food supply.  
Fluorescence spectroscopy has been commonly used in a variety of biological 
applications, and its feasibility for the detection of fecal contamination by exploiting 
fluorescent chlorophyll metabolites on meat during slaughter has been previously reported.11  
Instruments developed for this application are currently being used to screen carcasses in real 
time at beef processing plants in the United States and France.  A similar approach can be 
applied to CNS detection by exploiting lipofuscin, a highly fluorescent, heterogeneous, high-
molecular weight material that has been shown to accumulate in high concentrations in 
neural tissues.12-17  Our previous work has shown that brain and spinal cord samples display 
highly conserved spectral characteristics and these characteristics have potential for use in 
meat processing applications.18-20  We have investigated the spectra and spectral intensities of 
the two most important SRM tissues (brain and spinal cord) and compared the data to non-
CNS tissues.  Based upon a study of the spectral signatures of CNS tissue, we have 
previously suggested the development of devices for detecting CNS tissue in meat products 
by the rapid monitoring of fluorescence spectra.19  It is known that the amount of fluorescent 
lipofuscin in CNS tissue increases as a result of spontaneous and experimentally induced 
Creutzfeldt-Jakob’s disease (CJD).  Boellaard et al. have demonstrated a relationship 
between lipofuscin production, a decline in autophagocytosis activity, and the experimental 
induction of CJD in mice.13  Furthermore, there is substantial documentation linking 
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neurological disease produced by TSEs to eye damage and the accumulation of 
lipofuscin.13,21-28   
In this work, we investigate the use of fluorescence spectroscopy of the retina to 
identify scrapie, which we use as a model for TSEs.  Scrapie is the most widespread TSE 
affecting sheep and goats worldwide.  It is characterized by a gradual onset; and advanced 
cases show typical disease characteristics including unthriftiness, compulsive itching, 
balance and ambulatory abnormalities, convulsions, and eventual death.  The disease has 
been observed for centuries.  At present, it is incurable and the most common form of control 
is quarantine, euthanasia, and proper disposal of the carcass.  Scrapie is not considered to be 
infectious to humans. 
While several research groups are actively involved in developing spectral 
examinations of the eye to assess the extent of macular degeneration and other abnormalities 
27-35, to our knowledge, few have reported on the use of the retinal scans for this particular 
pathological application.25,26,36,37  The objective of this work is to find spectral signatures of 
intrinsic fluorescent markers of eye that can provide a nonlethal and noninvasive means of 
determining if a living animal is infected with a TSE.  Our experiments were designed to 
address the following questions:  1. Can spectra obtained from the eye be used for 
identification of neurological disease?   2. Can the effects of neurological disease observed in 
the eye be distinguished from those associated with normal aging? 3. Can images of the eye 
be obtained that report on neurological disease?  With these questions in mind we have now 
extended previous work and investigated fluorescence spectroscopy of the retina for potential 
diagnosis of neurological disease.  Our investigations, which have focused on scrapie-
positive and scrapie-negative sheep, suggest that the retina is a most promising part of the 
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eye for revealing spectroscopic signatures indicative of neurological disease. 
Materials and Methods 
Materials.  DAKO™ Target Retrieval Solution and biotinylated anti-mouse IgG 
(made in horse) were obtained from DAKO Corp., Carpinteria, CA and Vector Laboratories, 
Burlingame, CA respectively. Basic Alkaline Phosphatase Red Detection Kit and NexES 
IHC modules were acquired from Ventana Medical Systems, Inc., Tucson, AZ.  All other 
chemicals used for pathological procedures were obtained from Sigma Aldrich.   
Animal tissue samples.  Tissue samples from both scrapie-positive and scrapie-
negative sheep were obtained from several sources.  Samples from 73 sheep were collected 
for the study for a total of 140 eyeballs.  In some cases only one eye was collected from the 
animals sampled.  Both positive and negative tissue samples were harvested according to a 
standardized necropsy procedures from sheep identified through the National Scrapie 
Surveillance Plan administered by the Animal and Plant Health Inspection Service (APHIS), 
United States Department of Agriculture (USDA).38  Samples were also obtained from the 
Caine Veterinary Teaching Center, University of Idaho, Caldwell, ID.  The identity of 
individual producers if known has been withheld.  Scrapie-negative tissue samples were also 
obtained locally from sheep at the National Animal Disease Center (NADC), Ames, IA.  All 
procedures relating to the care and experimental use of live sheep used on site at NADC were 
approved by the NADC Institutional Animal Care and Use Committee.  Information 
regarding breed, age, and sex was also obtained for each tissue sample used in this study (see 
Table S-1 in the supporting information). 
Disease diagnosis.  All animals were diagnosed for scrapie infection status using 
conventional pathological methods.  To obtain brain tissue, the disarticulated heads of sheep 
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were split near sagittal midline with a bandsaw.  Each half of the brain was carefully 
removed from the calvarium and one of the halves was immersion fixed in 10% neutral 
buffered formalin for 2-3 weeks.  The formalin-fixed brain was cut into 2-4 mm wide coronal 
sections at four levels: 1) brainstem at the obex, 2) cerebellum at mid-level lateral lobe, 3) 
midbrain at the rostral colliculus, and 4) hippocampus and adjacent cerebral cortex.  The 
tissue blocks were placed in histopathology cassettes, dehydrated, and embedded in paraffin 
wax.  Paraffin-embedded tissues were sectioned to 5 µm thickness, affixed to charged glass 
slides, and stained with hematoxylin and eosin (HE) for examination by light microscopy or 
left unstained for immunohistochemistry (IHC) processing.  
An automated IHC method for detection of infectious prion protein (PrPsc) was used 
as described previously.39  In brief detail, following deparaffinization in xylene and 
rehydration through gradations of alcohol to water, tissue sections were autoclaved (121°C, 
1.38 x 105 Pa) for 30 minutes in an antigen retrieval solution and labeled with an indirect 
avidin biotin system designed for an automated immunostainer. The primary antibody was a 
cocktail of 2 monoclonal antibodies, F89/160.1.5 40 and F99/97.6.1 41, each used at a 
concentration of 5 µg/ml, and incubation was carried out at 37°C for 32 min.  The secondary 
antibody was biotinylated anti-mouse, diluted 1:200.  The preparation was incubated for 8 
min at 37°C.  
Sample preparation.  The eyeballs collected were stored frozen until use.  After 
thawing, the eyeballs were dissected; and the retina or other eye tissue was removed and 
placed on a plain glass microscope slide (25 x 75 x 1 mm).  The retina, in particular was 
oriented as a thin layer on the microscope slide enabling the entire area of the sample to be 
exposed to the excitation light.   
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Steady-State measurements.  Steady-state fluorescence spectra were obtained on a 
SPEX Fluoromax-2 (ISA Jobin-Yvon/SPEX, Edison, NJ) with a 5-nm band-pass unless 
otherwise specified and corrected for lamp spectral intensity and detector response.  
Fluorescence spectra were collected in the front-faced orientation. For the experiments 
reported in this study, the samples were excited at λex = 470 nm with an interference filter on 
the excitation side, and emission was collected at λem ≥ 505 nm using a cutoff filter before 
the detector to eliminate scattered light.  Polarized fluorescence spectra were obtained using 
two polarizers, with one on the excitation side and another on the emission side with the 
appropriate excitation interference and cut-off emission filters.  Fluorescence spectra were 
obtained using horizontal-horizontal (HH) and horizontal-vertical (HV) orientations of the 
polarizers. 
Hyperspectral fluorescence imaging microscopy.  The hyperspectral images were 
captured on a system located in the Roy J. Carver Laboratory for Ultrahigh Resolution 
Biological Microscopy, Iowa Sate University.  This system was based on a NIKON 
ECLIPSE TE 2000-E microscope. The illumination source was an X-Cite 120 PC from 
EXFO.  Samples were excited at 470 nm using an interference filter, and fluorescence was 
collected at ≥ 500 nm with a longpass filter and a Nikon Plan Fluor 10X/0.30 PH1-DL 
objective. The collected fluorescence was dispersed using a Spectral-DV spectrometer from 
Optical Insights and captured by a Photometrics Cascade 512 B CCD camera (Roper 
Scientific). Software used for image capture was Mélange V3.7.  
Results and Discussion 
 
We studied a total of 140 sheep eyeballs from 73 animals obtained from several 
sources. Thirty five of the animals were scrapie-positive and 38 of the animals were scrapie-
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negative.  In the sheep identified as scrapie-negative, there was no evidence of spongiform 
change or other significant lesions, as assessed by microscopic examination of hemotoxylin 
and eosin stained brain sections.  Likewise, there was no labeling indicative of PrPsc seen in 
brain tissue sections examined following IHC (immunohistochemical) processing.  
Conversely, in sheep diagnosed as scrapie-positive, the observation of both lesions and IHC 
labeling confirmed a positive diagnosis for scrapie.   
Fluorescence spectra from various parts of the sheep eye (cornea, iris, lens layer, lens 
gel, lens, vitreous humor, retina, tapetum, optic nerve, and sclera) were obtained at different 
excitation wavelengths using a fluorometer in a front-faced geometry.  The retina (and the 
sclera) show large differences in spectral features when comparisons are made between 
scrapie-negative and scrapie-positive samples.  The sclera is the protective tissue that covers 
the entire eyeball except the cornea.  The retina is the preferred part of eye for noninvasive 
diagnosis of TSE affected animal because it can be directly accessed by light to excite the 
pigments, in contrast with the sclera.  Front-faced fluorescence spectra of solid retina 
samples from scrapie-negative and scrapie-positive sheep excited at 470 nm are presented in 
Figure 8.1.  The data indicate that fluorescence spectra from eyes (especially the retina) are 
very rich and vary considerably with excitation wavelength (λex).  When λex = 470 nm, the 
fluorescence intensity of the scrapie-positive retinas is significantly greater than that of 
scrapie-negative sheep.  The spectra from scrapie-positive samples were also more structured 
and displayed two intense peaks at ~560 and ~600 nm with a shoulder at ~525 nm.  The 
scrapie-positive samples also displayed a minimum at ~575 nm.  The literature indicates that 
TSE is caused by an accumulation of protease-resistant prions in central nervous system 
tissues such as brain, spinal cord, and eye.5  It is also known that lipofuscin accumulation 
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occurs in diseased eye (e.g., in retinal pigment epithelium).42-48 The spectral differences in 
scrapie-positive retinas compared to scrapie-negative retinas can be attributed to the result of 
altered or increased lipofuscin owing to prion infection.  
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Figure 8.1.  Fluorescence spectra of the retina from scrapie-negative and scrapie-positive 
sheep.  Comparison of (a) scrapie-negative and (b) scrapie-positive sheep retinas at λex = 470 
nm.  Representative, different, front-faced fluorescence spectra from eight individual retinas 
are shown for each scrapie-negative and scrapie-positive animal.  Note that the intensity 
values are in the same range for both data sets on the primary graphs. The inset graph for the 
scrapie-negative data uses an expanded ordinate.  Significant differences of fluorescent 
intensity exist between the two data sets. 
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Given the pronounced structural differences observed in the spectra of the scrapie-
positive tissue, additional control experiments were undertaken to ensure that these data were 
not an experimental artifact, since spectra were collected from solid samples, which may 
have contributed to excessive light scattering.  Although spectral structure was not 
pronounced in the scrapie-negative samples, it was necessary to determine that the results 
were independent of the polarization of the excitation radiation.  The data in Figure 8.2 
demonstrate that the spectra observed were, indeed, independent of polarization.  We suggest 
that these spectral differences are the result of neurological disease or in this case, scrapie.  
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Figure 8.2.  Polarized fluorescence spectra from a scrapie-positive sheep. Spectra were 
collected in a front-faced orientation. Samples were excited at 470 nm with an interference 
filter in the excitation light path, and fluorescence was collected after 505 nm with a long 
pass filter.  In order to determine whether the observed structure is due to scattered light, the 
experiments were conducted with two polarizers in either of two positions: HH (horizontal 
excitation/horizontal emission) or HV (horizontal excitation/vertical emission).  The data 
indicate that the spectral structure observed is authentic and not an artifact.    
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It has been reported that the intracellular fluorescent pigment lipofuscin accumulates 
in the retina with increasing age.49-51   It is important to distinguish the spectral differences 
arising from scrapie with respect to those arising from normal aging.  A plot of integrated 
fluorescence intensity obtained from both scrapie-positive and scrapie-negative sheep retinas 
as a function of age is shown in Figure 8.3.  Samples were obtained from sheep up to 9 years 
of age.  The data indicate clear differences, with the scrapie-positive retinas being more 
fluorescent than those from the scrapie-negative retinas.  The differences in total 
fluorescence due to disease status greatly exceed any differences that result from other 
factors, such as age.  
In addition, hyperspectral fluorescence microscopy was used to compare images of 
retinas with respect to disease status.  Representative images from different regions of sex- 
and age-matched retinas for scrapie-negative and scrapie-positive sheep are displayed in 
Figure 8.4.  The scrapie-positive retina shows significantly higher fluorescence intensity as 
opposed to the scrapie-negative retina, as indicated by the grayscale intensity gradient of the 
images.  This result is also consistent with the data presented in Figures 8.1 and 8.3 
indicating that the scrapie-positive retinas are more fluorescent than those of scrapie-negative 
retinas.  The scrapie-positive images also contain aggregates of fluorescent material, as 
indicated by the arrows in Figure 8.4 and are more heterogeneously fluorescent.  In contrast 
the scrapie-negative tissue is more homogeneous and is weakly fluorescent.  This further 
supports our observations from front-faced fluorescence spectra that scrapie-positive retinas 
show higher fluorescence with prominent structure.  From this comparison of age-matched 
retinas, we conclude that the scrapie-positive retinas contain very bright regions of highly 
fluorescent material, which is suggestive of neurological damage as a result of disease.   
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Figure 8.3.  Plot of the integrated fluorescence intensity from scrapie-positive and scrapie-
negative sheep retinas as a function of age.  All points represent multiple spectroscopic 
determinations with standard error bars.  Those with visible error bars are an average of 4-12 
experimental replications.  The remaining data points with error bars smaller than the symbol 
are with N = 2.  Fluorescence spectra were collected as described in a front-faced orientation.  
For all experiments, samples were excited at 470 nm with an interference filter in the 
excitation light path, and fluorescence was collected at wavelengths greater than 505 nm to 
eliminate scattering.  Note that the differences in total fluorescence due to disease status 
greatly exceed any differences that result from age. 
 
Others have reported observations that support this current research.  Recently Smith 
et al. have shown that the function and morphology of retinas are altered in TSE-infected 
cattle and sheep infected with scrapie.25,26  Hortells et al. concluded that PrPsc  in the retina 
was highly correlated with the occurrence of scrapie 27 whereas Rubenstein et al. used 
ultraviolet fluorescent spectroscopy to detect different forms of PrPsc   in the eye.28  Fundus 
autofluorescence has also been investigated for possible diagnostic use in a large number of 
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retinal diseases 33,35 including the “conformational diseases” caused by accumulation of 
proteinaceous aggregates.34  Autofluorescence has also been used to map lipofuscin 
distribution in the retina of humans.33  In this study we have not determined the specific 
structures that are responsible for the fluorescence but others have suggested that lipofuscin 
and other macromolecular aggregates are responsible.27,34 
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Figure 8.4.  Hyperspectral fluorescence images of the retina of sheep.  Representative 
images from different regions of sex- and age-matched (31 months) (A) scrapie-negative and 
(B) scrapie-positive sheep retinas.  The samples were excited at 470 nm using an interference 
filter, and fluorescence was collected at wavelengths greater than 500 nm using a long-pass 
filter.  The images shown are 800 microns by 800 microns.  All images were captured under 
identical conditions.  High intensity is represented by white; low intensity, by black on a 
grayscale gradient.  Note the more intense fluorescence and aggregation of fluorescent 
material in the scrapie-positive images.  
 
Conclusion 
Given our results, we suggest that the distinct differences in the spectral signatures of 
the retina are diagnostic of animals naturally infected with scrapie.  We further suggest that 
the eye, and in particular the retina, will be a useful tissue for noninvasive determination of 
neurological pathologies such as scrapie.  
 
  
253 
Acknowledgement 
We thank Dr. Michelle Crocheck, Matt Inbody, Bob Morgan, Deb Lebo, Bob Doyle, 
Curtis Mosher and Dr. Eric Nicholson for their assistance in obtaining and analyzing the 
animal tissue samples.  Part of this work was supported by DOD contract DAMD17-03-1-
0460.    
References  
 (1) Kelly, J. W. Structure 1997, 5, 595. 
 (2) Tan, S. Y.; Pepys, M. B.; Hawkins, P. N. Am. J. Kidney Dis. 1995, 26, 267. 
 (3) Sunde, M.; Serpell, L. C.; Bartlam, M.; Fraser, P. E.; Pepys, M. B.; Blake, C. 
C. F. J. Mol. Biol. 1997, 273, 729. 
 (4) Conway, K. A.; Harper, J. D.; Lansbury, P. T. J. Biochemistry 2000, 39, 2552. 
 (5) Prusiner, S. B. Proc. Natl. Acad. Sci. USA 1998, 95, 13363. 
 (6) Ironside, J. W. Brain Pathol. 1996, 6, 379. 
 (7) Cousens, S.; Smith, P. G.; Ward, H.; Everington, D.; Knight, R. S.; Zeidler, 
M.; Stewart, G.; Smith-Bathgate, E. A.; Macleod, M. A.; Mackenzie, J.; Will, R. G. Lancet 
2001, 357, 1002. 
 (8) Comer, P. J.; Huntly, P. J. Stat. Methods Med. Res. 2003, 12, 279. 
 (9) (EFSA), E. F. S. A. “Quantitative Assessment of the Residual BSE Risk in 
Bovine-Derived Products, EFSA QRA Report 2004 - working document,” 2005. 
 (10) Evaluation of the Potential for Bovine Spongiform Encephalopathy in the 
United States, 2001; Harvard Center of Risk Analysis, Harvard School of Public Health, and 
Center of Computational Epidemiology, College of Veterinary Medicine, Tuskegee 
University, 2001; Vol. 2001; available at 
  
254 
http://www.fsis.usda.gov/Science/Risk_Assessments/. 
 (11) Ashby, K. D.; Wen, J.; Chowdhury, P.; Casey, T. A.; Rasmussen, M. A.; 
Petrich, J. W. J. Agric. Food Chem. 2003, 51, 3502. 
 (12) Yin, D. Free Radical Biol. Med. 1996, 21, 871. 
 (13) Boellaard, J. W.; Schlote, W.; Tateishi, J. Acta Neuropathol. 1989, 78, 410. 
 (14) Terman, A.; Brunk, U. T. Acta Pathol., Microbiol., Immunol. 1998, 106, 265. 
 (15) Tsuchida, M.; Miura, T.; Aibara, K. Chem. Phys. Lipids 1987, 44, 297. 
 (16) Curtis, H. J. Biological Mechanisms of Aging; Charles C. Thomas: 
Springfield, IL, 1966. 
 (17) Strehler, B. L. Time, Cells, and Aging; Academic Press: San Diego, 1977. 
 (18) Chowdhury, P. K.; Halder, M.; Choudhury, P. K.; Kraus, G. A.; Desai, M. J.; 
Armstrong, D. W.; Casey, T. A.; Rasmussen, M. A.; Petrich, J. W. Photochem. Photobiol. 
2004, 79, 21. 
 (19) Schönenbrücher, H.; Adhikary, R.; Mukherjee, P.; Casey, T. A.; Rasmussen, 
M. A.; Maistrovich, F. D.; Hamir, A. N.; Kehrli, M. J.; Richt, J.; Petrich, J. W. J. Agric. Food 
Chem. 2008, 56, 6220. 
 (20) Adhikary, R.; Schonenbrucher, H.; Rasmussen, M. A.; Casey, T. A.; Hamir, 
A. N.; Kehrli, M. E.; Richt, J. A.; Petrich, J. W. Photochem. Photobiol. 2009, 85, 1322. 
 (21) Foncin, J. F.; Gaches, J.; Le Beau, J. Rev. Neurol. (Paris) 1964, 111, 507. 
 (22) Jacobson, S.; Koenig, H.; Ross, E. J. Neuropathol. Exp. Neurol. 1967, 22, 
152. 
 (23) Kirschbaum, W. R. Jakob-Creutzfeldt disease; Elsevier: Amsterdam, New 
York, 1968. 
  
255 
 (24) Miyashita, M.; Stierstorfer, B.; Schmahl, W. J. Vet. Med. B 2004, 51, 209. 
 (25) Smith, J. D.; Greenlee, J. J.; Hamir, A. N.; Richt, J. A.; Greenlee, M. H. W. 
Vet. Pathol. 2009, 46, 810. 
 (26) Smith, J. D.; Greenlee, J. J.; Hamir, A. N.; Greenlee, M. H. W. Vet. Rec. 2009, 
165, 179. 
 (27) Hortells, P.; Monzon, M.; Monleon, E.; Acin, C.; Vargas, A.; Bolea, R.; 
Lujan, L.; Badiola, J. J. Brain Res. 2006, 1108, 188. 
 (28) Rubenstein, R.; Gray, P. C.; Wehlburg, C. M.; Wagner, J. S.; Tisone, G. C. 
Biochem. Biophys. Res. Commun. 1998, 246, 100. 
 (29) Holz, F. G.; Bellman, C.; Staudt, S.; Schutt, F.; Volcker, H. E. Invest. 
Ophthalmol. Vis. Sci. 2001, 42, 1051. 
 (30) Smith, R. T.; Nagasaki, T.; Sparrow, J. R.; Barbazetto, I.; Koniarek, J. P.; 
Bickmann, L. J. J. Biomed. Opt. 2004, 9, 162. 
 (31) Delori, F. C. Arch. Biochem. Biophys. 2004, 430, 156. 
 (32) Schweitzer, D.; Hammer, M.; Schweitzer, F.; Anders, R.; Doebbecke, T.; 
Schenke, S.; Gaillard, E. R. J. Biomed. Opt. 2004, 9, 1214. 
 (33) Schmitz-Valckenberg, S.; Holz, F. G.; Bird, A. C.; Spaide, R. F. Retina J. 
Retinal Vitreous Dis. 2008, 28, 385. 
 (34) Surguchev, A.; Surguchov, A. Brain Res. Bull. 2010, 81, 12. 
 (35) Smith, R. T.; Gomes Nuno, L.; Barile, G.; Busuioc, M.; Lee, N.; Laine, A. 
Invest. Ophthalmol. Vis. Sci. 2009, 50, 3907. 
 (36) Smith, J. D.; Greenlee, J. J.; Hamir, A. N.; West Greenlee, M. H. J. Comp. 
Pathol. 2008, 138, 12. 
  
256 
 (37) Greenlee, J. J.; Hamir, A. N.; Greenlee, M. H. W. Vet. Pathol. 2006, 43, 733. 
 (38) National Scrapie Surveillance Plan; APHIS, USDA, 2008; access at 
http://www.aphis.usda.gov/vs/nahss/sheep/national_scrapie_surveillance_plan_08192008.pdf
. 
 (39) Hamir, A. N.; Kunkle, R. A.; Richt, J. A.; Miller, J. M.; Cutlip, R. C.; Jenny, 
A. L. J. Vet. Diagn. Invest. 2005, 17, 3. 
 (40) O’Rourke, K. I.; Baszler, T. V.; Miller, J. M.; Spraker, T. R.; Sadler-
Riggleman, I.; Knowles, D. P. J. Clin. Microbiol. 1998, 36, 1750  
 (41) O'Rourke, K. I.; Baszler, T. V.; Besser, T. E.; Miller, J. M.; Cutlip, R. C.; 
Wells, G. A. H.; Ryder, S. J.; Parish, S. M.; Hamir, A. N.; Cockett, N. E.; Jenny, A.; 
Knowles, D. P. J. Clin. Microbiol. 2000, 38, 3254. 
 (42) Gaillard, E. R.; Atherton, S. J.; Eldred, G.; Dillon, J. Photochem. Photobiol. 
1995, 61, 448. 
 (43) Docchio, F.; Boulton, M.; Cubeddu, R.; Ramponi, R.; Barker, P. D. 
Photochem. Photobiol. 1991, 54, 247. 
 (44) Dillon, J.; Zheng, L.; Merriam, J. C.; Gaillard, E. R. Exp. Eye Res. 2004, 79, 
753. 
 (45) Mata, N. L.; Weng, J.; Travis, G. H. Proc. Natl. Acad. Sci. USA 2000, 97, 
7154. 
 (46) Boulton, M.; Docchio, F.; Dayhaw-Barker, P.; Ramponi, R.; Cubeddu, R. 
Vision Res. 1990, 30, 1291. 
 (47) Gaillard, E. R.; Zheng, L.; Merriam, J. C.; Dillon, J. Invest. Ophthalmol. Vis. 
Sci. 2000, 41, 1454. 
  
257 
 (48) Glickman, R. D. The Origin of Photo-Oxidative Stress in the Aging Eye. In 
Progress in Brain Research; Ripps, K. H. H., Wu, S., Eds., 2001; pp 699. 
 (49) Wing, G. L.; Blanchard, G. C.; Weiter, J. J. Invest. Ophthalmol. Vis. Sci. 
1978, 17, 601. 
 (50) Delori, F. C.; Staurenghi, G.; Arend, O.; Dorey, C. K.; Goger, D. G.; Weiter, 
J. J. Invest. Ophthalmol. Vis. Sci. 1995, 36, 2327. 
 (51) Mukherjee, P.; Bose, S.; Hurd, A. A.; Adhikary, R.; Schönenbrücher, H.; 
Hamir, A. N.; Richt, J. A.; Casey, T. A.; Rasmussen, M. A.; Petrich, J. W. Photochem. 
Photobiol. 2009, 85, 234. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
258 
CHAPTER 9.  GENERAL CONCLUSIONS 
Hypericin is a natural photosensitizing pigment which displays virucidal activity 
against several types of viruses as well as antiproliferative and cytotoxic effects in many 
tumor cell lines.  It has minimal dark toxicity, tumor selectivity and high clearance rate from 
the host body.  All these properties make hypericin a very promising photodynamic drug for 
the treatment of cancer and virus diseases.  Serum proteins primarily LDL binds with 
hypericin when it is administrated in the blood.  Since hypericin is aggregated in aqueous 
solution at physiological pH, interactions with the serum proteins help it to solubilize into its 
monomeric form that is crucial for its biological activity.  Literatures also show that 
photosensitizers mixed with LDL before administration lead to an increase in photodynamic 
efficiency in comparison with the administration of photosensitizers alone.  The precise 
knowledge of the interaction of hypericin with LDL is important in improving the efficiency 
of hypericin in therapeutic applications.  In chapter 3 we have shown results of interaction of 
hypericin with LDL from steady-state and time-resolved fluorescence spectroscopy.  Our 
results indicate that multiple hypericins can penetrate considerably deeply into the LDL 
molecule.  Very inefficient fluorescence quenching of hypericin by I− ions in 1:1 LDL- 
hypericin complex shows that hypericin is not exposed to the surface of LDL.  Fluorescence 
anisotropy data indicate that a single hypericin is rigidly held, and thus probably resides 
fairly deeply in LDL.  Fluorescence energy transfer from tryptophans in apoB-100 to 
hypericin is efficient.  The R0 for the hypericin-LDL complex is ~27Å.  This distance 
suggests that hypericin can be moderately close to the surface, where apoB-100 is located.  
Upon increasing the hypericin concentration, the fluorescence lifetime and quantum yield of 
hypericin decreases drastically after 1:20 LDL-hypercin, suggesting most likely the self 
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quenching of aggregated hypericin.  This indicates that up to ~ 20 nonaggregated hypericin 
molecules can enter one LDL.  The accommodation of multiple hypericins in LDL should 
not be surprising considering the diameter of LDL (~ 220 Å) and the dimensions of 
hypericin:   major axis, 10.5 Å; minor axis, 9.6 Å.  
PRODAN is a highly fluorescent hydrophobic molecule that has been used to probe 
biological system because its absorption and emission spectra are strongly dependent upon 
the polarity of its environment.  It has also been exploited to study solvation dynamics in 
polar liquids, ionic liquids, and supercritical fluids.  PRODAN based chromophores have 
been also used to probe the solvation dynamics in protein environments.  PRODAN is a 
charge-transfer chromophore that produces a substantial change in its excited-state dipole 
moment upon photoexcitation owing to the presence of an electron-donating and –
withdrawing group.  It can also emit from dual excited states (CT and LE) depending upon 
the polarity of its surrounding environment.  It has already been reported that PRODAN in a 
heterogeneous environment like reverse micelles emit from both the LE and the CT states 
due to the distribution of the chromophores to different polarity region of the reverse micelle.  
Protein environment is highly heterogamous in nature because of presence of polar, nonpolar 
and charged residues.  Our goal is to find if any chromophore capable of undergoing excited-
state photochemistry can induce artifacts into the interpretation of solvation dynamics in 
heterogeneous environments, such as a protein.  In chapter 4, we have studied the solvation 
dynamics of PRODAN in the heterogeneous environment provided by reverse micelles 
formed by sodium 1,4-bis-(2-ethylhexyl) sulfosuccinate (AOT)/n-heptane/water, and 
separated the contributions of the LE and CT states of to its solvation dynamics.  We have 
found that the LE and CT states of PRODAN solvate on different time scales in reverse 
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micelles (2 and ~ 0.4 ns, respectively), and have concluded that PRODAN’s use as a probe 
of heterogeneous environments must be used with caution.  
Curcumin is the subject of a large number of investigations in the fields of biology, 
medicine, and pharmacology owing to its profound effects on human health.  It has been 
shown that the curcumin can act as photodynamic agent particularly for the treatment of shin 
cancers, and its photodynamic action is greatly enhanced in the presence of light.  In order to 
further exploit its medicinal effects, it is important to gain a detailed level of understanding in 
the photophysics and photochemistry of curcumin.  Curcumin exists predominantly as a keto-
enol tautomer in a number of solvents with various polarities.  It follows that curcumin is 
capable of executing excited-state intramolecular hydrogen atom transfer (ESIHT) owing to 
the presence of strong intramolecular hydrogen bonding.  In chapter 5, we have demonstrated 
that curcumin undergoes excited state intramolecular hydrogen atom transfer (ESIHT) in 
methanol and ethylene glycol using ultrafast time-resolved fluorescence spectroscopy.  
Fluorescence upconversion decay traces of curcumin in methanol and ethylene glycol are 
best described with a biexponential function.  In methanol it shows ~12 ps and ~70 ps 
component with nearly equal amplitudes.  Cuccumin in ethylene glycol also exhibits 
biexponential fluorescence decay with time constants ~20 ps and ~105 ps.  However, the 
longer components in methanol and ethylene glycol show a prominent isotope effect.  The 
longer time constants are assigned as EHIST time in the respective solvents.  Solvation, in 
addition to ESIHT, is expected to play a role in the excited-state relaxation dynamics due to 
the significant dipole moment change reported for curcumin: ∆µ ~ 6.1 D.  Multiwavelength 
fluorescence upconversion results show that the short component (12-20 ps) insensitive to 
deuteration is due to solvation of excited-state curcumin.  
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 The major challenges in the application of curcumin as an effective treatment agent 
are the lack of bioavailability and severely limited stability in aqueous environments.  
Encapsulation of curcumin in surfactant micelles and binding to proteins resolve these major 
issues.  It is established that micelle-captured curcumin is well-dispersed in aqueous 
solutions, thereby increasing the bioavailability and stability significantly.  Apart from 
preventing degradation, micelles also serve as well-defined model systems for 
biomembranes.  It has been shown that a large portion of curcumin is membrane-bound in a 
biological environment.  In chapter 6 we have studied the ESIHT of curcumin in the TX-100, 
DTAB and SDS micelles.  The fluorescence upconversion transient of curcumin in each 
micelle shows a biexponential decay, with time constants of 3 – 8 ps (fast) and 50 – 80 ps 
(slow).  The slow component exhibits a pronounced isotope effect, producing a decay time 
constant of 80 – 130 ps in the micelles, which is assigned to ESIHT.  The ESIHT rate of 
curcumin in the TX-100 micelle is lower than those in the other two micellar system.  The 
hydrogen bonding between curcumin and the TX-100 surfactant may contribute to this effect.  
The fast decay component, unlike the ESIHT process, is insensitive to deuteration of 
curcumin and is attributed to solvation dynamics using results from multiwavelength 
fluorescence upconversion studies. 
Transmissible spongiform encephalopathies (TSEs) are are slowly progressive, 
insidiously degenerative diseases that affect the central nervous system (CNS) of both 
humans and animals.  The TSE of most concern for the food supply is bovine spongiform 
encephalopathy (BSE).  It is thought to be associated with variant Creutzfeldt-Jakob disease 
(vCJD) in humans.  The removal of central nervous system (CNS) tissues as part of BSE risk 
material is one of the highest priority tasks to avoid contamination of the human food chain 
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with BSE.  No currently available method enables the real-time detection of possible CNS 
tissue contamination on carcasses during slaughter.  In chapter 7 we investigate the 
fluorescence lipofuscin as a marker for the real-time detection of CNS contamination.  We 
have studied front-faced fluorescence of brain and spinal cord, and compared with 13 
different non-CNS tissues.  A comparison between the spectral intensity of CNS and various 
non-CNS tissues clearly indicates that the fluorescence intensity from brain and spinal cord is 
higher than that found for non-CNS tissues.  We have also demonstrated that small quantities 
of bovine spinal cord can be reliably detected in the presence of raw bovine skeletal muscle, 
fat, and vertebrae.  These data form the fundamental basis for the development of a prototype 
device allowing real-time monitoring of CNS tissue contamination on bovine carcasses and 
meat cuts.  
There are also no current methods which can detect TSE disease in live animals.  
Only post-mortem examinations and laboratory tests can confirm if the animal has been 
suffering from TSE disease.  Any technique which is capable of testing a live animal for TSE 
disease is of great interest.  Scrapie is the most widespread TSE affecting sheep and goats 
worldwide.  In chapter 8 we present the results from florescence spectroscopic studies of 
healthy and scrapie eye parts to identify scrapie, which we use as a model for TSEs.  Our 
data indicate that the fluorescence spectra from scrapie-positive retinas are more structured 
and intense compared to the scrapie-negative retinas.  The difference in the spectral 
properties can be attributed to the result of altered or increased lipofuscin owing to prion 
infection.  We suggest that the distinct differences in the spectral signatures of the retina are 
diagnostic for noninvasive examination of some neurological pathologies such as scrapie.  
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